
<html lang="en"     class="pb-page"  data-request-id="2557486a-94e8-4528-8aef-c6fd1a405d79"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-21;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.7b00979;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease" /></meta><meta name="dc.Creator" content="Jole  Fiorito" /></meta><meta name="dc.Creator" content="Jeremie  Vendome" /></meta><meta name="dc.Creator" content="Faisal  Saeed" /></meta><meta name="dc.Creator" content="Agnieszka  Staniszewski" /></meta><meta name="dc.Creator" content="Hong  Zhang" /></meta><meta name="dc.Creator" content="Shijun  Yan" /></meta><meta name="dc.Creator" content="Shi-Xian  Deng" /></meta><meta name="dc.Creator" content="Ottavio  Arancio" /></meta><meta name="dc.Creator" content="Donald W.  Landry" /></meta><meta name="dc.Description" content="Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased levels of the cAMP response element binding protein (CREB), a transcriptional factor involved with l..." /></meta><meta name="Description" content="Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased levels of the cAMP response element binding protein (CREB), a transcriptional factor involved with l..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 23, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00979" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00979" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00979" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00979" /></link>
        
    
    

<title>Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00979" /></meta><meta property="og:title" content="Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0011.jpeg" /></meta><meta property="og:description" content="Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased levels of the cAMP response element binding protein (CREB), a transcriptional factor involved with learning and memory processes. We previously reported potent quinoline-based PDE5 inhibitors (PDE5Is) for the treatment of Alzheimer’s disease (AD). However, the low aqueous solubility rendered them undesirable drug candidates. Here we report a series of novel PDE5Is with two new scaffolds, 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine and 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one. Among them, compound 6c, 2-acetyl-10-((3-chloro-4-methoxybenzyl)amino)-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine-8-carbonitrile, the most potent compound, has an excellent in vitro IC50 (0.056 nM) and improved aqueous solubility as well as good efficacy in a mouse model of AD. Furthermore, we are proposing two plausible binding modes obtained through in silico docking, which provide insights into the structural basis of the activity of the two series of compounds reported herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00979"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00979">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00979&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00979&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00979&amp;href=/doi/10.1021/acs.jmedchem.7b00979" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 8858-8875</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00971" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01102" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of a Novel 1,2,3,4-Tetrahydrobenzo[<i>b</i>][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jole++Fiorito">Jole Fiorito</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>¶</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeremie++Vendome">Jeremie Vendome</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol "><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Faisal++Saeed">Faisal Saeed</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Agnieszka++Staniszewski">Agnieszka Staniszewski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Zhang">Hong Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shijun++Yan">Shijun Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shi-Xian++Deng">Shi-Xian Deng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ottavio++Arancio">Ottavio Arancio</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0001-6335-164X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+W.++Landry">Donald W. Landry</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">‡</span> <span class="aff-text">Taub Institute for Research of Alzheimer’s Disease and the Aging Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Systems Biology, Columbia University Medical Center, New York, New York 10032, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Medicine, Columbia University, 650 W 168th Street, New York, New York 10032, United States</span></div><div class="corresp-info"><strong>*</strong>O.A.: E-mail: <a href="/cdn-cgi/l/email-protection#a0cfc191e0c3cfccd5cdc2c9c18ec5c4d5"><span class="__cf_email__" data-cfemail="18777929587b77746d757a7179367d7c6d">[email protected]</span></a>. Phone: +1 212 342 0533.</div><div class="corresp-info"><strong>*</strong>D.W.L.: E-mail: <a href="/cdn-cgi/l/email-protection#5b3f2c376a1b3834372e3639323a753e3f2e"><span class="__cf_email__" data-cfemail="640013085524070b081109060d054a010011">[email protected]</span></a>. Phone: +1 212 305 5838.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00979&amp;href=/doi/10.1021%2Facs.jmedchem.7b00979" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 8858–8875</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 6, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 July 2017</li><li><span class="item_label"><b>Published</b> online</span>23 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 November 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00979" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00979</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8858%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJole%2BFiorito%252C%2BJeremie%2BVendome%252C%2BFaisal%2BSaeed%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D21%26contentID%3Dacs.jmedchem.7b00979%26title%3DIdentification%2Bof%2Ba%2BNovel%2B1%252C2%252C3%252C4-Tetrahydrobenzo%255Bb%255D%255B1%252C6%255Dnaphthyridine%2BAnalogue%2Bas%2Ba%2BPotent%2BPhosphodiesterase%2B5%2BInhibitor%2Bwith%2BImproved%2BAqueous%2BSolubility%2Bfor%2Bthe%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8875%26publicationDate%3DNovember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00979"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2118</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">25</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00979" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer’s Disease&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jole&quot;,&quot;last_name&quot;:&quot;Fiorito&quot;},{&quot;first_name&quot;:&quot;Jeremie&quot;,&quot;last_name&quot;:&quot;Vendome&quot;},{&quot;first_name&quot;:&quot;Faisal&quot;,&quot;last_name&quot;:&quot;Saeed&quot;},{&quot;first_name&quot;:&quot;Agnieszka&quot;,&quot;last_name&quot;:&quot;Staniszewski&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Shijun&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Shi-Xian&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Ottavio&quot;,&quot;last_name&quot;:&quot;Arancio&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;W. Landry&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8858-8875&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00979&quot;},&quot;abstract&quot;:&quot;Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased levels of the cAMP response element binding protein (CREB), a transcriptional factor involved with learning and memory processes. We previously reported potent quinoline-based PDE5 inhibitors (PDE5Is) for the treatment of Alzheimer’s disease (AD). However, the low aqueous solubility rendered them undesirable drug candidates. Here we report a series of novel PDE5Is with two new scaffolds, 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine and 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one. Among them, compound 6c, 2-acetyl-10-((3-chloro-4-methoxybenzyl)amino)-1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridine-8-carbonitrile, the most potent compound, has an excellent in vitro IC50 (0.056 nM) and improved aqueous solubility as well as good efficacy in a mouse model of AD. Furthermore, we are proposing two plausible binding modes obtained through in silico docking, which provide insights into the structural basis of the activity of&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00979&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00979" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00979&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00979" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00979&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00979" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00979&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00979&amp;href=/doi/10.1021/acs.jmedchem.7b00979" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00979" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00979" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00979%26sid%3Dliteratum%253Aachs%26pmid%3D28985058%26genre%3Darticle%26aulast%3DFiorito%26date%3D2017%26atitle%3DIdentification%2Bof%2Ba%2BNovel%2B1%252C2%252C3%252C4-Tetrahydrobenzo%255Bb%255D%255B1%252C6%255Dnaphthyridine%2BAnalogue%2Bas%2Ba%2BPotent%2BPhosphodiesterase%2B5%2BInhibitor%2Bwith%2BImproved%2BAqueous%2BSolubility%2Bfor%2Bthe%2BTreatment%2Bof%2BAlzheimer%25E2%2580%2599s%2BDisease%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D21%26spage%3D8858%26epage%3D8875%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292580" title="Binding modes">Binding modes</a>,</li><li><a href="/action/doSearch?ConceptID=290792" title="Circuits">Circuits</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/jmcmar.2017.60.issue-21/20171109/jmcmar.2017.60.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phosphodiesterase 5 (PDE5) hydrolyzes cyclic guanosine monophosphate (cGMP) leading to increased levels of the cAMP response element binding protein (CREB), a transcriptional factor involved with learning and memory processes. We previously reported potent quinoline-based PDE5 inhibitors (PDE5Is) for the treatment of Alzheimer’s disease (AD). However, the low aqueous solubility rendered them undesirable drug candidates. Here we report a series of novel PDE5Is with two new scaffolds, 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine and 2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one. Among them, compound <b>6c</b>, 2-acetyl-10-((3-chloro-4-methoxybenzyl)amino)-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile, the most potent compound, has an excellent in vitro IC<sub>50</sub> (0.056 nM) and improved aqueous solubility as well as good efficacy in a mouse model of AD. Furthermore, we are proposing two plausible binding modes obtained through in silico docking, which provide insights into the structural basis of the activity of the two series of compounds reported herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common type of dementia and the sixth-leading cause of death in the United States. AD is a neurodegenerative disorder that compromises the ability of thinking, memory, and behavior. Senile plaques and neurofibrillary tangles, composed of amyloid-beta (Aβ) peptide and microtubule binding protein tau, respectively, are the two main pathological hallmarks of AD. To date, no effective therapies have been developed for AD and only symptomatic treatments are available.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Therefore, major efforts are ongoing to find better ways to prevent the progression of this disease. Several biological pathways have been considered for developing valid therapeutic approaches, such as Aβ-targeted strategies, tau-based therapies, oxidative stress reduction, anti-inflammatory drugs, and therapies targeting second messenger systems that are impaired by either Aβ or tau.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> However, drugs that entered the clinical trials, e.g., most recently solanezumab, bapineuzumab, and aducanumab, which are humanized anti-Aβ monoclonal antibodies, have failed to improve clinical outcomes in patients or shown to induce adverse effects, e.g., vasogenic edema, making the Aβ-removing therapy a doubtful strategy to pursue for the treatment of AD.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">Here we have focused our attention on therapies targeting the nitric oxide (NO) signaling pathway because of its relevance to learning and memory processes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Specifically, NO stimulates soluble guanylate cyclase (sGC), resulting in increased levels of second messenger cyclic guanosine monophosphate (cGMP) and activation of cGMP-dependent protein kinase (PKG), which is important for promoting the phosphorylation of the cyclic adenosine monophosphate (cAMP) response element binding protein (CREB) at its Ser133.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Phosphorylation of the CREB has been recognized as a crucial event for gene transcription during synaptic plasticity, which is one of the fundamental processes underlying learning and memory.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Targeting the NO/cGMP/PKG/CREB signaling pathway can be achieved through the inhibition of phosphodiesterases (PDEs). PDEs are a superfamily of enzymes consisting of 11 subfamilies (PDE1–11) that hydrolyze the two nucleotides cGMP and cAMP into their inactive forms. One fundamental distinction between the subfamilies is based on their different affinity for the two substrates. PDE5, 6, and 9 are cGMP-specific enzymes, PDE4, 7, and 8 are cAMP-specific enzymes, while the remaining enzymes are dual-substrate PDEs, having affinity for both cyclic nucleotides.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This superfamily of enzymes have been studied as targets for the treatment of various diseases, including erectile dysfunction, pulmonary arterial hypertension, cancer, schizophrenia, and AD.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a></div><div class="NLM_p">Over the past years, we have been interested in elucidating the involvement of the NO/cGMP/PKG/CREB signaling pathway in AD;<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> we have demonstrated that the inhibition of PDE5, which specifically catalyzes the hydrolysis of cGMP therefore reducing PKG activity, leads to an improvement of learning and memory in mouse models of AD.<a onclick="showRef(event, 'ref6 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref6 ref17 ref18">(6, 17, 18)</a> Previous research in our laboratories led to a novel series of quinoline inhibitors of PDE5 (PDE5Is) represented by compound <b>1</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Compound <b>1</b> is a potent and selective PDE5 inhibitor as determined by an in vitro enzymatic assay [IC<sub>50</sub> (PDE5) = 0.270 nM, IC<sub>50</sub> (PDE6) = 0.339 μM]. When dosed at 3 mg/kg, an elevation of cGMP in the hippocampus of mice was observed. Moreover, compound <b>1</b> rescues learning and memory as shown by a pharmacological treatment of two different AD mouse models.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> However, a turbidimetric (kinetic) solubility screening revealed that compound <b>1</b> has a low water solubility (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). This poor physicochemical property precluded the advancement of <b>1</b> into additional preclinical studies.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of compound <b>1</b> and new PDE5Is, 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine (scaffold A) and 2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (scaffold B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the course of our drug discovery program, we have also discovered other classes of heterocyclic PDE5Is, derived from compound <b>1</b> and represented by scaffolds A and B (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). The two scaffolds were designed by locking the rotatable bonds of the hydroxymethyl group of compound <b>1</b> into a ring. By rigidifying the conformation of the parent compound, we sought to improve the potency and selectivity of the new molecules. We then decided to investigate these new chemical entities with the aim to find a suitable lead compound. Herein, we report the design and synthesis of 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine (scaffold A) and 2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (scaffold B) ligands and their enzymatic activity. Notably, we could identify a PDE5 inhibitor, compound <b>6c</b>, that displays enhanced potency, retained selectivity, and improved water solubility with respect to compound <b>1</b>, as well as in vivo pharmacological efficacy in the APP/PS1 double transgenic mice<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> that manifest aberrant accumulation of human Aβ driven by mutations in APP<sub>695</sub><sup>K670N/M671L</sup> and PS1<sup>M146L</sup>. Additionally, we identified two plausible binding modes in the same pocket using in silico docking, which provides insights into the structural basis of the activity of the new series of compounds reported here. The validation of one of these binding modes as well as its usage for further optimization of the herein reported compounds via a structure-based approach are to be pursued in a following study.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">As the first step, we targeted the synthesis of a set of tricyclic analogues <b>6a</b>–<b>g</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), <b>10</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), and <b>13a</b>–<b>d</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). As show in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, 2-amino-5-cyanobenzoic acid <b>4</b> was prepared via the cyanation of methyl bromobenzoate <b>2</b> with copper cyanide<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(20)</a> followed by hydrolysis under basic conditions of ester <b>3</b>. For the synthesis of the 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine core, a condensation reaction was used to synthesize intermediates <b>5a</b>–<b>d</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(21)</a> Specifically, the reaction of <b>4</b> with the appropriate <i>N</i>-substituted piperidin-4-one in POCl<sub>3</sub> gave <b>5a</b>–<b>d</b> in moderate yields (21–55%). Then, 3-chloro-4-methoxibenzylamine was introduced on the tricyclic ring of <b>5a</b>–<b>c</b> via nucleophilic substitution to obtain the final compounds <b>6a</b>–<b>c</b>. Similarly, compounds <b>6d</b>–<b>f</b> were obtained by using the corresponding commercially available benzylamines (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for details). For the synthesis of compound <b>6g</b>, (3-chloro-5-fluoro-4-methoxyphenyl) methanamine hydrochloride (<b>10</b>) was prepared starting from the benzaldehyde <b>7</b>, which was initially reduced into benzyl alcohol <b>8</b> via a reduction reaction using NaBH<sub>4</sub>. Subsequently, benzylamine <b>10</b> was obtained by following the Gabriel synthesis procedure (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The synthetic route followed to prepare compound <b>14</b> was slightly different than the one used for synthesizing <b>6a</b>–<b>g</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Intermediate <b>5d</b> was first dealkylated by using α-chloroethyl chloroformate (ACE-Cl); subsequently, after protecting the aliphatic nitrogen of <b>11</b> with a Boc group, the synthesis of <b>13</b> was accomplished via the same nucleophilic substitution reaction conditions used for compounds <b>6a</b>–<b>g</b>. Finally, removal of the Boc group gave the desired analogue <b>14</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>6a</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) CuCN, NMP, 200 °C, 4 h; (ii) 1 M EtOH/KOH, 50 °C, 2 h; (iii) 1-substituted piperidin-4-one, POCl<sub>3</sub>, 60 °C, 6 h; (iv) appropriate benzylamine, TEA, NaI, NMP, 130 °C, overnight; (v) NaBH<sub>4</sub>, THF, rt, overnight; (vi) phthalimide, DIAD, PPh<sub>3</sub>, THF, rt, 24 h; (vii) (a) N<sub>2</sub>H<sub>4</sub>, MeOH, reflux, overnight; (b) HCl/Et<sub>2</sub>O</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) ACE-Cl, ClCH<sub>2</sub>CH<sub>2</sub>Cl, reflux; (b) MeOH, reflux, 2 h; (ii) Boc<sub>2</sub>O, CH<sub>2</sub>Cl; (iii) 3-chloro-4-methoxybenzylamine, TEA, NaI, NMP, 130 °C, overnight; (iv) 2.0 M Et<sub>2</sub>O/HCl, CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, rt, overnight.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>17a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1-substituted piperidin-4-one, POCl<sub>3</sub>, 60 °C, 6 h; (ii) benzylamine, TEA, NaI, NMP, 130 °C, overnight.</p></p></figure><div class="NLM_p">We also sought to introduce other functionalities at the naphthyridine 8-position. In the course of this effort, analogues <b>17a</b>–<b>d</b> were synthesized using the same synthetic route of <b>6a</b>–<b>g</b> but starting from commercially available materials <b>15a</b>–<b>c</b>, as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><div class="NLM_p">Of note, during the chemical characterization of the naphthyridine-based compounds by <sup>1</sup>H NMR and <sup>13</sup>C NMR spectroscopy, the appearance of extra peaks was observed for derivatives bearing the acetyl group at the naphthyridine 2-position. This phenomenon was attributed to the presence of equilibrating rotamers, which were confirmed by using additional spectroscopic techniques.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(22)</a> 1D NOESY experiments allowed us to identify the protons undergoing chemical exchange and to give a clear interpretation of the NMR spectra. A detailed description of the spectroscopic profile of compounds <b>5c</b> (Figure S1 and S2) and <b>6c</b> (Figure S3 and S4) as representative spectra is reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>. In addition, as already reported for our previous series of quinoline-based compounds,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> a spin–spin coupling between NH protons and their vicinal aliphatic CH<sub>2</sub> protons was observed for most of the naphthyridine-based compounds and confirmed by D<sub>2</sub>O exchange. The presence of clear split signals (doublets and triplets) was also depending on the solvent used to record the NMR experiment.</div><div class="NLM_p">The general synthesis of 1<i>H</i>-pyrroloquinolinone analogues <b>24a</b>–<b>f</b> is outlined in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Starting with 5-substituted 2-aminobenzoic acids <b>18a</b>–<b>c</b>, 2<i>H</i>-benzo[<i>d</i>][1,3]oxazine-2,4(1<i>H</i>)-diones <b>19a</b>–<b>c</b> were prepared from the reaction with triphosgene. Readily accessible isatoic anhydride <b>19d</b> and 5-chloroisatoic anhydride <b>19e</b> were utilized for the synthesis of intermediates <b>20d</b> and <b>20e</b>. Treatment of <b>19a</b>–<b>e</b> with methyl acetoacetate yielded the desired methyl 4-oxo-1,4-dihydroquinoline-3-carboxylate derivatives <b>20a</b>–<b>e</b>, which were subjected to a chlorination reaction to obtain the 2-methylquinoline derivatives <b>21a</b>–<b>e</b>. Next, bromination of the methyl group followed by cyclization with ethylamine in EtOH provided 2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one derivatives <b>22a</b>–<b>f</b>. The introduction of 3-chloro-4-methoxibenzylamine on the tricyclic template via nucleophilic substitution gave the final compounds <b>24a</b>–<b>f</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>24a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) triphosgene, 1,4-dioxane, 90 °C, 2 h; (ii) methyl acetoacetate, NaH, DMA, 120 °C, 20 min; (iii) POCl<sub>3</sub>, 110 °C, 30 min; (iv) NBS, AIBN, CCl<sub>4</sub>, reflux, 4 h; (v) ethylamine or <i>tert</i>-butylamine, EtOH, reflux, 2 h; (vi) 3-chloro-4-methoxybenzylamine HCl, DIPEA, <i>n</i>-propanol, 90 °C, 2 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Inhibition of PDE5 and Selectivity versus PDE6</h3><div class="NLM_p">Both naphthyridine (<b>6a</b>–<b>g</b>, <b>14</b>, and <b>17a</b>–<b>d</b>) and 1<i>H</i>-pyrroloquinolinone (<b>24a</b>–<b>f</b>) analogues were tested on human recombinant PDE5A1 in a fluorescent enzymatic assay performed by BPS Bioscience (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). With respect to <b>1</b>, both scaffolds A and B retained potent PDE5 activities. While compounds <b>6b</b>, <b>6g</b>, and <b>24c</b> showed a potency comparable to that of compound <b>1</b>, compounds <b>6c</b> and <b>24a</b> exhibited the highest inhibitory activity in the picomolar range. On the contrary, compounds <b>6d</b>, <b>17a</b>, and <b>24f</b> displayed the lowest potency, which was still in the nanomolar range. The most potent PDE5Is <b>6c</b> and <b>24a</b> were also evaluated for selectivity versus the PDE6C isozyme, which shares a high similarity in the catalytic site with PDE5 with respect to the molecular binding and therefore represents a major obstacle in developing highly selective PDE5Is.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(23)</a> Although both scaffolds were well tolerated, it appears that a larger aliphatic ring fused to the quinoline moiety contributes to increasing the PDE5 selectivity versus PDE6, as compound <b>6c</b> bearing a 6-membered aliphatic ring showed to be ∼500-fold more potent against PDE5, while the 5-membered fused ring in compound <b>24a</b> leads to a selectivity for PDE5 of ∼100-fold compared to PDE6.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. PDE5 and PDE6 Activity of Naphthyridine and 1<i>H</i>-Pyrroloquinolinone Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">PDE5A1 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">PDE6C IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">PDE5A1 IC<sub><b>50</b></sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">PDE6C IC<sub><b>50</b></sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">0.27<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">339<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="left">45.2 ± 2.3</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">0.59 ± 0.3</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="left">3.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">0.19 ± 0.01</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="left">21.6 ± 1.0</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">0.056 ± 0.01</td><td class="colsep0 rowsep0" align="left">30.1 ± 1.1</td><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">0.059 ± 0.005</td><td class="colsep0 rowsep0" align="left">6.6 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">337 ± 30.5</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>24b</b></td><td class="colsep0 rowsep0" align="left">3.8 ± 0.3</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">57 ± 6.8</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>24c</b></td><td class="colsep0 rowsep0" align="left">0.29 ± 0.018</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>24d</b></td><td class="colsep0 rowsep0" align="left">64 ± 5.4</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">0.32 ± 0.016</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>24e</b></td><td class="colsep0 rowsep0" align="left">1.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">1.55 ± 0.14</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"><b>24f</b></td><td class="colsep0 rowsep0" align="left">333 ± 26.3</td><td class="colsep0 rowsep0" align="left">nd</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="left">110 ± 3.3</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Enzymatic activity was performed by BPS Bioscience using recombinant human enzymes.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">As reported in ref <a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">18</a>. Values are reported as average ± SE (standard error).</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Computational Study</h3><div class="NLM_p">In order to better understand the structural basis of PDE5 inhibition by the new inhibitors reported here, we have conducted a computational study to identify a binding mode allowing to account for the experimental structure–activity relationship observed within the naphthyridine and the 1<i>H</i>-pyrroloquinolinone series (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, scaffold A and B, respectively).</div><div class="NLM_p">First, we performed unconstrained in silico docking of compounds <b>6c</b> and <b>24a</b>, the most potent compounds of the naphthyridine and the 1<i>H</i>-pyrroloquinolinone series, respectively, into the putative cGMP pocket of PDE5A1 (see methods in <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). We targeted this pocket based on the fact that multiple complex crystal structures show that diverse PDE5 small molecule inhibitors consistently bind in it (e.g., pdb codes 1UHO, 3BJC, 3B2R, 3HDZ, 3SIE, 4G2W, 4G2Y, 4I9Z, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OEW">4OEW</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OEX">4OEX</a>), showing that it has highly druggable characteristics (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5A). The docking pose with the best docking score obtained for compound <b>6c</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A,B) and compound <b>24a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7A) were very consistent (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S6A). Interestingly, a second binding mode, where the tricyclic ring is flipped compared to the best docking pose described above, was also consistently found for both compounds (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C and <a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7B). Of note, the two alternative binding poses occupy approximately the same space within the cGMP pocket for compounds <b>6c</b> and <b>24a</b>, as the tricyclic ring is rotated by ∼180° around its central axis (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S6C,D). Similarly to most PDE5 inhibitors, both compounds lack interaction with the structural Mg<sup>2+</sup> and Zn<sup>2+</sup> ions present in the enzymatic pocket.</div><figure id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked binding modes of compound <b>6c</b> into the PDE5 cGMP pocket. (A) Overview of PDE5 with compound <b>6c</b> docked in the cGMP pocket in its best docking pose. (B) Close-up view of the best docking pose for compound <b>6c</b>. This pose is very similar to the best docking pose found for compound <b>24a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S6A). Note that for both compounds, postdocking minimization led to a significant change in the Q775 side chain orientation compared to the PDB structure used for docking (3TGG). The refined side chain orientation, which optimizes the geometry of the hydrogen bond with the nitrile group of the two compounds, is consistent with alternative side chain orientations observed for residue Q775 in other PDE5 crystal structures (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5B,C). (C) Close-up view of the alternative docking pose found for compound <b>6c</b>. A very similar alternative docking pose was found for compound <b>24a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7B). Dashed lines in parts B and C represent intermolecular hydrogen bonds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In order to compare these two binding modes and potentially provide further validation for one of them, we explored whether they could account for the structure–activity relationship observed within the naphthyridine and the 1<i>H</i>-pyrroloquinolinone series. The interactions of compound <b>6c</b> with PDE5 for both binding modes are summarized in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>. Expectedly, the interactions of compound <b>24a</b> with PDE5 are very similar for both binding modes (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7). Noticeably, these interactions can provide a qualitative explanation for some of the structure–activity relationships observed for the two series of compounds. For the best docking pose, in particular, the hydrogen bond between the nitrile group of compound <b>6c</b> or <b>24a</b> and the amide group of residue Q775, located at the deep end of the binding pocket, can explain the significant impact of chemical changes at this position on potency (compare compounds <b>6c</b> and <b>17a</b>–<b>c</b> for the naphthyridine series and compounds <b>24a</b>–<b>d</b> and <b>24e</b> for the 1<i>H</i>-pyrroloquinolinone series). Among the groups that can be compared for this position, the best potency is obtained with a nitrile group (IC<sub>50</sub> ∼ 0.6 nM for both compound <b>6c</b> and <b>24a</b>), while the weakest potency, within both series, is obtained in the absence of any acceptor (IC<sub>50</sub> of 110 nM and 64 nM for compounds <b>17a</b> and <b>24d</b>, respectively). The presence of a weaker acceptor (e.g., F, Cl, or Br in compounds <b>24c</b>, <b>24e</b>, and <b>17c</b>, respectively) and/or of a shorter linker between the acceptor and the tricyclic ring core (e.g., —OMe in compounds <b>17b</b> and <b>24b</b>, respectively), which places the acceptor further away from the Q775 donor, results in intermediate potencies (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Two-dimensional interaction diagrams for compound <b>6c</b>. The best docking pose (left) as well as the alternative docking pose (right) are represented. The legend for the residue types and the types of interactions is indicated at the bottom of the figure. The two-dimensional interaction diagrams for compound <b>24a</b> are represented in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the other side of the tricyclic ring, for the naphthyridine series, the water bridge formed between the acetyl group and M816 backbone in the best docking pose can also explain the reduced potency with groups lacking a good acceptor or donor (e.g., IC<sub>50</sub> of 0.19 nM, 0.59 nM, and 1.55 nM with an ethyl group (compound <b>6b</b>), methyl group (compound <b>6a</b>), and hydrogen (compound <b>14</b>), respectively) (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This role of the acetyl group in the naphthyridine series could, however, also be explained in the alternative docking pose, by the hydrogen bond formed with residue Q817. In the alternative binding mode, however, the importance of the nitrile group is more difficult to explain as it is mostly solvent exposed.</div><div class="NLM_p">The two binding modes can also provide an explanation for the importance of the methoxy group in para- position of the benzyl ring of compound <b>6c</b> (IC<sub>50</sub> ∼ 0.056 nM for a methoxy group in compound <b>6c</b> compared to IC<sub>50</sub> of 337, 57, and 1.5 nM for a trifluoromethyl, unsubstituted pyridine and a single fluoride in compounds <b>6d</b>, <b>6e</b>, and <b>6f</b>, respectively). The benzyl ring carrying the group occupies the same small pocket lined by F786, F787, L804, I813, and M816 in both binding modes (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). When molecular dynamics simulations are preformed, water clustering and statistical thermodynamic analysis using WaterMap<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(24, 25)</a> shows that, in the absence of a ligand, this small pocket is likely to be occupied by several “high-energy” water molecules (i.e., predicted by WaterMap to be significantly more energetically stable in the bulk solvent than in the binding pocket, where it, however, binds in order to avoid a vacuum) (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S8). Overlapping of a ligand with one of these high-energy hydration sites by either a polar or a nonpolar group allows the simultaneous displacement of the unstable water into the bulk solvent while avoiding a vacuum and is energetically quite favorable. One of these high-energy hydration sites precisely overlaps with the position of the methoxy group for both docked binding modes of compound <b>6c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S8), while smaller groups like an unsubstituted pyridine or a fluoride (compounds <b>6e</b> and <b>6f</b>) would not be bulky enough to displace this water molecule to the solvent. For the case of the trifluoromethyl substituent (IC<sub>50</sub> of 337 nM for compound <b>6d</b>), the significantly reduced potency can be explained by the fact that, while it is certainly bulky enough to desolvate the pocket as well as the methoxy group, its significantly larger size does not sterically fit as well in the pocket.</div><div class="NLM_p last">Overall, these qualitative explanations globally argue rather in favor of the best docking pose relative to the alternative pose, although more work would be needed to further validate one of these poses.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Physicochemical Properties</h3><div class="NLM_p">To determine the potential drug-likeness of compounds <b>6c</b> and <b>24a</b>, their in silico physicochemical properties were evaluated and compared to those of compound <b>1</b>. As shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, both compounds <b>6c</b> and <b>24a</b> obey the Lipinski’s rule of five and fulfill the restrictions of topological polar surface area (tPSA) for drugs targeting the central nervous system.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(26)</a> Additionally, water solubility of compound <b>6c</b> and <b>24a</b> was assessed to establish whether the new scaffolds showed an increased solubility than compound <b>1</b>. Kinetic solubility was measured in phosphate buffered saline following an 18-h incubation period according to the procedure described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Compound <b>24a</b> was found to have a low kinetic solubility, while compound <b>6c</b> showed an improved water solubility with respect to compound <b>1</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). The melting points of compounds <b>6c</b>, <b>24a</b>, and <b>1</b> have been reported in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> as well. These findings suggest that compound <b>6c</b> represents a good candidate for further analyses. We then engaged compound <b>6c</b> in a set of experiments aimed at evaluating its pharmacological properties and potential use in AD.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Water Solubility and Physicochemical Properties of <b>1</b>, <b>6c</b>, and <b>24a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center" char=".">MW<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HBA<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">HBD<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogP<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">tPSA<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">water solubility (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">melting point (°C)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">393.87</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">3.42</td><td class="colsep0 rowsep0" align="char" char=".">78.17</td><td class="colsep0 rowsep0" align="left"><3.9</td><td class="colsep0 rowsep0" align="left">171.0–173.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="char" char=".">420.90</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3.41</td><td class="colsep0 rowsep0" align="char" char=".">78.25</td><td class="colsep0 rowsep0" align="left">>500</td><td class="colsep0 rowsep0" align="left">165.5–167.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="char" char=".">406.87</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">3.66</td><td class="colsep0 rowsep0" align="char" char=".">78.25</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">207.0–209.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RO5</td><td class="colsep0 rowsep0" align="char" char="."><450</td><td class="colsep0 rowsep0" align="char" char="."><10</td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."><90</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">MW: molecular weight. HBA: hydrogen-bond acceptor atoms. HBD: hydrogen-bond donor atoms. clogP: calculated logarithm of the octanol–water partition coefficient. tPSA: topological polar surface area, calculated using <a href="http://www.molinspiration.com/cgi-bin/properties" class="extLink">http://www.molinspiration.com/cgi-bin/properties</a>. RO5: Lipinski’s rule of five.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Calculated as the turbidimetric (kinetic) solubility by Cyprotex US, LLC.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">As an average of 2 independent measurements determined on Mel-Temp II, Laboratory devices, USA.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Effects of Compound <b>6c</b> on Hippocampal cGMP Levels and Synaptic Plasticity</h3><div class="NLM_p">Based on its potency and selectivity profile, as well as its favorable aqueous solubility, compound <b>6c</b> was moved into a functional assay aimed at evaluating its ability to increase the cGMP levels in the hippocampus of mice. Wild-type (WT) mice were treated with compound <b>6c</b> at two different concentrations (3 and 10 mg/kg). Mice were subjected to foot shock and sacrificed 10, 60, and 180 s afterward (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). These time points were chosen based on previous experiments in which we observed a change in the cGMP levels immediately after foot shock.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Increased levels of cGMP were observed at both concentrations and all of the 3 different time points. A dose-dependent increase of the cGMP levels was detected in hippocampi collected at 10 and 60 s after foot shock, with a 1.5- and 1.7-fold increase at 3 and 10 mg/kg, respectively, compared to untreated mice for both time points. At 180 s, a slight increase in the cGMP levels was detected in mice treated with 3 mg/kg of <b>6c</b>, but it failed to reach statistical significance (<i>p</i> = 0.097), while the higher dose produced a 1.3-fold increase of the cGMP levels with respect to vehicle-treated mice. A compensatory cellular mechanism leading to the hydrolysis of cGMP by other PDEs could explain the reduced increase of the cGMP levels at 180 s with respect to 60 s after foot shock for mice treated with 10 mg/kg of compound <b>6c</b>. However, longer time points or the employment of inhibitors of other cGMP-hydrolyzing PDEs were not explored to verify this hypothesis. In any case, the NO signal transduction cascade, involving cGMP, is sufficient to phosphorylate the CREB that leads to memory formation through transcription of memory-related genes. Such a cellular response is triggered by memory-stimulating events, such as foot shock. Indeed, vehicle-treated mice subjected to foot shock (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, veh) showed an increase of the cGMP levels compared to vehicle-treated mice that did not receive foot shock (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, basal). Notably, compound <b>6c</b> was effective in elevating the hippocampal cGMP levels, indirectly proving its ability to cross the blood-brain barrier (BBB).</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. cGMP levels in hippocampus of mice treated with compound <b>6c</b> at 3 and 10 mg/kg via intraperitoneally. Values are the mean of duplicate determinations. Error bars show SEM (<i>n</i> = 3 per group); *<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine whether compound <b>6c</b> was able to strengthen synaptic transmissions, we carried out electrophysiological experiments to measure the compound’s effects on the hippocampal long-term potentiation (LTP), a type of synaptic plasticity thought to underlie learning and memory and to be impaired by the elevation of Aβ.<a onclick="showRef(event, 'ref16 ref29'); return false;" href="javascript:void(0);" class="ref ref16 ref29">(16, 27)</a> Slices of the hippocampus were collected from 3 to 4 month old APP/PS1 transgenic mice and WT littermate controls and were treated either with vehicle or with <b>6c</b> (50 nM through the bath perfusion for 10 min prior to the tetanus) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). According to our previous results, vehicle-treated APP/PS1 mice showed a reduction in LTP compared to that of the WT mice.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(28)</a> Compound <b>6c</b> rescued the defect in LTP; the residual potentiation recorded in slices from APP/PS1 mice treated with compound <b>6c</b> (201.76% ± 14.09) was increased with respect to slices from APP/PS1 mice treated with vehicle (137.30% ± 10.83) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). Compound <b>6c</b> did not have any effect on WT slices, consisting with the possibility that the inhibitor is acting on the LTP mechanisms underlying memory loss instead of a more generalized effect (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). Thus, by acting on the NO/cGMP signaling pathway, compound <b>6c</b> re-established the normal increase of synaptic strength in the hippocampus of APP/PS1 mice (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). A similar beneficial effect was observed when compound <b>6c</b> was injected in APP/PS1 mice from the age of 3–4 months for 3 weeks, and hippocampal slices were harvested at 6–7 months of age (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C,D). LTP was restored in compound-treated APP/PS1 mice (226.22% ± 6.71) compared to nontreated transgenic mice (164.11% ± 10.36) (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C,D), suggesting an enduring effect of <b>6c</b> on potentiating synaptic plasticity. These results corroborate our previous findings on the prolonged beneficial effect induced by the PDE5 inhibition on synaptic and cognitive abnormalities in APP/PS1 mice that persists beyond the administration of the inhibitor.<a onclick="showRef(event, 'ref18 ref17'); return false;" href="javascript:void(0);" class="ref ref18 ref17">(18, 17)</a></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Beneficial effect of compound <b>6c</b> on synaptic deficits in APP/PS1 mice. Two hours recording following tetanic stimulation of the Schaffer collateral fibers at the CA3-CA1 connection. (A) Slices were prepared from 3-month-old WT and APP/PS1 mice treated with vehicle or compound <b>6c</b> at 50 nM (acute perfusion, *<i>p</i> < 0.01 and F<sub>(1,13)</sub> = 15.57). (B) Residual potentiation recorded during the last 5 min of a 2 h recording shown in panel A. (C) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months. Slices were recorded at 6–7 months of age, *<i>p</i> < 0.01 and F<sub>(1,15)</sub> = 27.0. (D) Residual potentiation recorded during the last 5 min of a 2 h recording shown in panel C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Plasma and Brain Levels and in Vitro Microsomal Stability of Compound <b>6c</b></h3><div class="NLM_p">To further validate compound <b>6c</b> as a promising candidate for treating a central nervous disease, a pharmacokinetic study was performed. We evaluated brain and plasma levels in mice after intraperitoneal (ip) administration of compound <b>6c</b> at 25 mg/kg at different time points (0, 5, 15, 30, 60, and 120 min). As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, peak plasma concentration of <b>6c</b> occurred 0.25 h after dosing and its plasma half-life was 1.07 h. At 0.25 h, the concentration of <b>6c</b> in the brain and plasma were 492.25 ng/g and 1571.44 ng/mL, respectively. The logBB value was used to evaluate BBB permeability; <b>6c</b> showed the logBB values of −0.50, which was within the established threshold that defines a compound as crossing the BBB (logBB ≥ −1).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(29)</a> Therefore, compound <b>6c</b> demonstrated crossing the BBB.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Plasma and Brain Concentrations, logBB, Half-Life, and in Vitro Microsomal Stability of Compound <b>6c</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">sample</th><th class="colsep0 rowsep0" align="center">plasma<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (ng/mL)</th><th class="colsep0 rowsep0" align="center">brain<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (ng/g)</th><th class="colsep0 rowsep0" align="center">logBB<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">half-life<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (h)</th><th class="colsep0 rowsep0" align="center">microsomal stability<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><i>n</i> = 3</td><td class="colsep0 rowsep0" rowspan="2" align="left">1571.44</td><td class="colsep0 rowsep0" rowspan="2" align="left">492.25</td><td class="colsep0 rowsep0" rowspan="2" align="left">–0.50</td><td class="colsep0 rowsep0" rowspan="2" align="left">1.07</td><td class="colsep0 rowsep0" align="left">6.0 (HLM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3.2 (MLM)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values determined 0.25 h after administration.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">BB: ratio of the brain to plasma concentration.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Microsomal stability was performed by Absorption Systems.</p></div></div></div><div class="NLM_p last">Microsomal stability of compound <b>6c</b> was measured in both mouse liver microsomes (MLM) and human liver microsomes (HLM) (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Such short half-lives were indicative of a rapid metabolism of the compound by both mouse and human microsomes. Optimizing the metabolic stability while maintaining potency is an effort to be pursued in a following study. The structural insights gained through the computational study presented above will be leveraged in this endeavor. The first possible metabolic liability to be further explored is the demethylation of the methoxy group on the benzyl ring of compound <b>6c</b>. If this metabolic liability is confirmed (for example through microsomal stability profiling of compounds <b>6d</b>, <b>6e</b>, and <b>6f</b>), the binding mode proposed for compound <b>6c</b> will be used to guide the choice of an isostere to replace the methoxy group (i.e., bulky enough to desolvate the pocket while not too bulky to sterically fit well in it).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Behavioral Studies of Compound <b>6c</b></h3><div class="NLM_p">Despite the fact that the analysis of microsomal stability suggested that further improvement is needed, we wanted to verify if the new scaffold (compound <b>6c</b>) retained the capability of rescuing the memory loss in the APP/PS1 mouse model of AD. To this end, two memory tasks, fear conditioning (FC) and 2-day radial arm water maze (RAWM), were performed to assess associative and spatial memory, respectively (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). APP/PS1 mice were subjected to both tasks at the age of 3–4 months (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A,B), when they clearly show cognitive impairment.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(28, 30)</a> In these experiments, both APP/PS1 and WT mice were treated with <b>6c</b> (3 mg/kg, ip) daily for 3 weeks and compared to vehicle-treated APP/PS1 and WT mice. The percentage of freezing in the FC task (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A) defines the animal response to an electric foot shock (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for detailed methods). <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A shows that vehicle-treated transgenic mice froze less (∼15% freezing) compared to vehicle- and compound-treated WT mice as well as compound-treated APP/PS1 mice, indicating the inability of these animals to associate the noxious stimulus with the environment where the stimulus occurs. Treatment with <b>6c</b>, however, rescued contextual learning in APP/PS1 mice (∼30% freezing) without affecting memory in WT mice (∼30% freezing). In the 2-day RAMW (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B), the number of errors refers to the ability of the animal to reach the hidden platform, which is placed in one of the six arms of a maze (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for detailed methods). Compared to vehicle-treated APP/PS1 (∼3 errors), compound-treated APP/PS1 showed a fewer number of errors (∼1 error), suggesting that compound <b>6c</b> is able to rescue spatial working memory. As expected, vehicle- and compound-treated WT mice performed well in the 2-day RAWM as they show no symptoms of memory impairment.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Beneficial effect of compound <b>6c</b> on cognitive deficits in APP/PS1 mice. (A) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months re-established normal freezing in a test for contextual fear memory. (B) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months reduced the number of errors with the 2-day radial arm water maze. (C) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months re-established normal freezing in a test for contextual fear memory when mice were examined at 6–7 months of age. (D) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months reduced the number of errors with the 2-day radial arm water maze when mice were examined at 6–7 months of age. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To investigate whether the beneficial effects of compound <b>6c</b> on synaptic and cognitive abnormalities in APP/PS1 mice was persisting beyond its administration, both WT and APP/PS1 mice that were treated for 3 weeks with <b>6c</b> at the age of 3 months were assessed for contextual and spatial memory when they were 6–7 months old (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C,D). In the contextual memory experiments, transgenic mice treated with the compound froze ∼40% of the time compared to ∼15% in vehicle-treated transgenic mice (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C) and made ∼1 error in the 2-day RAWM test compared to ∼2.5 in vehicle-treated transgenic mice (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D). Thus, synaptic and cognitive improvements persist beyond the administration of compound <b>6c</b>. For all experiments, we performed cued conditioning and visible platform tasks to verify that contextual memory-independent mechanisms interfere with the interpretation of the results. None of these controls showed differences among various groups of mice (see <a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figures S9 and S10).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87528" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87528" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We reported an extensive study of new chemical entities with PDE5 inhibitory activity. In particular, we reported the naphthyridine derivative <b>6c</b>, which was found to have excellent PDE5 potency and selectivity, with improved water solubility with respect to the quinoline analogue <b>1</b>.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Despite its lack of in vitro metabolic stability, which suggests the need of further effort toward the optimization of this drug property, physicochemical and pharmacological properties of compound <b>6c</b> were found to be optimal for a potential drug candidate.</div><div class="NLM_p">Using in silico docking, we were furthermore able to identify two plausible binding modes and provide structural insights into the structure–activity relationship for the two series of compounds reported here. Further validation of one of these binding modes is work for a following study and should open the way to the structure-based optimization of the compounds reported here.</div><div class="NLM_p last">We further showed that treatment with compound <b>6c</b> increased cGMP levels in the hippocampus of mice and improved learning and memory deficits in a mouse model of AD. These findings strengthen the hypothesis that the NO/cGMP/PKG/CREB molecular pathway plays an important role in learning and memory and that the inhibition of PDE5 represents a sound AD therapeutic approach for either slowing down or preventing the progress of the disease.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75410" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75410" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry. General Method</h3><div class="NLM_p last">All solvents and chemicals were reagent grade. Unless otherwise mentioned, all reagents and solvents were purchased from commercial vendors and used as received. Silica gel chromatography was performed using glass columns packed with silica gel (200–400 mesh, Aldrich Chemical). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on an Agilent-NMR-vnmrs400 (400 and 100 MHz, respectively) spectrometer and were determined in chloroform-<i>d</i>, DMSO-<i>d</i><sub>6</sub>, acetone-<i>d</i><sub>6</sub> or methanol-<i>d</i><sub>4</sub> with tetramethylsilane (TMS) (0.00 ppm) or solvent peaks as the internal reference. Chemical shifts (δ) are reported in ppm relative to the reference signal, and coupling constant (<i>J</i>) values are reported in Hertz (Hz), multiplicity (s = singlet, d = doublet, dd = double doublet, t = triplet, q = quartet, m = multiplet, br = broad). The purity of all final compounds was ≥95% and was determined by LC/MS at wavelengths 220 and 254 nm. Liquid chromatography–mass spectrometry (LC/MS) was performed on two different instruments, a Shimadzu 2010A and a Shimadzu 2020 UFLC mass spectrometer, using a Waters Sunfire column (C18, 5 μm, 2.1 mm × 50 mm, a linear gradient from 5% to 100% B over 15 min, then 100% B for 2 min (A = 0.1% formic acid + H<sub>2</sub>O, B = 0.1% formic acid + CH<sub>3</sub>CN), flow rate 0.2000 mL/min). HRMS (ESI) was performed by Furong Sun and associates at the University of Illinois (Urbana–Champaign). Thin-layer chromatography (TLC) was performed on EMD precoated silica gel 60 F254 plates, and spots were visualized with UV light (254 nm). All reagents and solvents were used as received from major commercial suppliers, such as Sigma-Aldrich, Fisher Scientific, and Alfa Aesar without further purification. All air- or moisture-sensitive reactions were run under an atmosphere of argon in oven-dried glassware unless otherwise noted.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure A for the Synthesis of 10-Chloro-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine</h3><div class="NLM_p last"><i>N</i>-substituted piperidin-4-one (1 equiv) and 5-substituted 2-aminobenzoic acid (1 equiv) were heated to 60 °C in POCl<sub>3</sub> (which was used as a reagent and a solvent) for 6 h. The excess of POCl<sub>3</sub> was evaporated off, and the residue was treated with iced H<sub>2</sub>O and 10% NaOH (until pH alkaline) and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layers were combined and dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The residue was purified by column chromatography on silica gel.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure B for the Nucleophilic Substitution on 10-Chloro-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine</h3><div class="NLM_p last">A mixture of 10-chloro-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine (1 equiv), benzylamine (3 equiv), TEA (3 equiv), and NaI (0.1 equiv) in NMP was heated to 130 °C overnight. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with H<sub>2</sub>O twice and brine once. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. The residues were purified by column chromatography on silica gel.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure C for the Synthesis of 2<i>H</i>-Benzo[<i>d</i>][1,3]oxazine-2,4(1<i>H</i>)-dione</h3><div class="NLM_p last">Triphosgene (1 equiv) was added to a suspension of 5-substituted 2-amino-benzoic acid (3 equiv) in 1,4-dioxane at 0 °C. The homogeneous reaction mixture was heated to 90 °C for 2 h and then cooled. The resulting precipitate was isolated by filtration.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure D for the Formation of 4-Oxo-1,4-dihydroquinoline-3-carboxylate</h3><div class="NLM_p last">NaH (1.2 equiv) was added portion wise to a solution of methyl acetoacetate (1.2 equiv) in DMA. 2<i>H</i>-Benzo[<i>d</i>][1,3]oxazine-2,4(1<i>H</i>)-dione (1 equiv) was added, and the reaction mixture was stirred to 120 °C for 30 min. The solvent was reduced, and water was added. The resulting precipitate was collected by filtration.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Procedure E for the Chlorination of Methyl 4-Oxo-1,4-dihydroquinoline-3-carboxylate</h3><div class="NLM_p last">Methyl 4-oxo-1,4-dihydroquinoline-3-carboxylate was suspended in POCl<sub>3</sub>, and the solution was heated to 110 °C for 30 min. The homogeneous reaction mixture was slowly poured into iced aq NH<sub>3,</sub> and the aqueous phase was extracted with AcOEt (3 × 50 mL). The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduce pressure to give the desire compound.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure F for the Bromination of Methyl 2-Methylquinoline-3-carboxylate</h3><div class="NLM_p last">A solution of methyl 2-methylquinoline-3-carboxylate (1.0 equiv), <i>N</i>-bromosuccinimide (1.5 equiv), and 2,2′-azobis(2-methylpropionitrile) (0.2 equiv) in CCl<sub>4</sub> was heated to reflux for 4 h. The reaction mixture was cooled down, and the solid was filtered off. The filtrate was concentrated, and the residue was purified by flash chromatography.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure G for the Formation of 2,3-Dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one</h3><div class="NLM_p last">EtNH<sub>2</sub> (2 M in THF, 3.0 equiv) or <i>tert-</i>butylamine (2 M in THF, 3.0 equiv) was added to a solution of methyl 2-(bromomethyl)-4-chloroquinoline-3-carboxylate (1.0 equiv) in ethanol. The reaction mixture was heated to reflux for 2 h. The solvent was evaporated off, and the residue was purified by flash chromatography to give the desired compound.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure H for the Nucleophilic Substitution on 2,3-Dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one</h3><div class="NLM_p last">A solution of 2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (1.0 equiv), 3-chloro-4-methoxybenzylamine hydrochloride (1.5 equiv), and DIPEA (6.0 equiv) in <i>n</i>-propanol was heated to 90 °C for 2 h. After cooling the mixture, the resulting precipitate was collected by filtration.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl 2-Amino-5-cyanobenzoate (<b>3</b>)</h3><div class="NLM_p last">A mixture of <b>2</b> (21.72 mmol) and CuCN (26.07 mmol) in NMP was stirred for 5 h at 210 °C. After cooling the reaction, the mixture was poured into 15 mL of an aqueous solution of FeCl<sub>3</sub> (15.0 g) and concentrated HCl (2.2 mL). The resulting mixture was stirred at 60 °C for 1 h and then cooled to room temperature. AcOEt was added, and the mixture was washed with a 1 N NaOH solution (×3) and brine (×1). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to give a dark solid, which was purified by flash chromatography using ethyl acetate: white solid; yield 56%; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.19 (d, 1H, <i>J</i> = 2.0 Hz), 7.45 (dd, 1H, <i>J</i> = 8.4, 2.0 Hz), 6.6 (d, <i>J</i> = 8.8 Hz), 6.28 (br s, 2H, NH<sub>2</sub>), 3.89 (s, 3H).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Amino-5-cyanobenzoic acid (<b>4</b>)</h3><div class="NLM_p last"><b>3</b> (17.0 mmol) was dissolved in EtOH (3 mL), and 1 M KOH (10 mL) was added. The reaction was heated to 50 °C for 2 h. After cooling the reaction, concentrated HCl was added to a pH = 6–7 and the resulting precipitate <b>4</b> (off-white solid) was collected by filtration. Compound <b>4</b> was used without further purification, crude yield 96%.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 10-Chloro-2-methyl-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>5a</b>)</h3><div class="NLM_p last">Following general procedure A, 1-methylpiperidin-4-one and <b>4</b> provided <b>5a</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 55%; ESI-MS <i>m</i>/<i>z</i> 286 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (s, 1H), 8.07 (d, 1H, <i>J</i> = 8.7 Hz), 7.83 (d, 1H, <i>J</i> = 8.7 Hz), 3.85 (s, 2H), 3.30 (t, 2H, <i>J</i> = 6.0 Hz), 2.89 (t, 2H, <i>J</i> = 6.0 Hz), 2.60 (s, 3H).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 10-Chloro-2-ethyl-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>5b</b>)</h3><div class="NLM_p last">Following general procedure A, 1-ethylpiperidin-4-one and <b>4</b> provided <b>5b</b>: column chromatography using methylene chloride/methanol, 95:5; yield 26%; ESI-MS <i>m</i>/<i>z</i> 286 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.58 (d, 1H, <i>J</i> = 1.8 Hz), 8.06 (d, 1H, <i>J</i> = 8.7 Hz), 7.82 (dd, 1H, <i>J</i> = 8.4, 1.8 Hz), 3.91 (s, 2H), 3.30 (t, 2H, <i>J</i> = 5.7 Hz), 2.93 (t, 2H, <i>J</i> = 5.7 Hz), 2.75 (q, 2H, <i>J</i> = 7.2 Hz), 1.26 (t, 3H, <i>J</i> = 7.2 Hz).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Acetyl-10-chloro-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>5c</b>)</h3><div class="NLM_p last">Following general procedure A, 1-acetylpiperidin-4-one and <b>4</b> provided <b>5c</b>: column chromatography using methylene chloride/methanol, 95:5; yield 38%. ESI-MS <i>m</i>/<i>z</i> 286 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.61 (s, 1H), 8.13–8.08 (m, 1H), 7.88–7.85 (m, 1H), 5.02 and 4.89 (2 s, 2H), 4.03 and 3.90 (2 t, 2H, <i>J</i> = 6.0 Hz), 3.30 and 3.24 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.28 and 2.27 (2 s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.57, 169.34, 160.14, 159.03, 148.03, 147.76, 140.42, 139.71, 130.94, 130.75, 130.57, 130.39, 130.15, 130.03, 127.09, 126.18, 124.93, 124.62, 118.24, 111.02, 110.96, 46.36, 43.23, 42.47, 38.73, 33.89, 33.03, 21.81, 21.44.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Benzyl-10-chloro-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>5d</b>)</h3><div class="NLM_p last">Following general procedure A, 1-benzylpiperidin-4-one and <b>4</b> provided <b>5d</b>: column chromatography using hexane/ethyl acetate, 50:50; yield 54%; ESI-MS <i>m</i>/<i>z</i> 334 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.56 (d, 1H, <i>J</i> = 1.8 Hz), 8.04 (d, 1H, <i>J</i> = 8.7 Hz), 7.82 (dd, 1H, <i>J</i> = 8.7, 1.8 Hz), 7.43–7.31 (m, 5H), 3.93 (s, 2H), 3.83 (s, 2H), 3.26 (t, 2H, <i>J</i> = 6.0 Hz), 2.92 (t, 2H, <i>J</i> = 6.0 Hz).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 10-[(3-Chloro-4-methoxybenzyl)amino]-2-methyl-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6a</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxibenzylamine HCl and <b>5a</b> provided <b>6a</b>: column chromatography using ethyl acetate/methanol, 90:10); yield 33%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>4</sub>OCl 393.1482, found 393.1487; LC/MS purity 99.2%, <i>t</i><sub>R</sub> = 6.6 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (d, 1H, <i>J</i> = 1.6 Hz), 7.96 (d, 1H, <i>J</i> = 8.8 Hz), 7.71 (dd, 1H, <i>J</i> = 8.4, 1.6 Hz), 7.37 (d, 1H, <i>J</i> = 2.4 Hz), 7.18 (dd, 1H, <i>J</i> = 8.8, 2.4 Hz), 6.94 (d, 1H, <i>J</i> = 8.4 Hz), 4.57 (d, 2H, <i>J</i> = 6.4 Hz, NH<u class="uu">CH</u><sub>2</sub>), 4.08 (t, 1H, <i>J</i> = 6.0 Hz, <u class="uu">NH</u>CH<sub>2</sub>), 3.92 (s, 3H, OCH<sub>3</sub>), 3.53 (s, 2H), 3.21 (t, 2H, <i>J</i> = 5.8 Hz), 2.83 (t, 2H, <i>J</i> = 5.8 Hz), 2.52 (s, 3H, COCH<sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.26, 154.87, 149.02, 148.67, 131.64, 130.40, 129.59, 129.47, 129.33, 126.98, 122.96, 119.40, 119.28, 115.68, 112.41, 107.17, 56.21, 54.23, 52.60, 52.16, 46.22, 33.86.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 10-[(3-Chloro-4-methoxybenzyl)amino]-2-ethyl-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6b</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxibenzylamine HCl and <b>5b</b> provided <b>6b</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 38%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>24</sub>N<sub>4</sub>OCl 407.1639, found 407.1658; LC/MS purity 99.5%, <i>t</i><sub>R</sub> = 6.67 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (d, 1H, <i>J</i> = 1.2 Hz), 7.96 (d, 1H, <i>J</i> = 8.8 Hz), 7.71 (dd, 1H, <i>J</i> = 8.8, 1.6 Hz), 7.37 (d, 1H, <i>J</i> = 2.0 Hz), 7.17 (dd, 1H, <i>J</i> = 8.0, 2.0 Hz), 6.93 (d, 1H, <i>J</i> = 8.8 Hz), 4.56 (d, 2H, <i>J</i> = 6.4 Hz, NH<u class="uu">CH</u><sub>2</sub>), 4.12 (t, 1H, <i>J</i> = 5.2 Hz, <u class="uu">NH</u>CH<sub>2</sub>), 3.92 (s, 3H, OCH<sub>3</sub>), 3.57 (s, 2H), 3.21 (t, 2H, <i>J</i> = 6.0 Hz), 2.86 (t, 2H, <i>J</i> = 6.0 Hz), 2.64 (q, 2H, <i>J</i> = 7.4 Hz, <u class="uu">CH</u><sub>2</sub>CH<sub>3</sub>), 1.18 (t, 3H, <i>J</i> = 7.0 Hz, CH<sub>2</sub><u class="uu">CH</u><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.80, 154.86, 149.00, 148.84, 131.75, 130.40, 129.51, 129.42, 129.32, 126.93, 123.00, 119.51, 119.29, 116.04, 112.42, 107.21, 56.22, 52.64, 52.10, 51.97, 49.61, 33.81, 12.35.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Acetyl-10-[(3-chloro-4-methoxybenzyl)amino]-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6c</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxibenzylamine HCl and <b>5c</b> provided <b>6c</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 20%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>Cl 421.1431, found 421.1429; LC/MS purity 96.79%, <i>t</i><sub>R</sub> = 8.075; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.32 and 8.33 (1H, 2 s), 8.01 and 7.94 (1H, 2 d, <i>J</i> = 8.7 Hz), 7.77 and 7.70 (1H, d, <i>J</i> = 8.8 Hz and dd, <i>J</i> = 9.0, 1.5 Hz), 7.36 and 7.28 (1H, s and d, <i>J</i> = 2.1 Hz), 7.18 and 7.13 (1H, dd, <i>J</i> = 8.4, 2.1 Hz and d, <i>J</i> = 8.4 Hz), 6.92 and 6.91 (1H, 2 d, <i>J</i> = 8.0 Hz), 4.68 and 4.53 (2H, 2 s), 4.62 (d, 2H, <i>J</i> = 6.0 Hz), 4.43 (br s, 1H, NH), 3.9 and 3.79 (2H, 2 t, <i>J</i> = 6.4 Hz), 3.88 (s, 3H), 3.17 and 3.13 (2H, 2 t, <i>J</i> = 6.0 Hz), 2.18 and 2.03 (2H, 2 s); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.63, 169.03, 159.80, 158.27, 154.93, 149.07, 148.76, 131.54, 131.26, 130.69, 130.44, 129.92, 129.75, 129.71, 129.38, 129.25, 129.00, 126.92, 126.73, 123.27, 123.03, 119.91, 119.40, 119.04, 114.09, 113.36, 112.53, 56.24, 56.19, 52.69, 52.47, 44.70, 43.38, 40.13, 39.16, 33.85, 33.08, 21.59, 21.47.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Acetyl-10-[3-chloro-4-(trifluoromethoxy)benzyl]amino-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6d</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-(trifluoromethoxy)-benzenemethanamine and <b>5c</b> provided <b>6d</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 37%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>N<sub>4</sub>O<sub>2</sub>ClF<sub>3</sub> 475.1149, found 475.1161; LC/MS purity 97.74%, <i>t</i><sub>R</sub> = 8.91 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.31 (d, 1H, <i>J</i> = 1.2 Hz), 8.04 and 7.99 (2 d, 0.75H, <i>J</i> = 8.8 Hz), 7.75 (dd, 1H, <i>J</i> = 8.6, 1.6 Hz), 7.48 (d, 1H, <i>J</i> = 2.0 Hz), 7.35 (dd, 1H, <i>J</i> = 8.4, 0.8 Hz), 7.30 (dd, 1H, <i>J</i> = 8.4, 2.4 Hz), 4.74 and 4.58 (2 s, 2H), 4.70 and 4,64 (2 d, 1.5H, <u class="uu">CH</u><sub>2</sub>NH, <i>J</i> = 6.8 Hz), 4.52 (s, 1H, NH), 3.94 and 3.83 (2 t, 2H, <i>J</i> = 6.4 Hz), 3.22 and 3.17 (2 t, 2H, <i>J</i> = 6.4 Hz), 2.21 and 2.04 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.72, 168.94, 158.58, 149.03, 148.71, 144.94, 138.71, 138.43, 130.88, 130.64, 130.03, 129.82, 129. 80, 129.62, 129.28, 129.49, 128.11, 126.74, 126.48, 123.30, 123.11, 121.66, 119.62, 119.08, 118.91, 114.13, 107.97, 52.07, 44.79, 43.36, 40.08, 39.19, 33.83, 33.09, 21.43.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Acetyl-10-[(2-chloropyridin-4-yl)methyl]amino-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6e</b>)</h3><div class="NLM_p last">Following general procedure B, 2-chloro-4-pyridinemethanamine and <b>5c</b> provided <b>6e</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 30%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>19</sub>N<sub>5</sub>OCl 392.1278, found 392.1270; LC/MS purity 99.5%, <i>t</i><sub>R</sub> = 7.22 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.42 (d, 1H, <i>J</i> = 4.8 Hz), 8.25 (d, 1H, <i>J</i> = 1.6 Hz), 8.01 (d, 1H, <i>J</i> = 8.4 Hz), 7.76 (dd, 1H, <i>J</i> = 9.2, 2.0 Hz), 7.36 (s, 1H), 7.24 (dd, 1H, <i>J</i> = 4.8, 1.2 Hz), 4.76 and 4.60 (2 s, 2H), 4.72 (s, 2H, <u class="uu">CH</u><sub>2</sub>NH), 4.64 (s, 1H, CH<sub>2</sub><u class="uu">NH</u>), 3.94 and 3.84 (2 t, 2H, <i>J</i> = 6.0 Hz), 3.24 and 3.18 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.22 and 2.06 (2 s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.82, 158.68, 152.49, 151.16, 150.43, 148.90, 148.43, 130.72, 130.00, 128.87, 122.45, 120.62, 119.61, 118.74, 114.53, 108.34, 51.43, 43.32, 39.98, 33.72, 21.46.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Acetyl-10-[(3-chloro-4-fluorobenzyl)amino]-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6f</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-fluoro-benzenemethanamine and <b>5c</b> provided <b>6f</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 18%. ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>N<sub>4</sub>OFCl 409.1231, found 409.1232; LC/MS purity 96.53%, <i>t</i><sub>R</sub> = 8.01 min; <sup>1</sup>H NMR (400 MHz, (CD<sub>3</sub>)<sub>2</sub>CO) (mixture of rotamers) δ 8.67 and 8.65 (2 s, 1H), 7.98–7.94 (m, 1H), 7.87–7.82 (m, 1H), 7.73–7.68 (m, 1H), 7.51 (s, 1H), 7.37–7.28 (m, 1H), 6.31 (s, 1H, NH), 4.89 (s, 2H), 4.84 (s, 2H), 3.92–3.86 (m, 2H), 3.19 and 3.06 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.17 and 2.02 (2 s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.72, 168.99, 159.92, 158.43, 157.80 (<sup>1</sup><i>J</i><sub>C,F</sub> = 248 Hz), 149.04, 148.87, 148.56, 135.31 (<sup>4</sup><i>J</i><sub>C,F</sub> = 3 Hz), 130.79, 130.56, 130.00, 129.79, 129.62, 129.51, 128.74, 127.11 (<sup>3</sup><i>J</i><sub>C,F</sub> = 7.6 Hz), 126.92 (<sup>3</sup><i>J</i><sub>C,F</sub> = 7.6 Hz), 121.80, 121.62, 119.24 (<sup>2</sup><i>J</i><sub>C,F</sub> = 50 Hz), 117.42 (<sup>2</sup><i>J</i><sub>C,F</sub> = 21.3 Hz), 117.30 (<sup>2</sup><i>J</i><sub>C,F</sub> = 21.3 Hz), 113.78, 108.26, 107.77, 52.27, 52.15, 44.75, 43.38, 40.11, 39.17, 33.83, 33.08, 21.62, 21.50.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Acetyl-10-[(3-chloro-5-fluoro-4-methoxybenzyl)amino]-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>6g</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-5-fluoro-4-methoxy-benzenemethanamine and <b>5c</b> provided <b>6g</b>: column chromatography using ethyl acetate/methanol, 95:5; yield 46%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub>FCl 439.1337, found 439.1344; LC/MS purity 96.89%, <i>t</i><sub>R</sub> = 8.11 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.29 (m, 1H), 8.04–7.97 (2 d, 1H, <i>J</i> = 8.8 Hz), 7.78 and 7.74 (1H, d, <i>J</i> = 8.8 Hz and dd, <i>J</i> = 8.8, 2.0 Hz), 7.19 and 7.16 (2 s, 1H), 7.02 (dd, 1H, <i>J</i> = 10.8, 1.6 Hz), 4.73 and 4.59 (2 s, 3H), 4.63 and 4.56 (2 d, 2H, <i>J</i> = 6.8 Hz), 4.47 (t, 1H, <i>J</i> = 6.4 Hz, NH), 4.21 and 3.83 (2 t, 2H, <i>J</i> = 6.4 Hz), 3.99 (s, 3H), 3.22 and 3.17 (2 t, 2H, <i>J</i> = 5.6 Hz), 2.22 and 2.08 (2 s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.76, 157.36, 154.85, 144.15, 144.02, 134.37, 130.05, 129.54, 129.03, 128.99, 128.77, 124.23, 124.20, 124.02, 119.24, 118.87, 114.55, 114.34, 113.55, 107.92, 61.53, 61.48, 51.91, 44.79, 43.26, 40.11, 39.12, 33.46, 29.64, 21.57, 21.45.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3-Chloro-5-fluoro-4-methoxyphenyl)methanol (<b>8</b>)</h3><div class="NLM_p last">NaBH<sub>4</sub> (52.15 mg, 1.38 mmol) was added to a solution of 3-chloro-5-fluoro-4-methoxybenzaldehyde <b>7</b> (200 mg, 1.06 mmol) in THF (5 mL). The mixture was stirred overnight at room temperature. Iced water was added to the reaction mixture, which was partitioned between ethyl ether (20 mL) and 4 N HCl  (20 mL). The organic phase was washed with 4 N HCl (3 × 20 mL) and dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and evaporated. Final product <b>8</b> was obtained in a quantitative amount: yield 98%; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.16 (t, 1H, <i>J</i> = 1.8 Hz), 7.04 (dd, 1H, <i>J</i> = 11.4, 1.8 Hz), 4.62 (s, 2H), 3.95 (2, 3H).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(3-Chloro-5-fluoro-4-methoxybenzyl)isoindoline-1,3-dione (<b>9</b>)</h3><div class="NLM_p last"><b>8</b> (200 mg, 1.05 mmol), phthalimide (200.7 mg, 1.36 mmol), and triphenylphosphine (356 mg, 1.36 mmol) were dissolved in THF (7 mL), and DIAD (275 mg, 1.36 mmol) was added at 0 °C. The reaction mixture was stirred at room temperature for 24 h. The solvent was evaporated, and the residue was partitioned between ethyl ether and H<sub>2</sub>O. The aqueous phase was extracted 3 times with Et<sub>2</sub>O (3 × 20 mL), and the organic phase was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash chromatography using hexane/ethyl acetate, 90:10: yield 54%; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.87–7.85 (m, 2H), 7.74–7.72 (m, 2H), 2.35 (t, 1H, <i>J</i> = 2.0 Hz), 7.10 (dd, 1H, <i>J</i> = 10.8, 2.4 Hz), 4.74 (s, 2H), 3.91 (s, 3H).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (3-Chloro-5-fluoro-4-methoxyphenyl)methanamine hydrochloride (<b>10</b>)</h3><div class="NLM_p last">N<sub>2</sub>H<sub>4</sub> (0.47 mmol) was added to a solution of <b>9</b> (0.09 mmol) in MeOH (2 mL), and the reaction was stirred to 70 °C overnight. The reaction was cooled, and H<sub>2</sub>O was added. The organic solvent was evaporated off, and concentrated HCl was added. The mixture was stirred at room temperature for 1 h, and the resulting precipitate was filtered off. The aqueous phase was extracted with DCM (3 × 10 mL), and the organic phase was discarded. Then the aqueous phase was basified and extracted with DCM (3 × 10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduce pressure. The residue was treated with 2 M HCl/Et<sub>2</sub>O to give <b>10</b>: yield 73%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.46 (s, 3H, NH<sub>3</sub><sup>+</sup>), 7.52–7.51 (m, 1H), 7.48 (d, 1H, <i>J</i> = 2.0 Hz), 3.99 (s, 2H), 3.90 (s, 3H).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 10-Chloro-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>11</b>)</h3><div class="NLM_p last">1-Chloroethyl chloroformate (1.5 equiv) was added dropwise to a solution of benzyl derivative (1 equiv) in DCE at 0 °C. The mixture was heated to reflux for 2 h. DCE was evaporated off, and the residue was dissolved in MeOH and refluxed for 1 h. The formation of a precipitate was observed. After the reaction mixture was cooled to rt, the precipitate was collected by filtration and partitioned between 1 N NaOH and AcOEt and the aqueous layer was extracted twice with AcOEt. The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to yield <b>11</b>: yield 62%; ESI-MS <i>m</i>/<i>z</i> 244 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.57 (d, 1H, <i>J</i> = 1.2 Hz), 8.04 (d, 1H, <i>J</i> = 8.7 Hz), 7.82 (dd, 1H, <i>J</i> = 8.4, 1.8 Hz), 4.28 (s, 2H), 3.30 (t, 2H, <i>J</i> = 6.0 Hz), 3.17 (t, 2H, <i>J</i> = 6.0 Hz), 1.73 (s, 1H).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> <i>tert</i>-Butyl 10-Chloro-8-cyano-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridine-2(1<i>H</i>)-carboxylate (<b>12</b>)</h3><div class="NLM_p last">Di<i>tert</i>-butyl dicarbonate (3.5 mmol) was added to a solution of <b>11</b> (3.5 mmol) in DCM (10 mL) at 0 °C. The reaction was stirred at rt for 1 h. The reaction was washed with a saturated NaHCO<sub>3</sub>  solution (2 × 30 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure to obtain <b>12</b>: yield 94%; ESI-MS <i>m</i>/<i>z</i> 385 [M + MeCN]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.60 (s, 1H), 8.09 (d, 1H, <i>J</i> = 8.8 Hz), 7.85 (d, 1H, <i>J</i> = 8.4 Hz), 4.85 (s, 2H), 3.85 (t, 2H, <i>J</i> = 5.8 Hz), 3.22 (t, 2H, <i>J</i> = 5.2 Hz), 1.52 (s, 9H).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>tert</i>-Butyl 10-[(3-Chloro-4-methoxybenzyl)amino]-8-cyano-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridine-2(1<i>H</i>)-carboxylate (<b>13</b>)</h3><div class="NLM_p last"><b>13</b> was obtained by column chromatography using hexane/ethyl acetate, 30:70: yield 49%; ESI-MS <i>m</i>/<i>z</i> 479.45 [M + H]<sup>+</sup>; LC/MS purity 99.5%, <i>t</i><sub>R</sub> = 6.75 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (d, 1H, <i>J</i> = 1.5 Hz), 7.94 (d, 1H, <i>J</i> = 8.7 Hz), 7.70 (dd, 1H, <i>J</i> = 8.7, 1.8 Hz), 7.31 (s, 1H), 7.17 (dd, 1H, <i>J</i> = 8.4, 2.1 Hz), 6.90 (d, 1H, <i>J</i> = 8.1 Hz), 4.60–4.55 (m, 4H), 4.36 (s, 1H), 3.89 (2, 3H), 3.75 (t, 2H, <i>J</i> = 6.0 Hz), 3.12 (t, 2H, <i>J</i> = 6.0 Hz), 1.47 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 154.98, 149.03, 148.65, 131.31, 130.51, 129.59, 129.49, 126.98, 123.10, 119.10, 112.52, 107.54, 80.56, 56.19, 52.58, 33.55, 28.36.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 10-((3-Chloro-4-methoxybenzyl)amino)-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine-8-carbonitrile (<b>14</b>)</h3><div class="NLM_p last">A solution of 2.0 M Et<sub>2</sub>O/HCl was added dropwise to a solution of <b>13</b> (0.21 mmol) in CH<sub>2</sub>Cl<sub>2</sub>/1,4-dioxane (1:2) (1.0 mL). The mixture was stirred at rt overnight. The reaction mixture was diluted with 1 N HCl, and the organic layer was discarded. The aqueous layer was then basified by using NaHCO<sub>3</sub> and extracted with DCM (3 × 10 mL). The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated under reduced pressure. Column chromatography using methylene chloride/methanol, 90:10, afforded <b>14</b> in 20% yield: ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>20</sub>N<sub>4</sub>OCl 379.1326, found 379.1338; LC/MS purity 97.38%, <i>t</i><sub>R</sub> = 6.62 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.32 (s, 1H), 7.97 (d, 1H, <i>J</i> = 9.7 Hz), 7.71 (d, 1H, <i>J</i> = 9.0 Hz), 7.33 (d, 1H, <i>J</i> = 1.8 Hz), 7.17 (d, 1H, <i>J</i> = 8.4 Hz), 6.93 (d, 1H, <i>J</i> = 8.7 Hz), 4.56 (d, 2H, <i>J</i> = 5.4 Hz), 4.09 (s, 1H), 3.97 (s, 2H), 3.92 (s, 3H), 3.25 (t, 2H, <i>J</i> = 6.0 Hz), 3.11 (t, 2H, <i>J</i> = 6.0 Hz); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.90, 154.90, 148.93, 148.60, 131.67, 130.38, 129.47, 129.43, 129.28, 126.93, 123.03, 119.58, 119.24, 116.91, 112.46, 107.26, 56.20, 52.59, 44.84, 43.34, 34.11.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 1-(10-Chloro-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridin-2(1<i>H</i>)-yl)ethan-1-one (<b>16a</b>)</h3><div class="NLM_p last">Following general procedure A, 1-acetylpiperidin-4-one and <b>11a</b> provided <b>16a</b>: column chromatography using methylene chloride/methanol, 95:5; yield 33%; ESI-MS <i>m</i>/<i>z</i> 261 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.22–8.20 (m, 1H), 8.04–8.00 (m, 1H), 7.77–7.72 (m, 1H), 7.64–7.59 (m, 1H), 5.00 and 4.87 (2 s, 2H), 4.01 and 3.88 (2 t, 2H, <i>J</i> = 5.6 Hz), 3.27 and 3.21 (2 t, 2H, <i>J</i> = 6.4), 2.28 and 2.26 (2 s, 3H).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-(10-Chloro-8-methoxy-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridin-2(1<i>H</i>)-yl)ethan-1-one (<b>16b</b>)</h3><div class="NLM_p last">Following general procedure A, 1-acetylpiperidin-4-one and <b>11b</b> provided <b>16b</b>: column chromatography using methylene chloride/methanol, 95:5; yield 24%; ESI-MS <i>m</i>/<i>z</i> 291 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 7.90 (d, 1H, <i>J</i> = 9.2 Hz), 7.42–7.40 (m, 1H), 7.39–7.36 (m, 1H), 4.98 and 4.85 (2 s, 2H), 4.00 and 3.86 (2 t, 2H, <i>J</i> = 6.0 Hz), 3.98 and 3.97 (2 s, 3H), 3.22 and 3.17 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.28 and 2.25 (2 s, 3H).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-(8-Bromo-10-chloro-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridin-2(1<i>H</i>)-yl)ethan-1-one (<b>16c</b>)</h3><div class="NLM_p last">Following general procedure A, 1-acetylpiperidin-4-one and <b>11c</b> provided <b>16c</b>: column chromatography using methylene chloride/methanol, 95:5; yield 21%; ESI-MS <i>m</i>/<i>z</i> 340 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.36 (s, 1H), 7.88–7.78 (m, 2H), 4.99 and 4.86 (2 s, 2H), 4.00 and 3.87 (2 t, 2H, <i>J</i> = 4.8 Hz), 3.24 and 3.18 (2 t, 2H, <i>J</i> = 4.8 Hz), 3.27 and 2.25 (2 s, 3H).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 8-Bromo-10-chloro-2-methyl-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine (<b>16d</b>)</h3><div class="NLM_p last">Following general procedure A, 1-methylpiperidin-4-one and 2-amino-5-bromobenzoic acid provided <b>16d</b>. The desired compound was purified by triturating with Et<sub>2</sub>O: yield 42%; ESI-MS <i>m</i>/<i>z</i> 352 [M + MeCN]<sup>+</sup>; <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.33 (d, 1H, <i>J</i> = 2.1 Hz), 7.86 (d, 1H, <i>J</i> = 9.0 Hz), 7.77 (dd, 1H, <i>J</i> = 9.0, 2.1 Hz), 3.99 (s, 2H), 3.34 (t, 2H, <i>J</i> = 5.7 Hz), 3.03 (t, 2H, <i>J</i> = 5.7 Hz), 2.69 (s, 3H).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-(10-((3-Chloro-4-methoxybenzyl)amino)-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridin-2(1<i>H</i>)-yl)ethan-1-one (<b>17a</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxy-benzenemethanamine and <b>16a</b> provided <b>17a</b>: column chromatography using ethyl acetate/methanol, 80:20; yield 24%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub>Cl 396.1479, found 396.1489; LC/MS purity 99.07%, <i>t</i><sub>R</sub> = 7.74 min; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) (mixture of rotamers) δ 8.11 (d, 1H), 7.71–7.67 (m, 1H), 7.55–7.50 (m, 1H), 7.43 and 7.380 (2 d, 1H), 7.35–7.29 (m, 1H), 7.22–7.18 (m, 1H), 7.03 and 7.98 (2 d, 1H), 6.45 (br s, 1H, NH, D<sub>2</sub>O exchange), 4.66 and 4.58 (2 s, 2H), 4.52 (m, 2H, <u class="uu">CH</u><sub>2</sub>NH), 3.75 and 3.73 (2 s, 3H), 3.70 and 3.66 (2 t, 2H, <i>J</i> = 6.4 Hz), 3.99 and 2.87 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.04 and 1.88 (2 s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.64, 169.15, 156.56, 155.34, 154.72, 154.58, 149.01, 148.62, 147.81, 147.72, 132.23, 132.14, 130.85, 129.37, 129.28, 129.19, 128.99, 128.75, 126.92, 126.73, 125.18, 124.78, 122.96, 122.70, 122.37, 121.55, 120.68, 120.36, 113.55, 112.76, 112.31, 56.21, 56.17, 52.48, 52.29, 44.87, 43.69, 40.30, 39.58, 33.66, 32.86, 21.68, 21.58.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-[10-((3-Chloro-4-methoxybenzyl)amino)-8-methoxy-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridin-2(1<i>H</i>)-yl]ethan-1-one (<b>17b</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxy-benzenemethanamine and <b>16b</b> provided <b>17b</b>: column chromatography using ethyl acetate/methanol, 80:20; yield 20%, ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>Cl 426.1584, found 426.1592; LC/MS purity 95.93%, <i>t</i><sub>R</sub> = 8.21 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 7.90 and 7.86 (2 d, 1H, <i>J</i> = 9.2 Hz), 7.41 and 7.37 (2 d, 1H <i>J</i> = 2.0 Hz), 7.31–7.27 (dd, 1H, <i>J</i> = 9.6, 2.8 Hz), 7.23 (dd, 1H, <i>J</i> = 8.0, 2.4 Hz), 7.15 and 7.11 (2 d, 1H, <i>J</i> = 2.8 Hz), 6.92–6.87 (m, 1H), 4.74 and 4.58 (2 s, 2H), 4.52 and 4.45 (s, 1.5H), 3.90 (s, 4H, OCH<sub>3</sub> and NH), 3.80 (t, 2H, <i>J</i> = 6.4 Hz), 3.84 and 3.75 (2 s, 3H), 3.18 and 3.13 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.21 and 2.08 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.67, 169.15, 157.07, 156.73, 154.69, 154.50, 153.92, 152.73, 148.24, 147.61, 143.74, 143.59, 132.48, 130.75, 130.39, 129.24, 129.17, 126.70, 122.99, 122.70, 121.75, 121.48, 121.41, 114.78, 114.08, 112.29, 101.19, 100.54, 56.19, 55.44, 55.32, 52.16, 51.81, 44.80, 43.77, 40.30, 39.61, 33.33, 32.53, 21.65, 21.54.</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-[8-Bromo-10-((3-chloro-4-methoxybenzyl)amino)-3,4-dihydrobenzo[<i>b</i>][1,6]naphthyridin-2(1<i>H</i>)-yl]ethan-1-one (<b>17c</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxy-benzenemethanamine and <b>16c</b> provided <b>17c</b>: column chromatography using methylene chloride/methanol, 95:5; yield 42%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub>ClBr 474.0584, found 474.0587; LC/MS purity 97.86%, <i>t</i><sub>R</sub> = 5.8 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 8.09 and 8.05 (2 d, 1H, <i>J</i> = 1.6 Hz), 7.86–7.82 (m, 1H), 7.73–7.67 (m, 1H), 7.37 and 7.32 (2 d, 1H, <i>J</i> = 2.0 Hz), 7.21 and 7.12 (2 dd, 1H, <i>J</i> = 8.8, 0.75 Hz), 6.94–6.90 (m, 1H), 4.71 and 4.48 (2 s, 2H), 4.56 (s, 2H), 3.91 (s, 3H), 3.8 (t, 2H, <i>J</i> = 6.0 Hz), 3.19 and 3.13 (2 t, 2H, <i>J</i> = 6.0 Hz), 2.21 and 2.05 (2 s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) (mixture of rotamers) δ 169.62, 169.08, 157.05, 155.79, 154.85, 154.71, 148.08, 147.69, 146.48, 146.45, 132.70, 132.48, 131.98, 131.85, 131.07, 130.79, 129.45, 129.29, 126.98, 126.74, 124.32, 125.09, 123.10, 122.80, 122.02, 121.64, 118.90, 118.38, 114.44, 113.67, 112.39, 112.36, 56.22, 56.18, 52.52, 52.35, 44.76, 43.56, 40.21, 33.65, 32.83, 21.59, 21.51.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 8-Bromo-<i>N</i>-(3-chloro-4-methoxybenzyl)-2-methyl-1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridin-10-amine (<b>17d</b>)</h3><div class="NLM_p last">Following general procedure B, 3-chloro-4-methoxy-benzenemethanamine and <b>16b</b> provided <b>17b</b>: column chromatography using ethyl acetate/methanol, 80:20; yield 38%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>OClBr 446.0557, found 446.0504; LC/MS purity 96.43%, <i>t</i><sub>R</sub> = 7.1 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.04 (d, 1H, <i>J</i> = 2.4 Hz), 7.80 (d, 1H, <i>J</i> = 8.8 Hz), 7.65 (dd, 1H, <i>J</i> = 9.0, 2.4 Hz), 7.38 (d, 1H, <i>J</i> = 2.0 Hz), 7.17 (dd, 1H, <i>J</i> = 8.4, 2.0 Hz), 6.92 (d, 1H, <i>J</i> = 8.8 Hz), 4.47 (s, 2H), 3.92 (s, 4H, OCH<sub>3</sub> and NH), 3.54 (s, 2H), 3.18 (t, 2H, <i>J</i> = 6.0 Hz), 2.812 (t, 2H, <i>J</i> = 6.0 Hz), 2.50 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 156.49, 154.64, 147.65, 146.41, 132.22, 132.05, 130.80, 129.50, 126.98, 124.82, 122.75, 121.65, 118.01, 115.97, 112.26, 56.19, 54.43, 52.378, 52.34, 46.22, 33.54.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 2,4-Dioxo-1,4-dihydro-2<i>H</i>-benzo[<i>d</i>][1,3]oxazine-6-carbonitrile (<b>19a</b>)</h3><div class="NLM_p last">Following general procedure C, <b>18a</b> (1.5 g, 8.25 mmol) and triphosgene (0.914 g, 3.08 mmol) provided <b>19a</b>: yield 87%; ESI-MS <i>m</i>/<i>z</i> 187 [M – H]<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (s, 1H), 8.38 (d, 1H, <i>J</i> = 1.6 Hz), 8.11 (dd, 1H, <i>J</i> = 8.8, 1.6 Hz), 7.25 (d, 1H, <i>J</i> = 8.4 Hz).</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 6-Methoxy-2<i>H</i>-benzo[<i>d</i>][1,3]oxazine-2,4(1<i>H</i>)-dione (<b>19b</b>)</h3><div class="NLM_p last">Following general procedure C, <b>18b</b> (0.5 g, 3.0 mmol) and triphosgene (0.297 g, 1.0 mmol) provided <b>19b</b>: yield 88%; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.61 (s, 1H), 7.38 (dd, 1H, <i>J</i> = 8.4, 2.8 Hz), 7.34 (d, 1H, <i>J</i> = 2.4 Hz), 7.11 (d, 1H, <i>J</i> = 8.4 Hz), 3.80 (s, 3H).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 6-(Trifluoromethyl)-2<i>H</i>-benzo[<i>d</i>][1,3]oxazine-2,4(1<i>H</i>)-dione (<b>19c</b>)</h3><div class="NLM_p last">Following general procedure C, <b>18c</b> (0.8 g, 3.9 mmol) and triphosgene (0.386 g, 1.3 mmol) provided <b>19c</b>: yield 84%; ESI-MS <i>m</i>/<i>z</i> 230 [M – H]<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.09 (s, 1H), 8.14 (d, 1H, <i>J</i> = 1.2 Hz), 8.07 (dd, 1H, <i>J</i> = 8.8, 1.6 Hz), 7.32 (d, 1H, <i>J</i> = 8.8 Hz).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl 6-Cyano-2-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>20a</b>)</h3><div class="NLM_p last">Following general procedure D, <b>19a</b> (1.0 g, 5.32 mmol) and methyl acetoacetate (0.740 g, 6.38 mmol) provided <b>20a</b>: yield 49%; ESI-MS <i>m</i>/<i>z</i> 243 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.25 (s, 1H), 8.39 (d, 1H, <i>J</i> = 2.0 Hz), 8.01 (dd, 1H, <i>J</i> = 8.8, 2.0 Hz), 7.66 (d, 1H, <i>J</i> = 8.8 Hz), 3.70 (s, 3H), 2.41 (s, 3H).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl 6-Methoxy-2-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>20b</b>)</h3><div class="NLM_p last">Following general procedure D, <b>19b</b> (0.502 g, 2.6 mmol) and methyl acetoacetate (0.360 g, 3.1 mmol) provided <b>20b</b>; Yield 70%; ESI-MS <i>m</i>/<i>z</i> 192 [M – H]<sup>−</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.61 (s, 1H), 7.38 (dd, 1H, <i>J</i> = 8.4, 2.8 Hz), 7.34 (d, 1H, <i>J</i> = 2.4 Hz), 7.11 (d, 1H, <i>J</i> = 8.4 Hz), 3.80 (s, 3H).</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl 2-Methyl-4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylate (<b>20c</b>)</h3><div class="NLM_p last">Following general procedure D, <b>19c</b> (0.6 g, 2.6 mmol) and methyl acetoacetate (0.360 g, 3.1 mmol) provided <b>20c</b>: yield 62%; ESI-MS <i>m</i>/<i>z</i> 286 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDOD<sub>3</sub>) δ 8.52 (s, 1H), 7.92 (d, 1H, <i>J</i> = 8.8 Hz), 7.70 (d, 1H, <i>J</i> = 8.8 Hz), 3.89 (s, 3H), 2.54 (s, 3H).</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Methyl 2-Methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>20d</b>)</h3><div class="NLM_p last">Following general procedure D, isatoic anhydride <b>19d</b> (1.0 g, 6.13 mmol) and methyl acetoacetate (0.854 g, 7.35 mmol) provided <b>20d</b>: yield 65%; ESI-MS <i>m</i>/<i>z</i> 218 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.05 (d, 1H, <i>J</i> = 8.0 Hz), 7.69–7.65 (m, 1H), 7.53 (d, 1H, <i>J</i> = 8.4 Hz), 7.36 (m, 1H), 3.76 (s, 3H), 2.39 (s, 3H).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl 6-Chloro-2-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate (<b>20e</b>)</h3><div class="NLM_p last">Following general procedure D, 5-chloroisatoic anhydride <b>19e</b> (1.5 g, 7.6 mmol) and methyl acetoacetate (1.05 g, 9.1 mmol) provided <b>20d</b>: yield 64%; ESI-MS <i>m</i>/<i>z</i> 252 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.07 (s, 1H), 7.98 (d, 1H, <i>J</i> = 2.4 Hz), 7.71 (dd, 1H, <i>J</i> = 8.4, 2.4 Hz), 7.57 (d, 1H, <i>J</i> = 8.8 Hz), 3.76 (s, 3H), 2.39 (s, 3H).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 4-Chloro-6-cyano-2-methylquinoline-3-carboxylate (<b>21a</b>)</h3><div class="NLM_p last">Following general procedure E, <b>20a</b> (0.485 g, 2.0 mmol) in POCl<sub>3</sub> (4.0 mL) provided <b>21a</b>: yield 19%; ESI-MS <i>m</i>/<i>z</i> 261 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.61 (d, 1H, <i>J</i> = 2.0 Hz), 8.12 (d, 1H, <i>J</i> = 8.8 Hz), 7.92 (dd, 1H, <i>J</i> = 8.4, 1.6 Hz), 4.05 (s, 3H), 2.75 (s, 3H).</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Methyl 4-Chloro-6-methoxy-2-methylquinoline-3-carboxylate (<b>21b</b>)</h3><div class="NLM_p last">Following general procedure E, <b>20b</b> (0.400 g, 1.6 mmol) in POCl<sub>3</sub> (3.0 mL) provided <b>21b</b>: yield 93%; ESI-MS <i>m</i>/<i>z</i> 266 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93 (d, 1H, <i>J</i> = 9.6 Hz), 7.43–7.41 (m, 2H), 4.03 (s, 3H), 3.97 (s, 3H), 2.67 (s, 3H).</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Methyl 4-Chloro-2-methyl-6-(trifluoromethyl)quinoline-3-carboxylate (<b>21c</b>)</h3><div class="NLM_p last">Following general procedure E, <b>20c</b> (0.456 g, 1.6 mmol) in POCl<sub>3</sub> (1.0 mL) provided <b>21c</b>: yield 51%; ESI-MS <i>m</i>/<i>z</i> 304 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.15 (d, 1H, <i>J</i> = 8.8 Hz), 7.95 (dd, 1H, <i>J</i> = 8.8, 1.6 Hz), 4.05 (s, 3H), 2.75 (s, 3H).</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Methyl 4-Chloro-2-methylquinoline-3-carboxylate (<b>21d</b>)</h3><div class="NLM_p last">Following general procedure E, <b>20d</b> (0.487 g, 3.9 mmol) in POCl<sub>3</sub> (3.0 mL) provided <b>21d</b>: yield 90%; ESI-MS <i>m</i>/<i>z</i> 236 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.4 (d, 1H, <i>J</i> = 8.4 Hz), 8.03 (d, 1H, <i>J</i> = 8.4 Hz), 7.79 (td, 1H, <i>J</i><sub>1</sub> = 1.2, <i>J</i><sub>2</sub> = 7.2), 7.63 (t, 1H, <i>J</i> = 8.4), 4.04 (s, 3H), 2.72 (s, 3H).</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Methyl 4,6-Dichloro-2-methylquinoline-3-carboxylate (<b>21e</b>)</h3><div class="NLM_p last">Following general procedure E, <b>20e</b> (0.755 g, 3.0 mmol) in POCl<sub>3</sub> (4.0 mL) provided <b>21e</b>: yield 91%; ESI-MS <i>m</i>/<i>z</i> 311 [M + MeCN]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.21 (d, 1H, <i>J</i> = 2.4 Hz), 8.08 (d, 1H, <i>J</i> = 9.2 Hz), 7.95 (dd, 1H, <i>J</i> = 8.8, 2.4 Hz), 4.01 (s, 3H), 2.63 (s, 3H).</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Methyl 2-(Bromomethyl)-4-chloro-6-cyanoquinoline-3-carboxylate (<b>22a</b>)</h3><div class="NLM_p last">Following general procedure F, <b>21a</b> (0.08 g, 0.3 mmol), <i>N</i>-bromosuccinimide (0.08 g, 0.46 mmol), and 2,2′-azobis(2-methylpropionitrile) (0.01 g, 0.06 mmol) provided <b>22a</b>: column chromatography using hexane/ethyl acetate, 90:10; yield 39%; ESI-MS <i>m</i>/<i>z</i> 341 [M + 1]<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Methyl 2-(Bromomethyl)-4-chloro-6-methoxyquinoline-3-carboxylate (<b>22b</b>)</h3><div class="NLM_p last">Following general procedure F, <b>21b</b> (0.390 g, 1.47 mmol), <i>N</i>-bromosuccinimide (0.392 g, 2.20 mmol), and 2,2′-azobis(2-methylpropionitrile) (0.048 g, 0.3 mmol) provided <b>22b</b>: column chromatography using hexane/ethyl acetate, 90:10; yield 16%; ESI-MS <i>m</i>/<i>z</i> 346 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98 (d, 1H, <i>J</i> = 10.4 Hz), 7.47–7.44 (m, 2H), 4.77 (s, 2H), 4.07 (s, 3H), 3.99 (s, 3H).</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Methyl 2-(Bromomethyl)-4-chloro-6-(trifluoromethyl)quinoline-3-carboxylate (<b>22c</b>)</h3><div class="NLM_p last">Following general procedure F, <b>21c</b> (0.130 g, 0.43 mmol), <i>N</i>-bromosuccinimide (0.115 g, 0.64 mmol), and 2,2′-azobis(2-methylpropionitrile) (0.014 g, 0.09 mmol) provided <b>22c</b>: column chromatography using hexane/ethyl acetate, 90:10; yield 55%; ESI-MS <i>m</i>/<i>z</i> 384 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (d, 1H, <i>J</i> = 1.2 Hz), 8.22 (d, 1H, <i>J</i> = 8.8 Hz), 8.01 (dd, 1H, <i>J</i> = 8.8, 2.0 Hz), 4.77 (s, 2H), 4.06 (s, 3H).</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Methyl 2-(Bromomethyl)-4-chloroquinoline-3-carboxylate (<b>22d</b>)</h3><div class="NLM_p last">Following general procedure F, <b>21d</b> (0.810 g, 3.44 mmol), <i>N</i>-bromosuccinimide (0.918 g, 5.15 mmol), and 2,2′-azobis(2-methylpropionitrile) (0.113 g, 0.7 mmol) provided <b>22d</b>: column chromatography using dichloromethane; yield 57%; ESI-MS <i>m</i>/<i>z</i> 315 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.28 (dd, 1H, <i>J</i> = 8.0, 1.2 Hz), 8.09 (d, 1H, <i>J</i> = 8.0 Hz), 7.86–7.82 (m, 1H), 7.73–7.68 (m, 1H), 4.80 (s, 2H), 4.08 (s, 3H).</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Methyl 2-(Bromomethyl)-4,6-dichloroquinoline-3-carboxylate (<b>22e</b>)</h3><div class="NLM_p last">Following general procedure F, <b>21e</b> (0.400 g, 1.5 mmol), <i>N</i>-bromosuccinimide (0.405 g, 2.25 mmol), and 2,2′-azobis(2-methylpropionitrile) (0.049 g, 0.3 mmol) provided <b>22e</b>: column chromatography using hexane/ethyl acetate, 60:40; yield 35%; ESI-MS <i>m</i>/<i>z</i> 350 [M + H]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26 (d, 1H, <i>J</i> = 2.0 Hz), 8.04 (d, 1H, <i>J</i> = 8.4 Hz), 7.78 (dd, 1H, <i>J</i> = 8.8, 2.4 Hz), 4.78 (s, 2H), 4.08 (s, 3H).</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 9-Chloro-2-ethyl-1-oxo-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinoline-7-carbonitrile (<b>23a</b>)</h3><div class="NLM_p last">Following general procedure G, <b>22a</b> (0.052 g, 0.15 mmol) and EtNH<sub>2</sub> (0.230 mL, 0.46 mmol) provided <b>23a</b>: column chromatography using hexane/ethyl acetate, 30:70; yield 25%; ESI-MS <i>m</i>/<i>z</i> 272 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.84 (d, 1H, <i>J</i> = 2.0 Hz), 8.23 (d, 1H, <i>J</i> = 1.4 Hz), 7.99 (dd, 1H, <i>J</i> = 8.8, 1.6 Hz), 4.57 (s, 2H), 3.78 (q, 2H, <i>J</i> = 7.2 Hz), 1.35 (t, 3H, <i>J</i> = 6.8 Hz).</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 9-Chloro-2-ethyl-7-methoxy-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>23b</b>)</h3><div class="NLM_p last">Following general procedure G, <b>22b</b> (0.060 g, 0.17 mmol) and EtNH<sub>2</sub> (0.260 mL, 0.52 mmol) provided <b>23b</b>: column chromatography using hexane/ethyl acetate, 30:70; yield 72%; ESI-MS <i>m</i>/<i>z</i> 277 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.01 (d, 1H, <i>J</i> = 8.8 Hz), 7.64 (d, 1H, <i>J</i> = 2.8 Hz), 7.50 (dd, 1H, <i>J</i> = 9.6, 2.8 Hz), 4.49 (s, 2H), 4.01 (s, 3H), 3.76 (q, 2H, <i>J</i> = 7.2 Hz), 1.33 (t, 3H, <i>J</i> = 7.2 Hz).</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 9-Chloro-2-ethyl-7-(trifluoromethyl)-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>23c</b>)</h3><div class="NLM_p last">Following general procedure G, <b>22c</b> (0.080 g, 0.21 mmol) and EtNH<sub>2</sub> (0.315 mL, 0.63 mmol) provided <b>23c</b>: column chromatography using hexane/ethyl acetate, 50:50; yield 45%; ESI-MS <i>m</i>/<i>z</i> 315 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.76 (s, 1H), 8.26 (d, 1H, <i>J</i> = 8.8 Hz), 8.03 (dd, 1H, <i>J</i> = 8.8, 2.0 Hz), 4.57 (s, 2H), 3.79 (q, 2H, <i>J</i> = 6.8 Hz), 1.35 (t, 3H, <i>J</i> = 6.8 Hz).</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 9-Chloro-2-ethyl-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>23d</b>)</h3><div class="NLM_p last">Following general procedure G, <b>22d</b> (0.080 g, 0.26 mmol) and EtNH<sub>2</sub> (0.382 mL, 0.76 mmol) provided <b>23d</b>: column chromatography using hexane/ethyl acetate, 30:70; yield 84%; ESI-MS <i>m</i>/<i>z</i> 247 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (d, 1H, <i>J</i> = 8.4 Hz), 8.13 (d, 1H, <i>J</i> = 8.4 Hz), 7.87 (m, 1H), 7.72 (m, 1H), 4.53 (s, 2H), 3.77 (q, 2H, <i>J</i> = 7.2 Hz), 1.34 (t, 3H, <i>J</i> = 7.2 Hz).</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 7,9-Dichloro-2-ethyl-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>23e</b>)</h3><div class="NLM_p last">Following general procedure G, <b>22e</b> (0.144 g, 0.41 mmol) and EtNH<sub>2</sub> (0.619 mL, 1.24 mmol) provided <b>23d</b>: column chromatography using hexane/ethyl acetate, 30:70; yield 54%; ESI-MS <i>m</i>/<i>z</i> 281 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (d, 1H, <i>J</i> = 2.0 Hz), 8.07 (d, 1H, <i>J</i> = 8.8 Hz), 7.79 (dd, 1H, <i>J</i> = 8.8, 2.4 Hz), 4.52 (s, 2H), 3.78 (q, 2H, <i>J</i> = 7.6 Hz), 1.33 (t, 3H, <i>J</i> = 7.6 Hz).</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 2-(<i>tert</i>-Butyl)-9-chloro-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>23f</b>)</h3><div class="NLM_p last">Following general procedure G, <b>22e</b> (0.100 g, 0.32 mmol) and <i>tert</i>-butylamine (0.101 mL, 0.95 mmol) provided <b>23f</b>: column chromatography using hexane/ethyl acetate, 30:70; yield 28%; ESI-MS <i>m</i>/<i>z</i> 275 [M + 1]<sup>+</sup>; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.46 (dd, 1H, <i>J</i> = 8.4, 1.2 Hz), 8.12 (d, 1H, <i>J</i> = 8.8 Hz), 7.88–7.84 (m, 1H), 7.73–7.69 (m, 1H), 4.60 (s, 2H), 1.63 (s, 9H).</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 9-((3-Chloro-4-methoxybenzyl)amino)-2-ethyl-1-oxo-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinoline-7-carbonitrile (<b>24a</b>)</h3><div class="NLM_p last">Following general procedure H, <b>23a</b> (0.01 g, 0.037 mmol), 3-chloro-4-methoxybenzylamine hydrochloride (0.012 g, 0.055 mmol), and DIPEA (0.029 g, 0.22 mmol) provided <b>24a</b>: yield 79%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>20</sub>N<sub>4</sub>O<sub>2</sub>Cl 407.1275, found 407.1264; LC/MS purity 95.4%, <i>R<sub>f</sub></i> = 10.7 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (t, 1H, <i>J</i> = 6.0 Hz), 8.53 (d, 1H, <i>J</i> = 1.6 Hz), 7.94 (d, 1H, <i>J</i> = 9.2 Hz), 7.75 (dd, 1H, <i>J</i> = 8.4, 1.6 Hz), 7.42 (d, 1H, <i>J</i> = 1.6 Hz), 7.30 (dd, 1H, <i>J</i> = 8.4, 2.4 Hz), 6.96 (d, 1H, <i>J</i> = 8.4 Hz), 4.93 (d, 2H, <i>J</i> = 5.6 Hz), 4.38 (s, 2H), 3.89 (s, 3H), 3.63 (q, 2H, <i>J</i> = 7.2 Hz), 1.27 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 168.73, 163.90, 155.00, 153.37, 151.20, 132.19, 131.26, 130.88, 129.84, 129.17, 126.54, 123.28, 118.73, 118.13, 112.65, 106.89, 105.80, 56.18, 50.68, 50.02, 36.56, 13.43.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 9-((3-Chloro-4-methoxybenzyl)amino)-2-ethyl-7-methoxy-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>24b</b>)</h3><div class="NLM_p last">Following general procedure H, <b>23b</b> (0.03 g, 0.11 mmol), 3-chloro-4-methoxybenzylamine hydrochloride (0.034 g, 0.16 mmol) and DIPEA (0.085 g, 0.66 mmol) provided <b>24b</b>: yield 55%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>Cl 412.1428, found 412.1429; LC/MS purity 98.5%, <i>R<sub>f</sub></i> = 8.8 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (t, 1H, <i>J</i> = 6.4 Hz), 7.85 (d, 1H, <i>J</i> = 9.6 Hz), 7.48 (d, 1H, <i>J</i> = 2.4 Hz), 7.37–7.29 (m, 3H), 6.95 (d, 1H, <i>J</i> = 8.8 Hz), 4.95 (d, 2H, <i>J</i> = 6.8 Hz), 4.38 (s, 2H), 3.90 (s, 3H), 3.66 (q, 2H, <i>J</i> = 7.2 Hz), 3.59 (s, 3H), 1.28 (t, 3H, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.39, 159.13, 155.70, 154.45, 151.42, 147.37, 131.83, 130.69, 128.63, 125.97, 122.89, 122.39, 119.22, 112.40, 105.64, 104.52, 56.19, 55.22, 50.45, 49.43, 36.50, 13.45.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 9-((3-Chloro-4-methoxybenzyl)amino)-2-ethyl-7-(trifluoromethyl)-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>24c</b>)</h3><div class="NLM_p last">Following general procedure H, <b>23c</b> (0.03 g, 0.1 mmol), 3-chloro-4-methoxybenzylamine hydrochloride (0.030 g, 0.14 mmol), and DIPEA (0.074 g, 0.57 mmol) provided <b>24c</b>: yield 99%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub>ClF<sub>3</sub> 450.1196, found 450.1189; LC/MS purity 95.0%, <i>R<sub>f</sub></i> = 11.5 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (t, 1H, <i>J</i> = 6.0 Hz), 8.46 (s, 1H), 8.0 (d, 1H, <i>J</i> = 8.8 Hz), 7.80 (dd, 1H, <i>J</i> = 9.2, 2.0 Hz), 7.45 (d, 1H, <i>J</i> = 2.0 Hz), 7.32 (dd, 1H, <i>J</i> = 8.4, 2.4 Hz), 6.95 (d, 1H, <i>J</i> = 8.0 Hz), 4.95 (d, 2H, <i>J</i> = 6.0 Hz), 4.41 (s, 2H), 3.90 (s, 3H), 3.67 (q, 2H, <i>J</i> = 7.2 Hz), 1.3 (t, 3H, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.01, 163.19, 154.81, 153.27, 151.89, 130.55, 130.34, 129.06, 126.40, 126.35 (<i>J</i><sub>CF</sub> = 3.0 Hz), 125.24 (<i>J</i><sub>CF</sub> = 32.0 Hz), 123.99 (<i>J</i><sub>CF</sub> = 270.1 Hz), 123.78 (<i>J</i><sub>CF</sub> = 4.5 Hz), 123.14, 117.52, 112.53, 105.59, 56.17, 50.65, 49.79, 36.53, 13.44.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 9-((3-Chloro-4-methoxybenzyl)amino)-2-ethyl-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>24d</b>)</h3><div class="NLM_p last">Following general procedure H, <b>23d</b> (0.054 g, 0.22 mmol), 3-chloro-4-methoxybenzylamine hydrochloride (0.068 g, 0.33 mmol), and DIPEA (0.170 g, 1.31 mmol) provided <b>24d</b>: yield 63%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>2</sub>Cl 382.1322, found 382.1334; LC/MS purity 99.5%, <i>R<sub>f</sub></i> = 8.5 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26 (t, 1H, <i>J</i> = 6.0 Hz), 8.14 (dd, 1H, <i>J</i> = 8.0, 1.2 Hz), 7.94 (dd, 1H, <i>J</i> = 8.8, 1.2 Hz), 7.68–7.64 (m, 1H), 7.45 (d, 1H, <i>J</i> = 2.4 Hz), 7.33–7.29 (m, 1H), 6.95 (d, 1H, <i>J</i> = 8.4 Hz), 4.98 (d, 2H, <i>J</i> = 5.6 Hz), 4.39 (s, 2H), 3.90 (s, 3H), 3.65 (q, 2H, <i>J</i> = 7.6 Hz), 1.29 (t, 3H, <i>J</i> = 7.6 Hz); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.38, 161.26, 154.59, 151.81, 131.19, 130.70, 129.50, 129.06, 126.35, 125.41, 123.81, 122.90, 118.68, 112.48, 104.93, 56.15, 50.56, 50.00, 36.47, 13.44.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 7-Chloro-9-((3-chloro-4-methoxybenzyl)amino)-2-ethyl-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>24e</b>)</h3><div class="NLM_p last">Following general procedure H, <b>23e</b> (0.050 g, 0.18 mmol), 3-chloro-4-methoxybenzylamine hydrochloride (0.056 g, 0.27 mmol), and DIPEA (0.140 g, 1.08 mmol) provided <b>24e</b>: yield 85%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub>Cl<sub>2</sub> 416.0933, found 416.0930; LC/MS purity 99.5%, <i>R<sub>f</sub></i> = 10.2 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (t, 1H, <i>J</i> = 5.6 Hz), 8.14 (d, 1H, <i>J</i> = 2.0 Hz), 7.86 (d, 1H, <i>J</i> = 9.2 Hz), 7.58 (dd, 1H, <i>J</i> = 9.2, 2.0 Hz), 7.45 (d, 1H, <i>J</i> = 1.2 Hz), 7.32 (d, 1H, <i>J</i> = 8.8 Hz), 6.95 (d, 1H, <i>J</i> = 8.4 Hz), 4.93 (d, 2H, <i>J</i> = 6.0 Hz), 4.37 (s, 2H), 3.91 (s, 3H), 3.64 (q, 2H, <i>J</i> = 7.6 Hz), 1.28 (t, 3H, <i>J</i> = 7.2 Hz); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.06, 161.48, 154.73, 150.79, 150.29, 131.24, 130.95, 130.75, 129.24, 129.22, 126.53, 124.65, 123.01, 119.21, 112.50, 105.36, 56.15, 50.52, 49.90, 36.51, 13.43.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-(<i>tert</i>-Butyl)-9-((3-chloro-4-methoxybenzyl)amino)-2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (<b>24f</b>)</h3><div class="NLM_p last">Following general procedure H, <b>23f</b> (0.121 g, 0.44 mmol), 3-chloro-4-methoxybenzylamine hydrochloride (0.137 g, 0.66 mmol), and DIPEA (0.341 g, 2.64 mmol) provided <b>24f</b>: yield 44%; ESI-HRMS (<i>m</i>/<i>z</i>) [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub>Cl 410.1595, found 410.1620; LC/MS purity 99.2%, <i>R<sub>f</sub></i> = 9.5 min; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (t, 1H, <i>J</i> = 6.4 Hz, CH<sub>2</sub><u class="uu">NH</u>), 8.10 (d, 1H, <i>J</i> = 8.4 Hz), 7.92 (d, 1H, <i>J</i> = 8.0 Hz), 7.63 (t, 1H, <i>J</i> = 7.6 Hz), 7.45 (d, 1H, <i>J</i> = 2.0 Hz), 7.33–7.25 (m, 2H), 6.94 (d, 1H, <i>J</i> = 8.8 Hz), 4.94 (d, 2H, <u class="uu">CH</u><sub>2</sub>NH, <i>J</i> = 6.8 Hz), 4.46 (s, 2H), 3.91 (s, 3H), 1.57 (s, 9H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 170.53, 160.84, 154.51, 152.02, 151.91, 131.32, 130.52, 129.44, 128.90, 126.23, 125.47, 123.54, 122.90, 118.65, 112.42, 106.16, 56.15, 54.39, 49.86, 49.76, 28.19.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> PDE Enzymatic Activity</h3><div class="NLM_p last">Experiments were performed by BPS Bioscience, Inc. The enzymatic reactions were conducted at room temperature for 60 min in a 50 μL volume containing PDE assay buffer, 100 nM FAM-cGMP or FAM-cAMP substrate, 0.1–0.45 ng PDE5 or 22.5–250 ng PDE6, and the test compound. After the enzymatic reaction, 100 μL of a binding solution (1:100 dilution of the binding agent with the binding agent diluent) was added to each sample. After 60 min at room temperature, fluorescence intensity was measured at an excitation of 485 nm and an emission of 528 nm using a Tecan Infinite M1000 microplate reader. PDE activity assays were performed in duplicate at each concentration. Fluorescence intensity was converted to fluorescence polarization using the Tecan Magellan6 software. The fluorescence polarization data were analyzed using the computer software, Graphpad Prism. The fluorescence polarization (FPt) in absence of the compound in each data set was defined as 100% activity. In the absence of PDE and the compound, the value of fluorescent polarization (FPb) in each data set was defined as 0% activity. The percent activity in the presence of the compound was calculated according to the following equation: % activity = (FP – FPb)/(FPt – FPb) × 100%, where FP = the fluorescence polarization in the presence of the compound. The values of % activity versus a series of compound concentrations were then plotted using nonlinear regression analysis of the Sigmoidal dose–response curve generated with the equation <i>Y</i> = <i>B</i> + (<i>T</i> – <i>B</i>)/1 + 10<sup>((logEC50–<i>X</i>)×Hill slope)</sup>, where <i>Y</i> = percent activity, <i>B</i> = minimum percent activity, <i>T</i> = maximum percent activity, <i>X</i> = logarithm of compound, and Hill slope = slope factor or Hill coefficient. The IC<sub>50</sub> value was determined by the concentration causing a half-maximal percent activity. Standard errors were calculated using the following equation <i>SE</i> = IC<sub>50</sub>(mean) −<span class="NLM_inline-formula"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/jm-2017-00979w_m001.gif" alt="" /></img></span></div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Computational Methods</h3><div class="NLM_p">All calculations were performed using the Schrodinger molecular modeling suite (version 2016-2). The protein structure used for PDE5A1 was obtained from the Protein Data Bank (3TGG.pdb)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(31)</a> and prepared using the Protein Preparation Wizard.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(32)</a> In this step, force field atom types and bond orders are assigned. Missing atoms are added, and tautomer/ionization states are assigned. Water orientations are sampled; Asn, Gln, and His residues are flipped to optimize the hydrogen bond network, and a constrained energy minimization is performed. The water molecules present in the crystal structures were conserved. Of note, only a few were present in the targeted binding site and were located at its periphery.</div><div id="sec4_69_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> In silico Docking</h4><div class="NLM_p last">Compounds <b>6c</b> and <b>24a</b> were docked into the cGMP binding site of PDE5A1 using Glide.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(33, 34)</a> In both cases, the docking region (grid) was centered on the position of the crystal ligand (in 3TGG.pdb) that occupies the targeted region in the cGMP binding site. Default box sizes were used. Glide docks flexible ligands into a rigid receptor structure by sampling of the conformational, positional, and orientational degrees of freedom of the ligand. No constraint was used for the docking calculations. The poses obtained were further refined using minimization of the binding pocket around the docked ligands.</div></div><div id="sec4_69_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> WaterMap Calculations</h4><div class="NLM_p last">WaterMap is a molecular dynamics-based method that predicts the locations and thermodynamic properties (entropy, enthalpy, and free energy) of explicit water molecules in a region of interest around a protein. The theoretical basis for the method as well as the specific computational algorithms used are fully described elsewhere.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(24, 25)</a> In brief, WaterMap clusters make the statistical analysis of the water molecules around the site of interest from many frames of a molecular dynamics simulation. Regions of high water density (high occupancy) are identified as “hydration sites”, and their corresponding enthalpies and entropies are computed relative to bulk solvent using the inhomogeneous solvation theory.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(35, 36)</a> In the work presented here, we ran WaterMap in the binding pocket in the absence of any ligand.</div></div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Kinetic Solubility Assay</h3><div class="NLM_p last">Experiments were performed by Cyprotex US, LLC. Serial dilutions of each compound were prepared in DMSO at 100× the final concentration. Test compound solutions were diluted 100-fold into buffer in a 96-well plate and mixed. After 18 h of incubation at 37 °C, the presence of precipitate was then detected by turbidity (absorbance at 540 nm). Precipitate forms when maximum aqueous solubility levels were reached. An absorbance value greater than mean + 3× standard deviation of the blank (after subtracting the background) was indicative of turbidity. For brightly colored compounds, a visual inspection of the plate was performed to verify the solubility limit determined by UV absorbance. The solubility limit was reported as the highest experimental concentration with no evidence of turbidity. Reserpine and tamoxifen were used as a low-solubility control, and verapamil was used as a high-solubility control.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Microsomal Stability</h3><div class="NLM_p last">Experiments were performed by Absorption Systems. Human liver microsomes were purchased from XenoTech. The test compounds were added into the reaction mixture at a final concentration of 1 μM. An aliquot of the reaction mixture (without cofactor) was incubated in a shaking water bath at 37 °C for 3 min. The control compound, testosterone, was run simultaneously with the test compounds in a separate reaction. The reaction was initiated by the addition of a cofactor, and the mixture was then incubated in a shaking water bath at 37 °C. Aliquots (100 μL) were withdrawn at 0, 10, 20, 30, and 60 min for the test compound and 0, 10, 30, and 60 min for testosterone. Test compound and testosterone samples were immediately combined with 400 μL of ice-cold 50:50 acetonitrile/H<sub>2</sub>O-<i>d</i> containing 0.1% formic acid and the internal standard to terminate the reaction. The samples were then mixed and centrifuged to precipitate microsomal proteins. Samples for test compounds were analyzed by LC-HRAMS for the disappearance of the test compound and appearance of metabolites. All the remaining samples were assayed by LC-MS/MS using electrospray ionization. The peak area response ratio (PARR) to the internal standard was compared to the PARR at time 0 to determine the percent of test compound or positive control remaining at each time point. Half-lives were calculated using the GraphPad software, fitting to a single-phase exponential decay equation.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Pharmacokinetics</h3><div class="NLM_p last">Compound <b>6c</b> was administered to mice ip at a dosage of 25 mg/kg. Blood and brain samples were collected at six time points (0, 0.25, 0.5, 1.0, and 2.0 h) from three animals at each time point. For plasma measurements, blood (approximately 250 μL) was collected via retro-orbital puncture into tubes containing sodium heparin anticoagulant. Plasma was separated via centrifugation (4 °C, 3500 rpm, 10 min) and stored at −80 °C. At the time of measurement, frozen plasma samples were thawed at room temperature and vortexed thoroughly. Plasma (25 μL) was transferred into a 1.5 mL Eppendorf tube. To each sample, 25 μL of methanol and 25 μL of the internal standard were added, followed by the addition of 100 μL of methanol. The sample mixture was vortexed for approximately 1 min. After centrifugation at 11 000 g for 5 min, the upper organic layer was transferred to a glass tube and evaporated at 40 °C under a gentle stream of nitrogen. Residues were dissolved in 150 μL of the mobile phase and mixed using a Vortex mixer. A 20 μL aliquot of the resulting solution was injected onto the liquid chromatography/mass spectrometry (LC/MS) Shimadzu system for analysis. For measurement of brain concentrations, mice were killed by cervical dislocation after blood harvest. Brains were immediately excised, weighed, and rinsed by cold saline and then frozen at −80 °C until further processing for LC/MS analysis. On the day of the assay, frozen tissue samples were thawed unassisted at room temperature. When completely thawed, each tissue sample of 200 mg was weighed and placed into a plastic tube. Methanol (1.0 mL) was added, and homogenization was conducted using a pellet pestle cordless motor homogenizer for approximately 1 min. Then, the samples were vortexed for 1 min, and a 25 μL aliquot was transferred into an Eppendorf tube. To each sample, 25 μL of methanol was added, and the samples were centrifuged at 11 000 g for 5 min. A 20 μL aliquot of the supernatants was diluted to 60 μL with the mobile phase (H<sub>2</sub>O/acetonitrile with 5% formic acid), and a 10 μL aliquot was injected onto the LC/MS system for analysis. Quantification of the drug concentration in each aliquot was achieved by using the standard curve method. Half-life was calculated using the GraphPad software, fitting to a single-phase exponential decay equation.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Hippocampal cGMP Levels</h3><div class="NLM_p last">Male and female mice (2–3 months old; 20–25 g; C57Bl6 mice) were injected with <b>6c</b> (3 mg/kg, 2% DMSO and 2% Tween, ip) or Vehicle (2% DMSO and 2% Tween, ip). Thirty min after administration of vehicle or <b>6c</b>, mice were subjected to foot shock and sacrificed 10 s, 1, and 3 min after shock by cervical dislocation and decapitation. The hippocampal samples were extracted and snap frozen in liquid nitrogen. Levels of cGMP were quantitated by the Enzyme Immunoassay procedure (Cayman Chemical Company, item no. 581021) following the manufacturer’s guidelines in duplicate. cGMP levels were normalized with the protein concentration calculated using BCA Protein Assay Reagent (Thermo Scientific).</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Electrophysiology</h3><div class="NLM_p last">Hippocampal slices were cut as previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Briefly, 3–4 month old animals were sacrificed, and their hippocampi were extracted. Slices (400 μm) were obtained and maintained in an interface chamber continuously perfused with a solution (ACSF) consisting of (in mM) 124.0 NaCl, 4.4 KCl, 1.0 Na<sub>2</sub>HPO<sub>4</sub>, 25.0 NaHCO<sub>3</sub>, 2.0 CaCl<sub>2</sub>, 2.0 MgCl<sub>2</sub>, and 10.0 glucose, and the solution was bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>. Extracellular recordings were performed by stimulating the Schaeffer collateral fibers and recording in CA1 stratum radiatum with a glass electrode filled with ACSF. Following the recording of a 20 min baseline, LTP was evoked through a theta-burst stimulation (four pulses at 100 Hz, with the bursts repeated at 5 Hz and each tetanus including three 10-burst trains separated by 15 s).</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Behavioral Studies</h3><div class="NLM_p">Fear conditioning was assessed as previously described.<a onclick="showRef(event, 'ref30 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref32">(28, 30)</a> Training for fear conditioning was performed by placing the mouse in a conditioning chamber for 2 min before the onset of a tone (conditioned stimulus (CS), 30 s, 85 dB sound at 2800 Hz). In the last 2 s of the CS, mice were given a 2 s, 0.7 mA mild foot shock (unconditioned stimulus, (US)) through the bars of the floor. After the US, the mice were left in the chamber for another 30 s. Freezing behavior, defined as the absence of movements except for respiratory excursions, was scored using Freezeview software (Med Associates, St. Albans, VT). Contextual fear learning was evaluated 24 h after training by measuring freezing responses for 5 min in the same chamber where the mice were trained. Cued fear learning was evaluated 24 h after contextual testing (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S9). The mice were placed in a novel context for 2 min (pre-CS test), after which they were given a CS for 3 min (CS test), and freezing behavior was measured during the first 30 s that mimic the CS–US conditioning and the remaining 2.5 min.</div><div class="NLM_p">The radial arm water maze task, a hybrid of the classic Morris Water Maze and the radial arm land maze, was performed as previously described.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(37)</a> The mouse had to swim in 6 alleys (arms) radiating from a central area until it found a hidden (submerged) platform at the end of one of the arms, based on visual cues placed in the room. The first day of the protocol was a training day on which mice were trained to identify the platform location by alternating between a visible and a hidden platform in a goal arm. The final 3 trials on that day and all 15 trials on day 2 used a hidden escape platform to force mice to use spatial cues to identify the location of the goal arm. To avoid learning limitations imposed by exhausting practice and to avoid fatigue that may result from consecutive trials, spaced practice training was established by running the mice in cohorts of 4 and alternating different cohorts through the 15 training trials over 3-h testing periods each day. The number of incorrect arm entries (entries to arms with no platform) was counted.</div><div class="NLM_p">If the animal entered the incorrect arm, it was gently pulled back to the start arm. Failure to select an arm after 15 s was counted as an error, and the mouse was returned to the start arm. Each trial lasted up to 1 min. After 1 min, if the platform had not been located, the mouse was guided gently through the water by placing a hand behind it to direct it toward the platform. The mouse rested on the platform for 15 s. The goal platform location was different for each mouse. On day 2, the same procedure was repeated as on day 1 for all 15 trials using only the hidden platform. For data analysis, averages for each mouse were calculated using blocks of 3 trials.</div><div class="NLM_p last">Behavioral testing also included control tasks. Specifically, evaluation of the visible platform task was performed to exclude motor, sensorial, and motivational defects. Speed and time (latency) to reach the platform was observed among the different groups of mice (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S10).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(28)</a></div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Statistical Analyses</h3><div class="NLM_p last">Experiments were performed in blind. Results were expressed as standard error of the mean (SEM). Level of significance was set for <i>p</i> < 0.05. Results were analyzed by student <i>t</i> test/2-way ANOVA for repeated measures. Planned comparisons were used for post hoc analysis.</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Animals</h3><div class="NLM_p last">The animal protocols for PK studies, measurement of hippocampal cGMP levels, and behavioral assessment were approved by the Columbia University Institutional Animal Care and Use Committee (IACUC). The animals were maintained on a 12 h light/dark cycle (with light onset at 6:00 a.m.) in temperature and humidity-controlled rooms of the Columbia University Animal Facility. Food and water were available ad libitum.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i98"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00979">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82322" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82322" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00979" class="ext-link">10.1021/acs.jmedchem.7b00979</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H NMR and 1D NOESY spectra of compound <b>5c</b> and <b>6c</b>, PDE5 cGMP pocket in available crystal structures, compounds <b>6c</b> and <b>24a</b> superposed in their two docking poses, interaction diagrams for compound <b>24a</b> docking poses, predicted binding free energies for compounds in the naphthydrine and 1<i>H</i>-pyrroloquinolinone series, cued learning test, and visible platform and speed tests for compound <b>6c</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES strings and IC<sub>50</sub> data for compounds <b>6a</b>–<b>g</b>, <b>14</b>, <b>17a</b>–<b>d</b>, and <b>24a</b>–<b>f</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf">jm7b00979_si_001.pdf (7.68 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_002.csv">jm7b00979_si_002.csv (2.82 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00979" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ottavio Arancio</span> - <span class="hlFld-Affiliation affiliation">Taub
Institute for Research of Alzheimer’s Disease and the Aging
Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6335-164X" title="Orcid link">http://orcid.org/0000-0001-6335-164X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1d727c2c5d7e727168707f747c33787968"><span class="__cf_email__" data-cfemail="4a252b7b0a2925263f2728232b642f2e3f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald W. Landry</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, Columbia University, 650 W 168th Street, New York, New York 10032, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e682918ad7a685898a938b848f87c8838293"><span class="__cf_email__" data-cfemail="b5d1c2d984f5d6dad9c0d8d7dcd49bd0d1c0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jole Fiorito</span> - <span class="hlFld-Affiliation affiliation">Taub
Institute for Research of Alzheimer’s Disease and the Aging
Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeremie Vendome</span> - <span class="hlFld-Affiliation affiliation">Department
of Systems Biology, Columbia University
Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Faisal Saeed</span> - <span class="hlFld-Affiliation affiliation">Taub
Institute for Research of Alzheimer’s Disease and the Aging
Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Agnieszka Staniszewski</span> - <span class="hlFld-Affiliation affiliation">Taub
Institute for Research of Alzheimer’s Disease and the Aging
Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Zhang</span> - <span class="hlFld-Affiliation affiliation">Taub
Institute for Research of Alzheimer’s Disease and the Aging
Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shijun Yan</span> - <span class="hlFld-Affiliation affiliation">Taub
Institute for Research of Alzheimer’s Disease and the Aging
Brain, Columbia University, 630 W 168th Street, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shi-Xian Deng</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, Columbia University, 650 W 168th Street, New York, New York 10032, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.F. and J.V. contributed equally. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e6228-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i104">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Institute of Aging at the National Institutes of Health (Grant no. U01-AG032973), the National Institutes of Health (Grant no. 1S10OD018121-01), and the National Center for Advancing Translational Sciences, National Institutes of Health (Grant no. UL1TR000040). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors gratefully thank Dr. Yitshak. I. Francis, Sudha Rao, and Devarshi M. Thakkar for helping with the cGMP ELISA experiment.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i105" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i105"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i106" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i106"> Abbreviations Used</h2><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">sGC</td><td class="NLM_def"><p class="first last">soluble guanylyl cyclase</p></td></tr><tr><td class="NLM_term">PKG</td><td class="NLM_def"><p class="first last">protein kinase G</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cAMP response element binding protein</p></td></tr><tr><td class="NLM_term">PS1</td><td class="NLM_def"><p class="first last">preseniline 1</p></td></tr><tr><td class="NLM_term">ACE-Cl</td><td class="NLM_def"><p class="first last">α-chloroethyl chloroformate</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsomes</p></td></tr><tr><td class="NLM_term">RAWM</td><td class="NLM_def"><p class="first last">radial arm water maze</p></td></tr><tr><td class="NLM_term">FC</td><td class="NLM_def"><p class="first last">fear conditioning</p></td></tr><tr><td class="NLM_term">NOESY</td><td class="NLM_def"><p class="first last">steady-state and transient NOE</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahdi, A. A.</span><span> </span><span class="NLM_article-title">Therapeutics of Alzheimer’s disease: Past, present and future</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.neuropharm.2013.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=23891641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wrt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=27-50&author=R.+Anandauthor=K.+D.+Gillauthor=A.+A.+Mahdi&title=Therapeutics+of+Alzheimer%E2%80%99s+disease%3A+Past%2C+present+and+future&doi=10.1016%2Fj.neuropharm.2013.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutics of Alzheimer's disease: Past, present and future</span></div><div class="casAuthors">Anand, R.; Gill, Kiran Dip; Mahdi, Abbas Ali</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">PA</span>),
    <span class="NLM_cas:pages">27-50</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common cause of dementia worldwide.  The etiol. is multifactorial, and pathophysiol. of the disease is complex.  Data indicate an exponential rise in the no. of cases of AD, emphasizing the need for developing an effective treatment.  AD also imposes tremendous emotional and financial burden to the patient's family and community.  The disease has been studied over a century, but acetylcholinesterase inhibitors and memantine are the only drugs currently approved for its management.  These drugs provide symptomatic improvement alone but do less to modify the disease process.  The extensive insight into the mol. and cellular pathomechanism in AD over the past few decades has provided us significant progress in the understanding of the disease.  A no. of novel strategies that seek to modify the disease process have been developed.  The major developments in this direction are the amyloid and tau based therapeutics, which could hold the key to treatment of AD in the near future.  Several putative drugs have been thoroughly investigated in preclin. studies, but many of them have failed to produce results in the clin. scenario; therefore it is only prudent that lessons be learned from the past mistakes.  The current rationales and targets evaluated for therapeutic benefit in AD are reviewed in this article. This article is part of the Special Issue entitled 'The Synaptic Basis of Neurodegenerative Disorders'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojc5hTOMAnpbVg90H21EOLACvtfcHk0liMJtgOv3xT6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wrt7%252FK&md5=6de96960a7d842eb0d8ffe5db1b452e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DK.%2BD.%26aulast%3DMahdi%26aufirst%3DA.%2BA.%26atitle%3DTherapeutics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Past%252C%2520present%2520and%2520future%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26spage%3D27%26epage%3D50%26doi%3D10.1016%2Fj.neuropharm.2013.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYGfB05HrfmWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu-Seifert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Cooperative Study Steering Committee; Solanezumab Study Group. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1056/NEJMoa1312889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1056%2FNEJMoa1312889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24450890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=311-321&author=R.+S.+Doodyauthor=R.+G.+Thomasauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=R.+Ramanauthor=X.+Sunauthor=P.+S.+Aisenauthor=E.+Siemersauthor=H.+Liu-Seifertauthor=R.+Mohs&title=Alzheimer%E2%80%99s+Disease+Cooperative+Study+Steering+Committee%3B+Solanezumab+Study+Group.+Phase+3+trials+of+solanezumab+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1312889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss.  Solanezumab, a humanized monoclonal antibody, preferentially binds sol. forms of amyloid and in preclin. studies promoted its clearance from the brain.  METHODS: In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, resp., with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered i.v. at a dose of 400 mg) every 4 wk for 18 mo.  The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning).  After anal. of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.  RESULTS: Neither study showed significant improvement in the primary outcomes.  The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P = 0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P = 0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P = 0.06) and 1.6 points (95% CI, -0.2 to 3.3; P = 0.08), resp., in EXPEDITION 2.  Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P = 0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P = 0.26).  In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P = 0.27) and 4.9% and 5.6%, resp., for hemorrhage (P = 0.49).  CONCLUSIONS: Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ej7A_YXNwLVg90H21EOLACvtfcHk0li_PDzd7d9WVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D&md5=c993836d4f7374cc78f155f9cedbc594</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1312889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1312889%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Cooperative%2520Study%2520Steering%2520Committee%253B%2520Solanezumab%2520Study%2520Group.%2520Phase%25203%2520trials%2520of%2520solanezumab%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D311%26epage%3D321%26doi%3D10.1056%2FNEJMoa1312889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsteinsson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketter, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejadnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenzler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miloslavsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, H. R.</span><span> </span><span class="NLM_article-title">Bapineuzumab 301 and 302 Clinical Trial Investigators. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1056/NEJMoa1304839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1056%2FNEJMoa1304839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24450891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=322-333&author=S.+Sallowayauthor=R.+Sperlingauthor=N.+C.+Foxauthor=K.+Blennowauthor=W.+Klunkauthor=M.+Raskindauthor=M.+Sabbaghauthor=L.+S.+Honigauthor=A.+P.+Porsteinssonauthor=S.+Ferrisauthor=M.+Reichertauthor=N.+Ketterauthor=B.+Nejadnikauthor=V.+Guenzlerauthor=M.+Miloslavskyauthor=D.+Wangauthor=Y.+Luauthor=J.+Lullauthor=I.+C.+Tudorauthor=E.+Liuauthor=M.+Grundmanauthor=E.+Yuenauthor=R.+Blackauthor=H.+R.+Brashear&title=Bapineuzumab+301+and+302+Clinical+Trial+Investigators.+Two+phase+3+trials+of+bapineuzumab+in+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1304839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Sperling, Reisa; Fox, Nick C.; Blennow, Kaj; Klunk, William; Raskind, Murray; Sabbagh, Marwan; Honig, Lawrence S.; Porsteinsson, Anton P.; Ferris, Steven; Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Lull, Julia; Tudor, Iulia Cristina; Liu, Enchi; Grundman, Michael; Yuen, Eric; Black, Ronald; Brashear, H. Robert</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">322-333</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clin. development for the treatment of Alzheimer's disease.  METHODS: We conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate Alzheimer's disease - one involving 1121 carriers of the apolipoprotein E (APOE) ε4 allele and the other involving 1331 noncarriers.  Bapineuzumab or placebo, with doses varying by study, was administered by i.v. infusion every 13 wk for 78 wk.  The primary outcome measures were scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11, with scores ranging from 0 to 70 and higher scores indicating greater impairment) and the Disability Assessment for Dementia (DAD, with scores ranging from 0 to 100 and higher scores indicating less impairment).  A total of 1090 carriers and 1114 noncarriers were included in the efficacy anal.  Secondary outcome measures included findings on positron-emission tomog. amyloid imaging with the use of Pittsburgh compd. B (PIB-PET) and cerebrospinal fluid phosphorylated tau (phospho-tau) concns.  RESULTS: There were no significant between-group differences in the primary outcomes.  At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo group) were -0.2 (P = 0.80) and -1.2 (P = 0.34), resp., in the carrier study; the corresponding differences in the noncarrier study were -0.3 (P = 0.64) and 2.8 (P = 0.07) with the 0.5-mg-per-kilogram dose of bapineuzumab and 0.4 (P = 0.62) and 0.9 (P = 0.55) with the 1.0-mg-per-kilogram dose.  The major safety finding was amyloid-related imaging abnormalities with edema among patients receiving bapineuzumab, which increased with bapineuzumab dose and APOE ε4 allele no. and which led to discontinuation of the 2.0-mg-per-kilogram dose.  Between-group differences were obsd. with respect to PIB-PET and cerebrospinal fluid phospho-tau concns. in APOE ε4 allele carriers but not in noncarriers.  CONCLUSIONS: Bapineuzumab did not improve clin. outcomes in patients with Alzheimer's disease, despite treatment differences in biomarkers obsd. in APOE ε4 carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEl0PP_aoc9LVg90H21EOLACvtfcHk0li_PDzd7d9WVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D&md5=932fe885aa8d2426379c786620bbd766</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304839%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DKlunk%26aufirst%3DW.%26aulast%3DRaskind%26aufirst%3DM.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DHonig%26aufirst%3DL.%2BS.%26aulast%3DPorsteinsson%26aufirst%3DA.%2BP.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DReichert%26aufirst%3DM.%26aulast%3DKetter%26aufirst%3DN.%26aulast%3DNejadnik%26aufirst%3DB.%26aulast%3DGuenzler%26aufirst%3DV.%26aulast%3DMiloslavsky%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLull%26aufirst%3DJ.%26aulast%3DTudor%26aufirst%3DI.%2BC.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DE.%26aulast%3DBlack%26aufirst%3DR.%26aulast%3DBrashear%26aufirst%3DH.%2BR.%26atitle%3DBapineuzumab%2520301%2520and%2520302%2520Clinical%2520Trial%2520Investigators.%2520Two%2520phase%25203%2520trials%2520of%2520bapineuzumab%2520in%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D322%26epage%3D333%26doi%3D10.1056%2FNEJMoa1304839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sevigny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunstan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero-Monzon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandrock, A.</span><span> </span><span class="NLM_article-title">The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">537</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1038/nature19323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fnature19323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=27582220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=50-56&author=J.+Sevignyauthor=P.+Chiaoauthor=T.+Bussiereauthor=P.+H.+Weinrebauthor=L.+Williamsauthor=M.+Maierauthor=R.+Dunstanauthor=S.+Sallowayauthor=T.+Chenauthor=Y.+Lingauthor=J.+O%E2%80%99Gormanauthor=F.+Qianauthor=M.+Arastuauthor=M.+Liauthor=S.+Chollateauthor=M.+S.+Brennanauthor=O.+Quintero-Monzonauthor=R.+H.+Scannevinauthor=H.+M.+Arnoldauthor=T.+Engberauthor=K.+Rhodesauthor=J.+Ferreroauthor=Y.+Hangauthor=A.+Mikulskisauthor=J.+Grimmauthor=C.+Hockauthor=R.+M.+Nitschauthor=A.+Sandrock&title=The+antibody+aducanumab+reduces+Abeta+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature19323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The antibody aducanumab reduces Aβ plaques in Alzheimer's disease</span></div><div class="casAuthors">Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Maier, Marcel; Dunstan, Robert; Salloway, Stephen; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7618</span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration.  Antibody-based immunotherapy against Aβ to trigger its clearance or mitigate its neurotoxicity has so far been unsuccessful.  Here we report the generation of aducanumab, a human monoclonal antibody that selectively targets aggregated Aβ.  In a transgenic mouse model of AD, aducanumab is shown to enter the brain, bind parenchymal Aβ, and reduce sol. and insol. Aβ in a dose-dependent manner.  In patients with prodromal or mild AD, one year of monthly i.v. infusions of aducanumab reduces brain Aβ in a dose- and time-dependent manner.  This is accompanied by a slowing of clin. decline measured by Clin. Dementia Rating-Sum of Boxes and Mini Mental State Examn. scores.  The main safety and tolerability findings are amyloid-related imaging abnormalities.  These results justify further development of aducanumab for the treatment of AD.  Should the slowing of clin. decline be confirmed in ongoing phase 3 clin. trials, it would provide compelling support for the amyloid hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFdrufBYOgbVg90H21EOLACvtfcHk0ljc5ix3woMJTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ&md5=62aa713f842093cead6b40cb523417a7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature19323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19323%26sid%3Dliteratum%253Aachs%26aulast%3DSevigny%26aufirst%3DJ.%26aulast%3DChiao%26aufirst%3DP.%26aulast%3DBussiere%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DMaier%26aufirst%3DM.%26aulast%3DDunstan%26aufirst%3DR.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DArastu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DQuintero-Monzon%26aufirst%3DO.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DFerrero%26aufirst%3DJ.%26aulast%3DHang%26aufirst%3DY.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DGrimm%26aufirst%3DJ.%26aulast%3DHock%26aufirst%3DC.%26aulast%3DNitsch%26aufirst%3DR.%2BM.%26aulast%3DSandrock%26aufirst%3DA.%26atitle%3DThe%2520antibody%2520aducanumab%2520reduces%2520Abeta%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D50%26epage%3D56%26doi%3D10.1038%2Fnature19323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer’s disease</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1515/REVNEURO.2006.17.5.497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1515%2FREVNEURO.2006.17.5.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=17180876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=497-523&author=D.+Puzzoauthor=A.+Palmeriauthor=O.+Arancio&title=Involvement+of+the+nitric+oxide+pathway+in+synaptic+dysfunction+following+amyloid+elevation+in+Alzheimer%E2%80%99s+disease&doi=10.1515%2FREVNEURO.2006.17.5.497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease</span></div><div class="casAuthors">Puzzo, Daniela; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-523</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  Amyloid-beta (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis.  Aβ has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory.  The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain crit. for memory storage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLKNBiiakNLVg90H21EOLACvtfcHk0ljc5ix3woMJTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ&md5=faa3271286d20c9cd431f9b001476089</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.5.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.5.497%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInvolvement%2520of%2520the%2520nitric%2520oxide%2520pathway%2520in%2520synaptic%2520dysfunction%2520following%2520amyloid%2520elevation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRev.%2520Neurosci.%26date%3D2006%26volume%3D17%26spage%3D497%26epage%3D523%26doi%3D10.1515%2FREVNEURO.2006.17.5.497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Lu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">10250</span><span class="NLM_x">–</span> <span class="NLM_lpage">10261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&author=Y.+F.+Luauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+oxide+signaling+contributes+to+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0lgVrJG7-heFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520oxide%2520signaling%2520contributes%2520to%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D10250%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wong, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiscus, R. R.</span><span> </span><span class="NLM_article-title">Cyclic GMP/protein kinase G type-Ialpha (PKG-Ialpha) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Ialpha kinase activity synergizes with cisplatin in non-small cell lung cancer cells</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">–</span> <span class="NLM_lpage">3598</span><span class="refDoi"> DOI: 10.1002/jcb.24237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1002%2Fjcb.24237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2012&pages=3587-3598&author=J.+C.+Wongauthor=M.+Bathinaauthor=R.+R.+Fiscus&title=Cyclic+GMP%2Fprotein+kinase+G+type-Ialpha+%28PKG-Ialpha%29+signaling+pathway+promotes+CREB+phosphorylation+and+maintains+higher+c-IAP1%2C+livin%2C+survivin%2C+and+Mcl-1+expression+and+the+inhibition+of+PKG-Ialpha+kinase+activity+synergizes+with+cisplatin+in+non-small+cell+lung+cancer+cells&doi=10.1002%2Fjcb.24237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fjcb.24237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.24237%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DJ.%2BC.%26aulast%3DBathina%26aufirst%3DM.%26aulast%3DFiscus%26aufirst%3DR.%2BR.%26atitle%3DCyclic%2520GMP%252Fprotein%2520kinase%2520G%2520type-Ialpha%2520%2528PKG-Ialpha%2529%2520signaling%2520pathway%2520promotes%2520CREB%2520phosphorylation%2520and%2520maintains%2520higher%2520c-IAP1%252C%2520livin%252C%2520survivin%252C%2520and%2520Mcl-1%2520expression%2520and%2520the%2520inhibition%2520of%2520PKG-Ialpha%2520kinase%2520activity%2520synergizes%2520with%2520cisplatin%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2012%26volume%3D113%26spage%3D3587%26epage%3D3598%26doi%3D10.1002%2Fjcb.24237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Silva, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankland, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, S.</span><span> </span><span class="NLM_article-title">CREB and memory</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.21.1.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1146%2Fannurev.neuro.21.1.127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=9530494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=127-148&author=A.+J.+Silvaauthor=J.+H.+Koganauthor=P.+W.+Franklandauthor=S.+Kida&title=CREB+and+memory&doi=10.1146%2Fannurev.neuro.21.1.127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">CREB and memory</span></div><div class="casAuthors">Silva, Alcino J.; Kogan, Jeffrey H.; Frankland, Paul W.; Kida, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-148</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  The cAMP responsive element binding protein (CREB) is a nuclear protein that modulates the transcription of genes with cAMP responsive elements in their promoters.  Increases in the concn. of either calcium or cAMP can trigger the phosphorylation and activation of CREB.  This transcription factor is a component of intracellular signaling events that regulate a wide range of biol. functions, from spermatogenesis to circadian rhythms and memory.  Here we review the key features of CREB-dependent transcription, as well as the involvement of CREB in memory formation.  Evidence from Aplysia, Drosophila, mice, and rats shows that CREB-dependent transcription is required for the cellular events underlying long-term but not short-term memory.  While the work in Aplysia and Drosophila only involved CREB function in very simple forms of conditioning, genetic and pharmacol. studies in mice and rats demonstrate that CREB is required for a variety of complex forms of memory, including spatial and social learning, thus indicating that CREB may be a universal modulator of processes required for memory formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIxnm0AHtktbVg90H21EOLACvtfcHk0lgVrJG7-heFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyitbs%253D&md5=de4b3f14712110f1d3693e8286317e3d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.127%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26aulast%3DKogan%26aufirst%3DJ.%2BH.%26aulast%3DFrankland%26aufirst%3DP.%2BW.%26aulast%3DKida%26aufirst%3DS.%26atitle%3DCREB%2520and%2520memory%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D127%26epage%3D148%26doi%3D10.1146%2Fannurev.neuro.21.1.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Barco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span> </span><span class="NLM_article-title">Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.1016/S0092-8674(02)00657-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2FS0092-8674%2802%2900657-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2002&pages=689-703&author=A.+Barcoauthor=J.+M.+Alarconauthor=E.+R.+Kandel&title=Expression+of+constitutively+active+CREB+protein+facilitates+the+late+phase+of+long-term+potentiation+by+enhancing+synaptic+capture&doi=10.1016%2FS0092-8674%2802%2900657-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900657-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900657-8%26sid%3Dliteratum%253Aachs%26aulast%3DBarco%26aufirst%3DA.%26aulast%3DAlarcon%26aufirst%3DJ.%2BM.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26atitle%3DExpression%2520of%2520constitutively%2520active%2520CREB%2520protein%2520facilitates%2520the%2520late%2520phase%2520of%2520long-term%2520potentiation%2520by%2520enhancing%2520synaptic%2520capture%26jtitle%3DCell%26date%3D2002%26volume%3D108%26spage%3D689%26epage%3D703%26doi%3D10.1016%2FS0092-8674%2802%2900657-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Benito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barco, A.</span><span> </span><span class="NLM_article-title">CREB’s control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1016/j.tins.2010.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.tins.2010.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=230-240&author=E.+Benitoauthor=A.+Barco&title=CREB%E2%80%99s+control+of+intrinsic+and+synaptic+plasticity%3A+implications+for+CREB-dependent+memory+models&doi=10.1016%2Fj.tins.2010.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2010.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2010.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DE.%26aulast%3DBarco%26aufirst%3DA.%26atitle%3DCREB%25E2%2580%2599s%2520control%2520of%2520intrinsic%2520and%2520synaptic%2520plasticity%253A%2520implications%2520for%2520CREB-dependent%2520memory%2520models%26jtitle%3DTrends%2520Neurosci.%26date%3D2010%26volume%3D33%26spage%3D230%26epage%3D240%26doi%3D10.1016%2Fj.tins.2010.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bender, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beavo, J. A.</span><span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1124/pr.58.3.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1124%2Fpr.58.3.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=16968949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=488-520&author=A.+T.+Benderauthor=J.+A.+Beavo&title=Cyclic+nucleotide+phosphodiesterases%3A+molecular+regulation+to+clinical+use&doi=10.1124%2Fpr.58.3.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span></div><div class="casAuthors">Bender, Andrew T.; Beavo, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">488-520</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels of the second messengers, cAMP and cGMP, by controlling their rates of degrdn.  There are 11 different PDE families, with each family typically having several different isoforms and splice variants.  These unique PDEs differ in their three-dimensional structure, kinetic properties, modes of regulation, intracellular localization, cellular expression, and inhibitor sensitivities.  Current data suggest that individual isoenzymes modulate distinct regulatory pathways in the cell.  These properties therefore offer the opportunity for selectively targeting specific PDEs for treatment of specific disease states.  The feasibility of these enzymes as drug targets is exemplified by the com. and clin. successes of the erectile dysfunction drugs, sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra).  PDE inhibitors are also currently available or in development for treatment of a variety of other pathol. conditions.  In this review the basic biochem. properties, cellular regulation, expression patterns, and physiol. functions of the different PDE isoforms will be discussed.  How these properties relate to the current and future development of PDE inhibitors as pharmacol. agents is esp. considered.  PDEs hold great promise as drug targets and recent research advances make this an exciting time for the field of PDE research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJl4RDiZ0ugrVg90H21EOLACvtfcHk0lgq8ZKsrp-IPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI&md5=af31cf6952efe7adb428a951779f36bc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.5%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DA.%2BT.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%253A%2520molecular%2520regulation%2520to%2520clinical%2520use%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D488%26epage%3D520%26doi%3D10.1124%2Fpr.58.3.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Maurice, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manganiello, V. C.</span><span> </span><span class="NLM_article-title">Advances in targeting cyclic nucleotide phosphodiesterases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1038/nrd4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fnrd4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24687066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=290-314&author=D.+H.+Mauriceauthor=H.+Keauthor=F.+Ahmadauthor=Y.+Wangauthor=J.+Chungauthor=V.+C.+Manganiello&title=Advances+in+targeting+cyclic+nucleotide+phosphodiesterases&doi=10.1038%2Fnrd4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in targeting cyclic nucleotide phosphodiesterases</span></div><div class="casAuthors">Maurice, Donald H.; Ke, Hengming; Ahmad, Faiyaz; Wang, Yousheng; Chung, Jay; Manganiello, Vincent C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-314</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cyclic GMP, thereby regulating the intracellular concns. of these cyclic nucleotides, their signalling pathways and, consequently, myriad biol. responses in health and disease.  Currently, a small no. of PDE inhibitors are used clin. for treating the pathophysiol. dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.  However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMRfUs-zUmLVg90H21EOLACvtfcHk0lgq8ZKsrp-IPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D&md5=410c8d5bb5fbd7d2906e30dc1b5f2876</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4228%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DD.%2BH.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DManganiello%26aufirst%3DV.%2BC.%26atitle%3DAdvances%2520in%2520targeting%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D290%26epage%3D314%26doi%3D10.1038%2Fnrd4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Heckman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer’s disease: a translational overview</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.2174/1381612820666140826114601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.2174%2F1381612820666140826114601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=317-331&author=P.+R.+Heckmanauthor=C.+Woutersauthor=J.+Prickaerts&title=Phosphodiesterase+inhibitors+as+a+target+for+cognition+enhancement+in+aging+and+Alzheimer%E2%80%99s+disease%3A+a+translational+overview&doi=10.2174%2F1381612820666140826114601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140826114601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140826114601%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DP.%2BR.%26aulast%3DWouters%26aufirst%3DC.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520inhibitors%2520as%2520a%2520target%2520for%2520cognition%2520enhancement%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520translational%2520overview%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D21%26spage%3D317%26epage%3D331%26doi%3D10.2174%2F1381612820666140826114601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Garcia-Osta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado-Tejedor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barroso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Phosphodiesterases as therapeutic targets for Alzheimer’s disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1021/cn3000907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn3000907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=832-844&author=A.+Garcia-Ostaauthor=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+Oyarzabalauthor=R.+Franco&title=Phosphodiesterases+as+therapeutic+targets+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn3000907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease</span></div><div class="casAuthors">Garcia-Osta, Ana; Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Oyarzabal, Julen; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">832-844</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia among the elderly.  In AD patients, memory loss is accompanied by the formation of beta-amyloid plaques and the appearance of tau in a pathol. form.  Given the lack of effective treatments for AD, the development of new management strategies for these patients is crit.  The continued failure to find effective therapies using mols. aimed at addressing the anti-beta amyloid pathol. has led researchers to focus on other non-amyloid-based approaches to restore memory function.  Promising non-amyloid related candidate targets include phosphosdiesterases (PDEs), and indeed, Rolipram, a specific PDE4 inhibitor, was the first compd. found to effectively restore cognitive deficits in animal models of AD.  More recently, PDE5 inhibitors have also been shown to effectively restore memory function.  Accordingly, inhibitors of other members of the PDE family may also improve memory performance in AD and non-AD animal models.  Hence, in this review, we will summarize the data supporting the use of PDE inhibitors as cognitive enhancers and we will discuss the possible mechanisms of action underlying these effects.  We shall also adopt a medicinal chem. perspective that leads us to propose the most promising PDE candidates on the basis of inhibitor selectivity, brain distribution, and mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeOP4NskdvrVg90H21EOLACvtfcHk0liYMK6r-3TDKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK&md5=53c6dfed22bb240b17132672b13fdcf1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcn3000907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn3000907%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPhosphodiesterases%2520as%2520therapeutic%2520targets%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D832%26epage%3D844%26doi%3D10.1021%2Fcn3000907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6897</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.5291-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&author=D.+Puzzoauthor=O.+Vitoloauthor=F.+Trincheseauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+peptide+inhibits+activation+of+the+nitric+oxide%2FcGMP%2FcAMP-responsive+element-binding+protein+pathway+during+hippocampal+synaptic+plasticity&doi=10.1523%2FJNEUROSCI.5291-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0ljCUMIkfZP2Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%2520inhibits%2520activation%2520of%2520the%2520nitric%2520oxide%252FcGMP%252FcAMP-responsive%2520element-binding%2520protein%2520pathway%2520during%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6887%26epage%3D6897%26doi%3D10.1523%2FJNEUROSCI.5291-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privitera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leznik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer’s disease mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">8075</span><span class="NLM_x">–</span> <span class="NLM_lpage">8086</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0864-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-beta+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1523%2FJNEUROSCI.0864-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0li3FBB0aiPqSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-beta%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D8075%26epage%3D8086%26doi%3D10.1523%2FJNEUROSCI.0864-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fiorito, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeed, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.ejmech.2012.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=23313637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=285-294&author=J.+Fioritoauthor=F.+Saeedauthor=H.+Zhangauthor=A.+Staniszewskiauthor=Y.+Fengauthor=Y.+I.+Francisauthor=S.+Raoauthor=D.+M.+Thakkarauthor=S.+X.+Dengauthor=D.+W.+Landryauthor=O.+Arancio&title=Synthesis+of+quinoline+derivatives%3A+discovery+of+a+potent+and+selective+phosphodiesterase+5+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2012.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Fiorito, Jole; Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Feng, Yan; Francis, Yitshak I.; Rao, Sudha; Thakkar, Devarshi M.; Deng, Shi-Xian; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">285-294</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphodiesterase type 5 (PDE5) mediates the degrdn. of cGMP in a variety of tissues including brain.  Recent studies have demonstrated the importance of the nitric oxide/cGMP/cAMP-responsive element-binding protein (CREB) pathway to the process of learning and memory.  Thus, PDE5 inhibitors (PDE5Is) are thought to be promising new therapeutic agents for the treatment of Alzheimer's disease (AD), a neurodegenerative disorder characterized by memory loss.  To explore this possibility, a series of quinoline derivs. were synthesized and evaluated.  We found that compd. I selectively inhibits PDE5 with an IC50 of 0.27 nM and readily crosses the blood brain barrier.  In an in vivo mouse model of AD, compd. I rescues synaptic and memory defects.  Quinoline-based, CNS-permeant PDE5Is have potential for AD therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6B39cj4LBh7Vg90H21EOLACvtfcHk0li3FBB0aiPqSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D&md5=335f11f0576ec3fe8dc1bcf5df2cebdc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFrancis%26aufirst%3DY.%2BI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DThakkar%26aufirst%3DD.%2BM.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520quinoline%2520derivatives%253A%2520discovery%2520of%2520a%2520potent%2520and%2520selective%2520phosphodiesterase%25205%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D285%26epage%3D294%26doi%3D10.1016%2Fj.ejmech.2012.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Behavioral assays with mouse models of Alzheimer’s disease: practical considerations and guidelines</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span><span class="refDoi"> DOI: 10.1016/j.bcp.2014.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.bcp.2014.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24462904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=450-467&author=D.+Puzzoauthor=L.+Leeauthor=A.+Palmeriauthor=G.+Calabreseauthor=O.+Arancio&title=Behavioral+assays+with+mouse+models+of+Alzheimer%E2%80%99s+disease%3A+practical+considerations+and+guidelines&doi=10.1016%2Fj.bcp.2014.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines</span></div><div class="casAuthors">Puzzo, Daniela; Lee, Linda; Palmeri, Agostino; Calabrese, Giorgio; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-467</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In Alzheimer's disease (AD) basic research and drug discovery, mouse models are essential resources for uncovering biol. mechanisms, validating mol. targets and screening potential compds.  Both transgenic and non-genetically modified mouse models enable access to different types of AD-like pathol. in vivo.  Although there is a wealth of genetic and biochem. studies on proposed AD pathogenic pathways, as a disease that centrally features cognitive failure, the ultimate readout for any interventions should be measures of learning and memory.  This is particularly important given the lack of knowledge on disease etiol. - assessment by cognitive assays offers the advantage of targeting relevant memory systems without requiring assumptions about pathogenesis.  A multitude of behavioral assays are available for assessing cognitive functioning in mouse models, including ones specific for hippocampal-dependent learning and memory.  Here we review the basics of available transgenic and non-transgenic AD mouse models and detail three well-established behavioral tasks commonly used for testing hippocampal-dependent cognition in mice - contextual fear conditioning, radial arm water maze and Morris water maze.  In particular, we discuss the practical considerations, requirements and caveats of these behavioral testing paradigms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-saArfdb-bVg90H21EOLACvtfcHk0lhPwG12af5ccA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGqsbc%253D&md5=91f85c57030dd20d389187cd73009f92</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DCalabrese%26aufirst%3DG.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DBehavioral%2520assays%2520with%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520practical%2520considerations%2520and%2520guidelines%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D88%26spage%3D450%26epage%3D467%26doi%3D10.1016%2Fj.bcp.2014.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Snieckus, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boekelheide, V.</span><span> </span><span class="NLM_article-title">Stereoselective syntheses of isoquinuclidones. I</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2845</span><span class="NLM_x">–</span> <span class="NLM_lpage">2848</span><span class="refDoi"> DOI: 10.1021/jo00983a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00983a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1972&pages=2845-2848&author=V.+A.+Snieckusauthor=T.+Onouchiauthor=V.+Boekelheide&title=Stereoselective+syntheses+of+isoquinuclidones.+I&doi=10.1021%2Fjo00983a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00983a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00983a011%26sid%3Dliteratum%253Aachs%26aulast%3DSnieckus%26aufirst%3DV.%2BA.%26aulast%3DOnouchi%26aufirst%3DT.%26aulast%3DBoekelheide%26aufirst%3DV.%26atitle%3DStereoselective%2520syntheses%2520of%2520isoquinuclidones.%2520I%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1972%26volume%3D37%26spage%3D2845%26epage%3D2848%26doi%3D10.1021%2Fjo00983a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Wolinska, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekaterina</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strekowski, L.</span><span> </span><span class="NLM_article-title">Facile synthesis of 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridines</span> <span class="citation_source-journal">Heterocycl. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1515%2FHC.2009.15.1.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlShtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=63-65&author=E.+P.+Wolinskaauthor=+Ekaterinaauthor=L.+Strekowski&title=Facile+synthesis+of+1%2C2%2C3%2C4-tetrahydrobenzo%5Bb%5D%5B1%2C6%5Dnaphthyridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridines</span></div><div class="casAuthors">Wolinska, Ewa; Paliakov, Ekaterina; Strekowski, Lucjan</div><div class="citationInfo"><span class="NLM_cas:title">Heterocyclic Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-65</span>CODEN:
                <span class="NLM_cas:coden">HCOMEX</span>;
        ISSN:<span class="NLM_cas:issn">0793-0283</span>.
    
            (<span class="NLM_cas:orgname">Freund Publishing House Ltd.</span>)
        </div><div class="casAbstract">Synthesis of title compds. I [R1 = H, MeO, OH; R2 = Me, Et; R3 = (CH2)2NMe2, CH(Me)(CH2)3NEt2], which analogs of known immunosuppressive quinolines, by cyclocondensation of corresponding anthranilic acids with N-alkyl-4-piperidones followed by nucleophilic substitution/amination with with alkyl diamines and (in 1 case) demethylation, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZqG8uv82j9bVg90H21EOLACvtfcHk0lhPwG12af5ccA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlShtb7K&md5=57a93680f3f0b0d556115830bff7a3ad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1515%2FHC.2009.15.1.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FHC.2009.15.1.63%26sid%3Dliteratum%253Aachs%26aulast%3DWolinska%26aufirst%3DE.%2BP.%26aulast%3DEkaterina%26aulast%3DStrekowski%26aufirst%3DL.%26atitle%3DFacile%2520synthesis%2520of%25201%252C2%252C3%252C4-tetrahydrobenzo%255Bb%255D%255B1%252C6%255Dnaphthyridines%26jtitle%3DHeterocycl.%2520Commun.%26date%3D2009%26volume%3D15%26spage%3D63%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hu, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grice, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. V.</span><span> </span><span class="NLM_article-title">Rotamers or diastereomers? An overlooked NMR solution</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5198</span><span class="NLM_x">–</span> <span class="NLM_lpage">5202</span><span class="refDoi"> DOI: 10.1021/jo300734r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo300734r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1WktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=5198-5202&author=D.+X.+Huauthor=P.+Griceauthor=S.+V.+Ley&title=Rotamers+or+diastereomers%3F+An+overlooked+NMR+solution&doi=10.1021%2Fjo300734r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rotamers or Diastereomers? An Overlooked NMR Solution</span></div><div class="casAuthors">Hu, Dennis X.; Grice, Peter; Ley, Steven V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5198-5202</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The existence of rotamers in a soln. of analyte complicates 1H NMR anal., esp. when the presence of diastereomers is also possible.  Org. chemists have often responded to this problem by conducting variable-temp. (VT) NMR expts., changing NMR solvents, or adding complexing agents.  Here, with specific examples, we illustrate the use of simple yet widely overlooked chem.-exchange NMR expts. which allow the nonintrusive rapid distinguishment of rapidly equilibrating small mols. such as rotamers from nonequilibrating diastereomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtqd6tSDTVhLVg90H21EOLACvtfcHk0liSZLoP0p-o-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1WktLs%253D&md5=0bd585493dc77fd7c9c8c441ddd6cd88</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo300734r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo300734r%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DD.%2BX.%26aulast%3DGrice%26aufirst%3DP.%26aulast%3DLey%26aufirst%3DS.%2BV.%26atitle%3DRotamers%2520or%2520diastereomers%253F%2520An%2520overlooked%2520NMR%2520solution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D5198%26epage%3D5202%26doi%3D10.1021%2Fjo300734r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Cote, R. H.</span><span> </span><span class="NLM_article-title">Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5</span> <span class="citation_source-journal">Int. J. Impotence Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">S28</span><span class="NLM_x">–</span> <span class="NLM_lpage">S33</span><span class="refDoi"> DOI: 10.1038/sj.ijir.3901212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fsj.ijir.3901212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=15224133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=S28-S33&author=R.+H.+Cote&title=Characteristics+of+photoreceptor+PDE+%28PDE6%29%3A+similarities+and+differences+to+PDE5&doi=10.1038%2Fsj.ijir.3901212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5</span></div><div class="casAuthors">Cote, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S28-S33</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 6 (PDE6) is highly concd. in the retina.  It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cGMP in rod and cone outer segments in response to light.  The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits.  Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding).  The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cAMP (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains.  Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrGvfie0U1bVg90H21EOLACvtfcHk0liSZLoP0p-o-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D&md5=7700b18905668782047be0bbdd461726</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901212%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DCharacteristics%2520of%2520photoreceptor%2520PDE%2520%2528PDE6%2529%253A%2520similarities%2520and%2520differences%2520to%2520PDE5%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2004%26volume%3D16%26spage%3DS28%26epage%3DS33%26doi%3D10.1038%2Fsj.ijir.3901212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Role of the active-site solvent in the thermodynamics of factor Xa ligand binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">2817</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span><span class="refDoi"> DOI: 10.1021/ja0771033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0771033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=2817-2831&author=R.+Abelauthor=T.+Youngauthor=R.+Faridauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Role+of+the+active-site+solvent+in+the+thermodynamics+of+factor+Xa+ligand+binding&doi=10.1021%2Fja0771033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span></div><div class="casAuthors">Abel, Robert; Young, Tom; Farid, Ramy; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2817-2831</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the underlying physics of the binding of small-mol. ligands to protein active sites is a key objective of computational chem. and biol.  It is widely believed that displacement of water mols. from the active site by the ligand is a principal (if not the dominant) source of binding free energy.  Although continuum theories of hydration are routinely used to describe the contributions of the solvent to the binding affinity of the complex, it is still an unsettled question as to whether or not these continuum solvation theories describe the underlying mol. physics with sufficient accuracy to reliably rank the binding affinities of a set of ligands for a given protein.  Here we develop a novel, computationally efficient descriptor of the contribution of the solvent to the binding free energy of a small mol. and its assocd. receptor that captures the effects of the ligand displacing the solvent from the protein active site with at. detail.  This descriptor quant. predicts (R2 = 0.81) the binding free energy differences between congeneric ligand pairs for the test system factor Xa, elucidates phys. properties of the active site solvent that appear to be missing in most continuum theories of hydration, and identifies several features of the hydration of the factor Xa active site relevant to the structure-activity relationship of its inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS42r59nNXH7Vg90H21EOLACvtfcHk0liSZLoP0p-o-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D&md5=8eefe76547a82bccaea38f2c84e6cd5f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja0771033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0771033%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%2520the%2520active-site%2520solvent%2520in%2520the%2520thermodynamics%2520of%2520factor%2520Xa%2520ligand%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D2817%26epage%3D2831%26doi%3D10.1021%2Fja0771033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1073/pnas.0610202104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1073%2Fpnas.0610202104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=17204562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=808-813&author=T.+Youngauthor=R.+Abelauthor=B.+Kimauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Motifs+for+molecular+recognition+exploiting+hydrophobic+enclosure+in+protein-ligand+binding&doi=10.1073%2Fpnas.0610202104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span></div><div class="casAuthors">Young, Tom; Abel, Robert; Kim, Byungchan; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The thermodn. properties and phase behavior of water in confined regions can vary significantly from that obsd. in the bulk.  This is particularly true for systems in which the confinement is on the mol.-length scale.  In this study, we use mol. dynamics simulations and a powerful solvent anal. technique based on inhomogeneous solvation theory to investigate the properties of water mols. that solvate the confined regions of protein active sites.  Our simulations and anal. indicate that the solvation of protein active sites that are characterized by hydrophobic enclosure and correlated hydrogen bonds induce atypical entropic and enthalpic penalties of hydration.  These penalties apparently stabilize the protein-ligand complex with respect to the independently solvated ligand and protein, which leads to enhanced binding affinities.  Our anal. elucidates several challenging cases, including the super affinity of the streptavidin-biotin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWumQ61YTqILVg90H21EOLACvtfcHk0lhKszMrrcGl9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D&md5=1109e3f48670cd910885f7fd527eb880</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610202104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610202104%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DMotifs%2520for%2520molecular%2520recognition%2520exploiting%2520hydrophobic%2520enclosure%2520in%2520protein-ligand%2520binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D808%26epage%3D813%26doi%3D10.1073%2Fpnas.0610202104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0lhKszMrrcGl9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Rowan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyubin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span> </span><span class="NLM_article-title">Synaptic plasticity in animal models of early Alzheimer’s disease</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span><span class="refDoi"> DOI: 10.1098/rstb.2002.1240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1098%2Frstb.2002.1240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=12740129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlSrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2003&pages=821-828&author=M.+J.+Rowanauthor=I.+Klyubinauthor=W.+K.+Cullenauthor=R.+Anwyl&title=Synaptic+plasticity+in+animal+models+of+early+Alzheimer%E2%80%99s+disease&doi=10.1098%2Frstb.2002.1240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic plasticity in animal models of early Alzheimer's disease</span></div><div class="casAuthors">Rowan, Michael J.; Klyubin, Igor; Cullen, William K.; Anwyl, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1432</span>),
    <span class="NLM_cas:pages">821-828</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  Amyloid β-protein (Aβ) is believed to be a primary cause of Alzheimer's disease (AD).  Recent research has examd. the potential importance of sol. species of Aβ in synaptic dysfunction, long before fibrillary Aβ is deposited and neurodegenerative changes occur.  Hippocampal excitatory synaptic transmission and plasticity are disrupted in transgenic mice overexpressing human amyloid precursor protein with early onset familial AD mutations, and in rats after exogenous application of synthetic Aβ both in vitro and in vivo.  Recently, naturally produced sol. Aβ was shown to block the persistence of long-term potentiation (LTP) in the intact hippocampus.  Sub-nanomolar concns. of oligomeric Aβ were sufficient to inhibit late LTP, pointing to a possible reason for the sensitivity of hippocampus-dependent memory to impairment in the early preclin. stages of AD.  Having identified the active species of Aβ that can play havoc with synaptic plasticity, it is hoped that new ways of targeting early AD can be developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkl4rsjYmPzbVg90H21EOLACvtfcHk0lhKszMrrcGl9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlSrurg%253D&md5=930c93d4f02254e38482ec26140905e4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1098%2Frstb.2002.1240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2002.1240%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26aulast%3DKlyubin%26aufirst%3DI.%26aulast%3DCullen%26aufirst%3DW.%2BK.%26aulast%3DAnwyl%26aufirst%3DR.%26atitle%3DSynaptic%2520plasticity%2520in%2520animal%2520models%2520of%2520early%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2003%26volume%3D358%26spage%3D821%26epage%3D828%26doi%3D10.1098%2Frstb.2002.1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span><span class="refDoi"> DOI: 10.1002/ana.20101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1002%2Fana.20101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=15174014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=801-814&author=F.+Trincheseauthor=S.+Liuauthor=F.+Battagliaauthor=S.+Walterauthor=P.+M.+Mathewsauthor=O.+Arancio&title=Progressive+age-related+development+of+Alzheimer-like+pathology+in+APP%2FPS1+mice&doi=10.1002%2Fana.20101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span></div><div class="casAuthors">Trinchese, Fabrizio; Liu, Shumin; Battaglia, Fortunato; Walter, Sean; Mathews, Paul M.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-814</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasing evidence points to synaptic plasticity impairment as one of the first events in Alzheimer's disease (AD).  However, studies on synaptic dysfunction in different transgenic AD models that overexpress familial AD mutant forms of amyloid precursor protein (APP) and/or presenilin (PS) have provided conflicting results.  Both long-term potentiation (LTP) and basal synaptic transmission (BST) have been found to be both unchanged and altered in different models and under differing exptl. conditions.  Because of their more robust amyloid-β (Aβ) deposition, double transgenic mice currently are used by several labs. as an AD model.  Here, we report that mice overexpressing APP (K670N: M671L) together with PS1 (M146L) have abnormal LTP as early as 3 mo of age.  Interestingly, reduced LTP paralleled plaque appearance and increased Aβ levels and abnormal short-term memory (working memory).  BST and long-term memory (ref. memory) are impaired only later (approx. 6 mo) as amyloid burden increases.  Aβ pathol. across different ages did not correlate with synaptic and cognitive deficits, suggesting that Aβ levels are not a marker of memory decline.  In contrast, progression of LTP impairment correlated with the deterioration of working memory, suggesting that percentage of potentiation might be an indicator of the cognitive decline and disease progression in the APP/PS1 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-0Sep8mnVgLVg90H21EOLACvtfcHk0ljhQ79A7btgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D&md5=87f7a6dea17b0d35a775712088213641</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fana.20101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20101%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DProgressive%2520age-related%2520development%2520of%2520Alzheimer-like%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D801%26epage%3D814%26doi%3D10.1002%2Fana.20101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mensch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span> </span><span class="NLM_article-title">In vivo, in vitro and in silico methods for small molecule transfer across the BBB</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span><span class="refDoi"> DOI: 10.1002/jps.21745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1002%2Fjps.21745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=4429-4468&author=J.+Menschauthor=J.+Oyarzabalauthor=C.+Mackieauthor=P.+Augustijns&title=In+vivo%2C+in+vitro+and+in+silico+methods+for+small+molecule+transfer+across+the+BBB&doi=10.1002%2Fjps.21745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjps.21745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21745%26sid%3Dliteratum%253Aachs%26aulast%3DMensch%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAugustijns%26aufirst%3DP.%26atitle%3DIn%2520vivo%252C%2520in%2520vitro%2520and%2520in%2520silico%2520methods%2520for%2520small%2520molecule%2520transfer%2520across%2520the%2520BBB%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D4429%26epage%3D4468%26doi%3D10.1002%2Fjps.21745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Gong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span><span class="refDoi"> DOI: 10.1172/JCI22831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1172%2FJCI22831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=15578094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2004&pages=1624-1634&author=B.+Gongauthor=O.+V.+Vitoloauthor=F.+Trincheseauthor=S.+Liuauthor=M.+Shelanskiauthor=O.+Arancio&title=Persistent+improvement+in+synaptic+and+cognitive+functions+in+an+Alzheimer+mouse+model+after+rolipram+treatment&doi=10.1172%2FJCI22831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span></div><div class="casAuthors">Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1624-1634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42).  Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V).  Here the authors demonstrate that brief treatment with the phosphodiesterase 4 inhibitor rolipram ameliorates deficits in both long-term potentiation (LTP) and contextual learning in the double-transgenic mice.  Most importantly, this beneficial effect can be extended beyond the duration of the administration.  One course of long-term systemic treatment with rolipram improves LTP and basal synaptic transmission as well as working, ref., and associative memory deficits for at least 2 mo after the end of the treatment.  This protective effect is possibly due to stabilization of synaptic circuitry via alterations in gene expression by activation of the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway that make the synapses more resistant to the insult inflicted by Aβ.  Thus, agents that enhance the cAMP/PKA/CREB pathway have potential for the treatment of AD and other diseases assocd. with elevated Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI79h3DC1rU7Vg90H21EOLACvtfcHk0ljhQ79A7btgJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I&md5=72e43d10754678b58a452160fe7142e2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1172%2FJCI22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI22831%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DVitolo%26aufirst%3DO.%2BV.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DShelanski%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPersistent%2520improvement%2520in%2520synaptic%2520and%2520cognitive%2520functions%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520after%2520rolipram%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D114%26spage%3D1624%26epage%3D1634%26doi%3D10.1172%2FJCI22831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Hughes, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph Rogier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jon Jacobsen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumsey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macinnes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span> </span><span class="NLM_article-title">Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6348</span><span class="NLM_x">–</span> <span class="NLM_lpage">6352</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.bmcl.2011.08.106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6348-6352&author=R.+O.+Hughesauthor=T.+Madduxauthor=D.+Joseph+Rogierauthor=S.+Luauthor=J.+K.+Walkerauthor=E.+Jon+Jacobsenauthor=J.+M.+Rumseyauthor=Y.+Zhengauthor=A.+Macinnesauthor=B.+R.+Bondauthor=S.+Han&title=Investigation+of+the+pyrazinones+as+PDE5+inhibitors%3A+evaluation+of+regioisomeric+projections+into+the+solvent+region&doi=10.1016%2Fj.bmcl.2011.08.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.106%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DR.%2BO.%26aulast%3DMaddux%26aufirst%3DT.%26aulast%3DJoseph%2BRogier%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DJon%2BJacobsen%26aufirst%3DE.%26aulast%3DRumsey%26aufirst%3DJ.%2BM.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMacinnes%26aufirst%3DA.%26aulast%3DBond%26aufirst%3DB.%2BR.%26aulast%3DHan%26aufirst%3DS.%26atitle%3DInvestigation%2520of%2520the%2520pyrazinones%2520as%2520PDE5%2520inhibitors%253A%2520evaluation%2520of%2520regioisomeric%2520projections%2520into%2520the%2520solvent%2520region%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6348%26epage%3D6352%26doi%3D10.1016%2Fj.bmcl.2011.08.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sastry, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adzhigirey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annabhimoju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2ebbV9HNjAcq2rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span><span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0ljs1lkKL7BMqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span><span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhdtpCIwDU70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lazaridis, T.</span><span> </span><span class="NLM_article-title">Inhomogeneous fluid approach to solvation thermodynamics. 1. Theory</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3531</span><span class="NLM_x">–</span> <span class="NLM_lpage">3541</span><span class="refDoi"> DOI: 10.1021/jp9723574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp9723574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1cXivVOltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3531-3541&author=T.+Lazaridis&title=Inhomogeneous+fluid+approach+to+solvation+thermodynamics.+1.+Theory&doi=10.1021%2Fjp9723574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhomogeneous Fluid Approach to Solvation Thermodynamics. 1. Theory</span></div><div class="casAuthors">Lazaridis, Themis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3531-3541</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The solvation energy and entropy at infinite diln. consist of a solute-solvent term and a solvent reorganization term representing the contributions of changes in solvent structure upon solute insertion.  In the std., homogeneous treatment of solns., changes in solvent structure are expressed through derivs. of the homogeneous pair correlation function, which are very difficult to obtain by simulation.  Tractable expressions for the solvation energy and entropy are here derived by viewing the soln. as an inhomogeneous system with the solute fixed at a certain point.  The solvent reorganization terms in the inhomogeneous view contain two contributions: the local, "correlation" contributions, which are due to correlations between the solute and the solvent and dominate at high densities, and the nonlocal, "liberation" contributions, which are due to the effective diln. of the solvent caused by the thermal motion of the solute and dominate at low densities.  The liberation contributions are independent of the nature or size of the solute and depend only on the properties of the solvent.  For common liq. solvents the nonlocal terms are negligible and the solvation properties arise almost entirely from effects localized around the solute.  The new expressions are tested by calcns. of the solvent reorganization energy and entropy in ideal hard-sphere and Lennard-Jones mixts. (solute identical to solvent).  The solvent reorganization energy and entropy make distinct and significant contributions to the solvation free energy.  The theory can be applied to truly inhomogeneous systems as well as small solute solvation, thus providing a connection between interfacial phenomena and microscopic solvation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxEN_nWI8WfbVg90H21EOLACvtfcHk0lhdtpCIwDU70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVOltr8%253D&md5=99755c87ffc33abd5e7df89c9996a665</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjp9723574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp9723574%26sid%3Dliteratum%253Aachs%26aulast%3DLazaridis%26aufirst%3DT.%26atitle%3DInhomogeneous%2520fluid%2520approach%2520to%2520solvation%2520thermodynamics.%25201.%2520Theory%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D1998%26volume%3D102%26spage%3D3531%26epage%3D3541%26doi%3D10.1021%2Fjp9723574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Lazaridis, T.</span><span> </span><span class="NLM_article-title">Inhomogeneous fluid approach to solvation thermodynamics. 2. Applications to simple fluids</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3542</span><span class="NLM_x">–</span> <span class="NLM_lpage">3550</span><span class="refDoi"> DOI: 10.1021/jp972358w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp972358w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1cXivVOltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3542-3550&author=T.+Lazaridis&title=Inhomogeneous+fluid+approach+to+solvation+thermodynamics.+2.+Applications+to+simple+fluids&doi=10.1021%2Fjp972358w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhomogeneous Fluid Approach to Solvation Thermodynamics. 2. Applications to Simple Fluids</span></div><div class="casAuthors">Lazaridis, Themis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3542-3550</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the previous paper expressions for the partial molar energy and entropy at infinite diln. have been derived based on the inhomogeneous forms of the energy equation and the correlation expansion for the entropy.  These expressions are here applied to a series of solutes of varying size in dense hard-sphere and Lennard-Jones solvents, some of which serve as ref. systems for comparison with water.  Numerical results are obtained under the assumption that the inhomogeneous solvent-solvent pair correlation function in the mixt. is equal to the bulk solvent radial distribution function (Kirkwood superposition approxn.).  The correlation functions required are obtained by both integral equation theory (Percus-Yevick approxn.) and Monte Carlo simulations.  The thermodn. results are compared with equation of state, integral equation, and free energy simulation results for the same systems.  For hard-sphere systems the excess entropies are in good agreement with equation-of-state results but in many Lennard-Jones systems the calcd. partial molar energies and entropies are lower than the expected values.  This is attributable to overestimation of the structure of the bulk triplet correlation function by the superposition approxn.  The decompn. of the chem. potential shows that similar solvation free energies can have entirely different phys. origins.  Specifically, in solvents of high cohesive energy d. the chem. potential is dominated by the breakup of solvent-solvent interactions locally around the solute.  In solvents of low cohesive energy d. it is dominated by the pressure-vol. term.  Increase in solvent-solvent interaction strength leads to increase in the chem. potential of the solute due to the higher solvent reorganization energy, which is insufficiently compensated by an increase in solvent reorganization entropy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwkuoqtHxPLVg90H21EOLACvtfcHk0lhdtpCIwDU70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVOltrw%253D&md5=63ce8d44f2f6c8d50f81303dba75924f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjp972358w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp972358w%26sid%3Dliteratum%253Aachs%26aulast%3DLazaridis%26aufirst%3DT.%26atitle%3DInhomogeneous%2520fluid%2520approach%2520to%2520solvation%2520thermodynamics.%25202.%2520Applications%2520to%2520simple%2520fluids%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D1998%26volume%3D102%26spage%3D3542%26epage%3D3550%26doi%3D10.1021%2Fjp972358w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Alamed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span> </span><span class="NLM_article-title">Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1671</span><span class="NLM_x">–</span> <span class="NLM_lpage">1679</span><span class="refDoi"> DOI: 10.1038/nprot.2006.275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fnprot.2006.275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1671-1679&author=J.+Alamedauthor=D.+M.+Wilcockauthor=D.+M.+Diamondauthor=M.+N.+Gordonauthor=D.+Morgan&title=Two-day+radial-arm+water+maze+learning+and+memory+task%3B+robust+resolution+of+amyloid-related+memory+deficits+in+transgenic+mice&doi=10.1038%2Fnprot.2006.275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.275%26sid%3Dliteratum%253Aachs%26aulast%3DAlamed%26aufirst%3DJ.%26aulast%3DWilcock%26aufirst%3DD.%2BM.%26aulast%3DDiamond%26aufirst%3DD.%2BM.%26aulast%3DGordon%26aufirst%3DM.%2BN.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DTwo-day%2520radial-arm%2520water%2520maze%2520learning%2520and%2520memory%2520task%253B%2520robust%2520resolution%2520of%2520amyloid-related%2520memory%2520deficits%2520in%2520transgenic%2520mice%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D1671%26epage%3D1679%26doi%3D10.1038%2Fnprot.2006.275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 25 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mohammad Abdel-Halim, Sara Sigler, Nora A. S. Racheed, Amr Hefnawy, Reem K. Fathalla, Mennatallah A. Hammam, Ahmed Maher, Yulia Maxuitenko, Adam B. Keeton, Rolf W. Hartmann, Matthias Engel, Gary A. Piazza, <span class="NLM_string-name hlFld-ContribAuthor">Ashraf H. Abadi</span>. </span><span class="cited-content_cbyCitation_article-title">From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4462-4477. <a href="https://doi.org/10.1021/acs.jmedchem.0c01120" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01120%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BCelecoxib%252Bto%252Ba%252BNovel%252BClass%252Bof%252BPhosphodiesterase%252B5%252BInhibitors%25253A%252BTrisubstituted%252BPyrazolines%252Bas%252BNovel%252BPhosphodiesterase%252B5%252BInhibitors%252Bwith%252BExtremely%252BHigh%252BPotency%252Band%252BPhosphodiesterase%252BIsozyme%252BSelectivity%26aulast%3DAbdel-Halim%26aufirst%3DMohammad%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30062020%26date%3D01042021%26volume%3D64%26issue%3D8%26spage%3D4462%26epage%3D4477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan He, Zhi Zheng, Qimeng Liu, Xinying Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xuesen Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent-Regulated Coupling of 2-Alkynylbenzaldehydes with Cyclic Amines: Selective Synthesis of Fused N-Heterocycles and Functionalized Naphthalene Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (22)
                                     , 9053-9058. <a href="https://doi.org/10.1021/acs.orglett.0c03442" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03442%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSolvent-Regulated%252BCoupling%252Bof%252B2-Alkynylbenzaldehydes%252Bwith%252BCyclic%252BAmines%25253A%252BSelective%252BSynthesis%252Bof%252BFused%252BN-Heterocycles%252Band%252BFunctionalized%252BNaphthalene%252BDerivatives%26aulast%3DHe%26aufirst%3DYan%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14102020%26date%3D05112020%26volume%3D22%26issue%3D22%26spage%3D9053%26epage%3D9058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maria Dichiara, Benedetto Amata, Rita Turnaturi, Agostino Marrazzo, <span class="NLM_string-name hlFld-ContribAuthor">Emanuele Amata</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning Properties for Blood–Brain Barrier Permeation: A Statistics-Based Analysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     , 34-44. <a href="https://doi.org/10.1021/acschemneuro.9b00541" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00541%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DTuning%252BProperties%252Bfor%252BBlood%2525E2%252580%252593Brain%252BBarrier%252BPermeation%25253A%252BA%252BStatistics-Based%252BAnalysis%26aulast%3DDichiara%26aufirst%3DMaria%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D07102019%26date%3D03122019%26date%3D18122019%26date%3D03122019%26volume%3D11%26issue%3D1%26spage%3D34%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Austin Horton, Kevin Nash, Ethel Tackie-Yarboi, Alexander Kostrevski, Adam Novak, Aparna Raghavan, Jatin Tulsulkar, Qasim Alhadidi, Nathan Wamer, Bryn Langenderfer, Kalee Royster, Maxwell Ducharme, Katelyn Hagood, Megan Post, Zahoor A. Shah, <span class="NLM_string-name hlFld-ContribAuthor">Isaac T. Schiefer</span>. </span><span class="cited-content_cbyCitation_article-title">Furoxans (Oxadiazole-4N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (10)
                                     , 4593-4607. <a href="https://doi.org/10.1021/acs.jmedchem.8b00389" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00389%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFuroxans%252B%252528Oxadiazole-4N-oxides%252529%252Bwith%252BAttenuated%252BReactivity%252Bare%252BNeuroprotective%25252C%252BCross%252Bthe%252BBlood%252BBrain%252BBarrier%25252C%252Band%252BImprove%252BPassive%252BAvoidance%252BMemory%26aulast%3DHorton%26aufirst%3DAustin%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D09032018%26date%3D07052018%26date%3D23042018%26volume%3D61%26issue%3D10%26spage%3D4593%26epage%3D4607" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunmei  Li</span>, <span class="hlFld-ContribAuthor ">Furen  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenlu  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Strategy for the Synthesis of Naphtho[2,3-b][1,6]naphthyridines Promoted by Acetic Acid. </span><span class="cited-content_cbyCitation_journal-name">Synlett</span><span> <strong>2021,</strong> <em>32 </em>
                                    (11)
                                     , 1117-1122. <a href="https://doi.org/10.1055/a-1479-4420" title="DOI URL">https://doi.org/10.1055/a-1479-4420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1479-4420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1479-4420%26sid%3Dliteratum%253Aachs%26jtitle%3DSynlett%26atitle%3DAn%252BEfficient%252BStrategy%252Bfor%252Bthe%252BSynthesis%252Bof%252BNaphtho%25255B2%25252C3-b%25255D%25255B1%25252C6%25255Dnaphthyridines%252BPromoted%252Bby%252BAcetic%252BAcid%26aulast%3DLi%26aufirst%3DChunmei%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D11%26spage%3D1117%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mallu  Lavanya</span>, <span class="hlFld-ContribAuthor ">Chong  Lin</span>, <span class="hlFld-ContribAuthor ">Jincheng  Mao</span>, <span class="hlFld-ContribAuthor ">Dhakshanamurthy  Thirumalai</span>, <span class="hlFld-ContribAuthor ">Sreenath Reddy  Aabaka</span>, <span class="hlFld-ContribAuthor ">Xiaojiang  Yang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Mao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Huang</span>, <span class="hlFld-ContribAuthor ">Jinzhou  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-00314-6" title="DOI URL">https://doi.org/10.1007/s41061-020-00314-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00314-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnticancer%252BProperties%252Bof%252BFunctionalized%252B1%25252C6-Naphthyridines%26aulast%3DLavanya%26aufirst%3DMallu%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susann  Schröder</span>, <span class="hlFld-ContribAuthor ">Matthias  Scheunemann</span>, <span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (8)
                                     , 3832. <a href="https://doi.org/10.3390/ijms22083832" title="DOI URL">https://doi.org/10.3390/ijms22083832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22083832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22083832%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DChallenges%252Bon%252BCyclic%252BNucleotide%252BPhosphodiesterases%252BImaging%252Bwith%252BPositron%252BEmission%252BTomography%25253A%252BNovel%252BRadioligands%252Band%252B%252528Pre-%252529Clinical%252BInsights%252Bsince%252B2016%26aulast%3DSchr%25C3%25B6der%26aufirst%3DSusann%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D8%26spage%3D3832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicole  Gorny</span>, <span class="hlFld-ContribAuthor ">Michy P.  Kelly</span>. </span><span class="cited-content_cbyCitation_article-title">Alterations in cyclic nucleotide signaling are implicated in healthy aging and age-related pathologies of the brain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 265-316. <a href="https://doi.org/10.1016/bs.vh.2020.12.012" title="DOI URL">https://doi.org/10.1016/bs.vh.2020.12.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.vh.2020.12.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.vh.2020.12.012%26sid%3Dliteratum%253Aachs%26atitle%3DAlterations%252Bin%252Bcyclic%252Bnucleotide%252Bsignaling%252Bare%252Bimplicated%252Bin%252Bhealthy%252Baging%252Band%252Bage-related%252Bpathologies%252Bof%252Bthe%252Bbrain%26aulast%3DGorny%26aufirst%3DNicole%26date%3D2021%26spage%3D265%26epage%3D316%26pub%3DElsevier%26atitle%3DHormones%252Band%252BAging%26date%3D2021%26volume%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-Shu  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Gong</span>, <span class="hlFld-ContribAuthor ">Zhi-Cheng  Yu</span>, <span class="hlFld-ContribAuthor ">Yan-Guang  Tian</span>, <span class="hlFld-ContribAuthor ">Lin-Sheng  Zhuo</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Neng-Fang  She</span>. </span><span class="cited-content_cbyCitation_article-title">Grignard Reagent Utilization Enables a Practical and Scalable Construction of 3-Substituted 5-Chloro-1,6-naphthyridin-4-one Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5667. <a href="https://doi.org/10.3390/molecules25235667" title="DOI URL">https://doi.org/10.3390/molecules25235667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235667%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DGrignard%252BReagent%252BUtilization%252BEnables%252Ba%252BPractical%252Band%252BScalable%252BConstruction%252Bof%252B3-Substituted%252B5-Chloro-1%25252C6-naphthyridin-4-one%252BDerivatives%26aulast%3DWang%26aufirst%3DMing-Shu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mayara  dos Santos Maia</span>, <span class="hlFld-ContribAuthor ">Gabriela Cristina Soares  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Natália Ferreira  de Sousa</span>, <span class="hlFld-ContribAuthor ">Marcus Tullius  Scotti</span>, <span class="hlFld-ContribAuthor ">Luciana  Scotti</span>, <span class="hlFld-ContribAuthor ">Francisco Jaime B.  Mendonça-Junior</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of New Targets and the Virtual Screening of Lignans against Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2020,</strong> <em>2020 </em>, 1-19. <a href="https://doi.org/10.1155/2020/3098673" title="DOI URL">https://doi.org/10.1155/2020/3098673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/3098673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F3098673%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DIdentification%252Bof%252BNew%252BTargets%252Band%252Bthe%252BVirtual%252BScreening%252Bof%252BLignans%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3Ddos%2BSantos%2BMaia%26aufirst%3DMayara%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Limeng  Jia</span>, <span class="hlFld-ContribAuthor ">Wenqing  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Song</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [11C]TPN171 as a new potential PET heart imaging agent. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2020,</strong> <em>162 </em>, 109190. <a href="https://doi.org/10.1016/j.apradiso.2020.109190" title="DOI URL">https://doi.org/10.1016/j.apradiso.2020.109190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2020.109190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2020.109190%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DRadiosynthesis%252Bof%252Ba%252Bcarbon-11%252Blabeled%252BPDE5%252Binhibitor%252B%25255B11C%25255DTPN171%252Bas%252Ba%252Bnew%252Bpotential%252BPET%252Bheart%252Bimaging%252Bagent%26aulast%3DXu%26aufirst%3DZhidong%26date%3D2020%26volume%3D162%26spage%3D109190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunmei  Li</span>, <span class="hlFld-ContribAuthor ">Chenze  Qi</span>, <span class="hlFld-ContribAuthor ">Furen  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasonic promoted synthesis of 1,6-naphthyridine derivatives catalyzed by solid acid in water. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (30)
                                     , 152144. <a href="https://doi.org/10.1016/j.tetlet.2020.152144" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152144</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152144%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DUltrasonic%252Bpromoted%252Bsynthesis%252Bof%252B1%25252C6-naphthyridine%252Bderivatives%252Bcatalyzed%252Bby%252Bsolid%252Bacid%252Bin%252Bwater%26aulast%3DLi%26aufirst%3DChunmei%26date%3D2020%26volume%3D61%26issue%3D30%26spage%3D152144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisa  Zuccarello</span>, <span class="hlFld-ContribAuthor ">Erica  Acquarone</span>, <span class="hlFld-ContribAuthor ">Elisa  Calcagno</span>, <span class="hlFld-ContribAuthor ">Elentina K.  Argyrousi</span>, <span class="hlFld-ContribAuthor ">Shi-Xian  Deng</span>, <span class="hlFld-ContribAuthor ">Donald W.  Landry</span>, <span class="hlFld-ContribAuthor ">Ottavio  Arancio</span>, <span class="hlFld-ContribAuthor ">Jole  Fiorito</span>. </span><span class="cited-content_cbyCitation_article-title">Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2020,</strong> <em>176 </em>, 113818. <a href="https://doi.org/10.1016/j.bcp.2020.113818" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.113818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.113818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.113818%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Bnovel%252Bphosphodiesterase%252B5%252Binhibitors%252Bfor%252Bthe%252Btherapy%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZuccarello%26aufirst%3DElisa%26date%3D2020%26volume%3D176%26spage%3D113818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elentina K.  Argyrousi</span>, <span class="hlFld-ContribAuthor ">Pim R.A.  Heckman</span>, <span class="hlFld-ContribAuthor ">Jos  Prickaerts</span>. </span><span class="cited-content_cbyCitation_article-title">Role of cyclic nucleotides and their downstream signaling cascades in memory function: Being at the right time at the right spot. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2020,</strong> <em>113 </em>, 12-38. <a href="https://doi.org/10.1016/j.neubiorev.2020.02.004" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2020.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2020.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2020.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DRole%252Bof%252Bcyclic%252Bnucleotides%252Band%252Btheir%252Bdownstream%252Bsignaling%252Bcascades%252Bin%252Bmemory%252Bfunction%25253A%252BBeing%252Bat%252Bthe%252Bright%252Btime%252Bat%252Bthe%252Bright%252Bspot%26aulast%3DArgyrousi%26aufirst%3DElentina%2BK.%26date%3D2020%26volume%3D113%26spage%3D12%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fugui  Dong</span>, <span class="hlFld-ContribAuthor ">Jie  Du</span>, <span class="hlFld-ContribAuthor ">Caihong  Miao</span>, <span class="hlFld-ContribAuthor ">Limeng  Jia</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhidong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2019,</strong> <em>154 </em>, 108873. <a href="https://doi.org/10.1016/j.apradiso.2019.108873" title="DOI URL">https://doi.org/10.1016/j.apradiso.2019.108873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2019.108873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2019.108873%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DRadiosynthesis%252Bof%252Bcarbon-11%252Blabeled%252BPDE5%252Binhibitors%252Bas%252Bnew%252Bpotential%252BPET%252Bradiotracers%252Bfor%252Bimaging%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DDong%26aufirst%3DFugui%26date%3D2019%26volume%3D154%26spage%3D108873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erica  Acquarone</span>, <span class="hlFld-ContribAuthor ">Elentina K.  Argyrousi</span>, <span class="hlFld-ContribAuthor ">Manon  van den Berg</span>, <span class="hlFld-ContribAuthor ">Walter  Gulisano</span>, <span class="hlFld-ContribAuthor ">Mauro  Fà</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Staniszewski</span>, <span class="hlFld-ContribAuthor ">Elisa  Calcagno</span>, <span class="hlFld-ContribAuthor ">Elisa  Zuccarello</span>, <span class="hlFld-ContribAuthor ">Luciano  D’Adamio</span>, <span class="hlFld-ContribAuthor ">Shi-Xian  Deng</span>, <span class="hlFld-ContribAuthor ">Daniela  Puzzo</span>, <span class="hlFld-ContribAuthor ">Ottavio  Arancio</span>, <span class="hlFld-ContribAuthor ">Jole  Fiorito</span>. </span><span class="cited-content_cbyCitation_article-title">Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurodegeneration</span><span> <strong>2019,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13024-019-0326-4" title="DOI URL">https://doi.org/10.1186/s13024-019-0326-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13024-019-0326-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13024-019-0326-4%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurodegeneration%26atitle%3DSynaptic%252Band%252Bmemory%252Bdysfunction%252Binduced%252Bby%252Btau%252Boligomers%252Bis%252Brescued%252Bby%252Bup-regulation%252Bof%252Bthe%252Bnitric%252Boxide%252Bcascade%26aulast%3DAcquarone%26aufirst%3DErica%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rayala  Swetha</span>, <span class="hlFld-ContribAuthor ">Devendra  Kumar</span>, <span class="hlFld-ContribAuthor ">Sukesh K  Gupta</span>, <span class="hlFld-ContribAuthor ">Ankit  Ganeshpurkar</span>, <span class="hlFld-ContribAuthor ">Ravi  Singh</span>, <span class="hlFld-ContribAuthor ">Gopichand  Gutti</span>, <span class="hlFld-ContribAuthor ">Dileep  Kumar</span>, <span class="hlFld-ContribAuthor ">Srabanti  Jana</span>, <span class="hlFld-ContribAuthor ">Sairam  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Sushil K  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (24)
                                     , 3161-3178. <a href="https://doi.org/10.4155/fmc-2019-0106" title="DOI URL">https://doi.org/10.4155/fmc-2019-0106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2019-0106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2019-0106%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMultifunctional%252Bhybrid%252Bsulfonamides%252Bas%252Bnovel%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSwetha%26aufirst%3DRayala%26date%3D2019%26volume%3D11%26issue%3D24%26spage%3D3161%26epage%3D3178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Huang  Xu</span>, <span class="hlFld-ContribAuthor ">Shumin  Ding</span>, <span class="hlFld-ContribAuthor ">Dongyan  Wang</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Song</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 5 inhibitors as novel agents for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2019,</strong> <em>153 </em>, 223-231. <a href="https://doi.org/10.1016/j.brainresbull.2019.09.001" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2019.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2019.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2019.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DPhosphodiesterase%252B5%252Binhibitors%252Bas%252Bnovel%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DLiu%26aufirst%3DLi%26date%3D2019%26volume%3D153%26spage%3D223%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jole  Fiorito</span>, <span class="hlFld-ContribAuthor ">Shi-Xian  Deng</span>, <span class="hlFld-ContribAuthor ">Donald  W. Landry</span>, <span class="hlFld-ContribAuthor ">Ottavio  Arancio</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the NO/cGMP/CREB Phosphorylation Signaling Pathway in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.81029" title="DOI URL">https://doi.org/10.5772/intechopen.81029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.81029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.81029%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252Bthe%252BNO%25252FcGMP%25252FCREB%252BPhosphorylation%252BSignaling%252BPathway%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DFiorito%26aufirst%3DJole%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DNeurochemical%252BBasis%252Bof%252BBrain%252BFunction%252Band%252BDysfunction%26aulast%3DHeinbockel%26aufirst%3DThomas%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wesam  El-Bakly</span>, <span class="hlFld-ContribAuthor ">Omar  Wagdy</span>, <span class="hlFld-ContribAuthor ">Ahmed  Sobhy</span>, <span class="hlFld-ContribAuthor ">Omar  abo elenain</span>, <span class="hlFld-ContribAuthor ">Mohamed S.  Riad</span>, <span class="hlFld-ContribAuthor ">Mahmoud  El Sayed</span>, <span class="hlFld-ContribAuthor ">Sherif  Tarkhan</span>, <span class="hlFld-ContribAuthor ">Mahmoud  Yassen</span>, <span class="hlFld-ContribAuthor ">Abdelrahman  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Mohamed  Bassiony</span>, <span class="hlFld-ContribAuthor ">Nesreen  Nabil</span>. </span><span class="cited-content_cbyCitation_article-title">The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies. </span><span class="cited-content_cbyCitation_journal-name">Behavioural Brain Research</span><span> <strong>2019,</strong> <em>372 </em>, 112004. <a href="https://doi.org/10.1016/j.bbr.2019.112004" title="DOI URL">https://doi.org/10.1016/j.bbr.2019.112004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbr.2019.112004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbr.2019.112004%26sid%3Dliteratum%253Aachs%26jtitle%3DBehavioural%2520Brain%2520Research%26atitle%3DThe%252Befficacy%252Band%252Bunderlying%252Bmechanism%252Bof%252Bphosphodiesterase-%252B5%252Binhibitors%252Bin%252Bpreventing%252Bcognitive%252Bimpairment%252Band%252BAlzheimer%252Bpathology%25253A%252BA%252Bsystematic%252Breview%252Bof%252Banimal%252Bstudies%26aulast%3DEl-Bakly%26aufirst%3DWesam%26date%3D2019%26volume%3D372%26spage%3D112004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nancy  Bartolotti</span>, <span class="hlFld-ContribAuthor ">Orly  Lazarov</span>. </span><span class="cited-content_cbyCitation_article-title">CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis. </span><span class="cited-content_cbyCitation_journal-name">Brain, Behavior, and Immunity</span><span> <strong>2019,</strong> <em>78 </em>, 9-20. <a href="https://doi.org/10.1016/j.bbi.2019.01.004" title="DOI URL">https://doi.org/10.1016/j.bbi.2019.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbi.2019.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbi.2019.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%252C%2520Behavior%252C%2520and%2520Immunity%26atitle%3DCREB%252Bsignals%252Bas%252BPBMC-based%252Bbiomarkers%252Bof%252Bcognitive%252Bdysfunction%25253A%252BA%252Bnovel%252Bperspective%252Bof%252Bthe%252Bbrain-immune%252Baxis%26aulast%3DBartolotti%26aufirst%3DNancy%26date%3D2019%26volume%3D78%26spage%3D9%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piyoosh  Sharma</span>, <span class="hlFld-ContribAuthor ">Pavan  Srivastava</span>, <span class="hlFld-ContribAuthor ">Ankit  Seth</span>, <span class="hlFld-ContribAuthor ">Prabhash Nath  Tripathi</span>, <span class="hlFld-ContribAuthor ">Anupam G.  Banerjee</span>, <span class="hlFld-ContribAuthor ">Sushant K.  Shrivastava</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Progress in Neurobiology</span><span> <strong>2019,</strong> <em>174 </em>, 53-89. <a href="https://doi.org/10.1016/j.pneurobio.2018.12.006" title="DOI URL">https://doi.org/10.1016/j.pneurobio.2018.12.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pneurobio.2018.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pneurobio.2018.12.006%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Neurobiology%26atitle%3DComprehensive%252Breview%252Bof%252Bmechanisms%252Bof%252Bpathogenesis%252Binvolved%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bpotential%252Btherapeutic%252Bstrategies%26aulast%3DSharma%26aufirst%3DPiyoosh%26date%3D2019%26volume%3D174%26spage%3D53%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Hollas</span>, <span class="hlFld-ContribAuthor ">Manel  Ben Aissa</span>, <span class="hlFld-ContribAuthor ">Sue H.  Lee</span>, <span class="hlFld-ContribAuthor ">Jesse M.  Gordon-Blake</span>, <span class="hlFld-ContribAuthor ">Gregory R.J.  Thatcher</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nitric Oxide</span><span> <strong>2019,</strong> <em>82 </em>, 59-74. <a href="https://doi.org/10.1016/j.niox.2018.10.006" title="DOI URL">https://doi.org/10.1016/j.niox.2018.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.niox.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.niox.2018.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DNitric%2520Oxide%26atitle%3DPharmacological%252Bmanipulation%252Bof%252BcGMP%252Band%252BNO%25252FcGMP%252Bin%252BCNS%252Bdrug%252Bdiscovery%26aulast%3DHollas%26aufirst%3DMichael%2BA.%26date%3D2019%26volume%3D82%26spage%3D59%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongbo  Zheng</span>, <span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Yun  Gao</span>, <span class="hlFld-ContribAuthor ">Wei  Song</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanhui  Gao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Xie</span>, <span class="hlFld-ContribAuthor ">Nianzhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianbo  Ji</span>, <span class="hlFld-ContribAuthor ">Huiqing  Yuan</span>, <span class="hlFld-ContribAuthor ">Hongxiang  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of furyl/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>150 </em>, 30-38. <a href="https://doi.org/10.1016/j.ejmech.2018.02.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bfuryl%25252Fthineyl%252Bpyrroloquinolones%252Bbased%252Bon%252Bnatural%252Balkaloid%252Bperlolyrine%25252C%252Blead%252Bto%252Bthe%252Bdiscovery%252Bof%252Bpotent%252Band%252Bselective%252BPDE5%252Binhibitors%26aulast%3DZheng%26aufirst%3DHongbo%26date%3D2018%26volume%3D150%26spage%3D30%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.R.A.  Heckman</span>, <span class="hlFld-ContribAuthor ">A.  Blokland</span>, <span class="hlFld-ContribAuthor ">E.P.P.  Bollen</span>, <span class="hlFld-ContribAuthor ">J.  Prickaerts</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2018,</strong> <em>87 </em>, 233-254. <a href="https://doi.org/10.1016/j.neubiorev.2018.02.007" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2018.02.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2018.02.007%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DPhosphodiesterase%252Binhibition%252Band%252Bmodulation%252Bof%252Bcorticostriatal%252Band%252Bhippocampal%252Bcircuits%25253A%252BClinical%252Boverview%252Band%252Btranslational%252Bconsiderations%26aulast%3DHeckman%26aufirst%3DP.R.A.%26date%3D2018%26volume%3D87%26spage%3D233%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of compound <b>1</b> and new PDE5Is, 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridine (scaffold A) and 2,3-dihydro-1<i>H</i>-pyrrolo[3,4-<i>b</i>]quinolin-1-one (scaffold B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>6a</b>–<b>g</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) CuCN, NMP, 200 °C, 4 h; (ii) 1 M EtOH/KOH, 50 °C, 2 h; (iii) 1-substituted piperidin-4-one, POCl<sub>3</sub>, 60 °C, 6 h; (iv) appropriate benzylamine, TEA, NaI, NMP, 130 °C, overnight; (v) NaBH<sub>4</sub>, THF, rt, overnight; (vi) phthalimide, DIAD, PPh<sub>3</sub>, THF, rt, 24 h; (vii) (a) N<sub>2</sub>H<sub>4</sub>, MeOH, reflux, overnight; (b) HCl/Et<sub>2</sub>O</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compound <b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) ACE-Cl, ClCH<sub>2</sub>CH<sub>2</sub>Cl, reflux; (b) MeOH, reflux, 2 h; (ii) Boc<sub>2</sub>O, CH<sub>2</sub>Cl; (iii) 3-chloro-4-methoxybenzylamine, TEA, NaI, NMP, 130 °C, overnight; (iv) 2.0 M Et<sub>2</sub>O/HCl, CH<sub>2</sub>Cl<sub>2</sub>, 1,4-dioxane, rt, overnight.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>17a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1-substituted piperidin-4-one, POCl<sub>3</sub>, 60 °C, 6 h; (ii) benzylamine, TEA, NaI, NMP, 130 °C, overnight.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>24a</b>–<b>f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) triphosgene, 1,4-dioxane, 90 °C, 2 h; (ii) methyl acetoacetate, NaH, DMA, 120 °C, 20 min; (iii) POCl<sub>3</sub>, 110 °C, 30 min; (iv) NBS, AIBN, CCl<sub>4</sub>, reflux, 4 h; (v) ethylamine or <i>tert</i>-butylamine, EtOH, reflux, 2 h; (vi) 3-chloro-4-methoxybenzylamine HCl, DIPEA, <i>n</i>-propanol, 90 °C, 2 h.</p></p></figure><figure data-id="fig2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docked binding modes of compound <b>6c</b> into the PDE5 cGMP pocket. (A) Overview of PDE5 with compound <b>6c</b> docked in the cGMP pocket in its best docking pose. (B) Close-up view of the best docking pose for compound <b>6c</b>. This pose is very similar to the best docking pose found for compound <b>24a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S6A). Note that for both compounds, postdocking minimization led to a significant change in the Q775 side chain orientation compared to the PDB structure used for docking (3TGG). The refined side chain orientation, which optimizes the geometry of the hydrogen bond with the nitrile group of the two compounds, is consistent with alternative side chain orientations observed for residue Q775 in other PDE5 crystal structures (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S5B,C). (C) Close-up view of the alternative docking pose found for compound <b>6c</b>. A very similar alternative docking pose was found for compound <b>24a</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7B). Dashed lines in parts B and C represent intermolecular hydrogen bonds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Two-dimensional interaction diagrams for compound <b>6c</b>. The best docking pose (left) as well as the alternative docking pose (right) are represented. The legend for the residue types and the types of interactions is indicated at the bottom of the figure. The two-dimensional interaction diagrams for compound <b>24a</b> are represented in the <a href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf" class="ext-link">Supporting Information</a>, Figure S7.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. cGMP levels in hippocampus of mice treated with compound <b>6c</b> at 3 and 10 mg/kg via intraperitoneally. Values are the mean of duplicate determinations. Error bars show SEM (<i>n</i> = 3 per group); *<i>p</i> < 0.01.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Beneficial effect of compound <b>6c</b> on synaptic deficits in APP/PS1 mice. Two hours recording following tetanic stimulation of the Schaffer collateral fibers at the CA3-CA1 connection. (A) Slices were prepared from 3-month-old WT and APP/PS1 mice treated with vehicle or compound <b>6c</b> at 50 nM (acute perfusion, *<i>p</i> < 0.01 and F<sub>(1,13)</sub> = 15.57). (B) Residual potentiation recorded during the last 5 min of a 2 h recording shown in panel A. (C) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months. Slices were recorded at 6–7 months of age, *<i>p</i> < 0.01 and F<sub>(1,15)</sub> = 27.0. (D) Residual potentiation recorded during the last 5 min of a 2 h recording shown in panel C.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/medium/jm-2017-00979w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Beneficial effect of compound <b>6c</b> on cognitive deficits in APP/PS1 mice. (A) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months re-established normal freezing in a test for contextual fear memory. (B) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months reduced the number of errors with the 2-day radial arm water maze. (C) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months re-established normal freezing in a test for contextual fear memory when mice were examined at 6–7 months of age. (D) Daily treatment with compound <b>6c</b> (3 mg/kg, ip) for 3 weeks at the age of 3–4 months reduced the number of errors with the 2-day radial arm water maze when mice were examined at 6–7 months of age. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-21/acs.jmedchem.7b00979/20171103/images/large/jm-2017-00979w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00979&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahdi, A. A.</span><span> </span><span class="NLM_article-title">Therapeutics of Alzheimer’s disease: Past, present and future</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span><span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.neuropharm.2013.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=23891641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Wrt7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=27-50&author=R.+Anandauthor=K.+D.+Gillauthor=A.+A.+Mahdi&title=Therapeutics+of+Alzheimer%E2%80%99s+disease%3A+Past%2C+present+and+future&doi=10.1016%2Fj.neuropharm.2013.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutics of Alzheimer's disease: Past, present and future</span></div><div class="casAuthors">Anand, R.; Gill, Kiran Dip; Mahdi, Abbas Ali</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">PA</span>),
    <span class="NLM_cas:pages">27-50</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common cause of dementia worldwide.  The etiol. is multifactorial, and pathophysiol. of the disease is complex.  Data indicate an exponential rise in the no. of cases of AD, emphasizing the need for developing an effective treatment.  AD also imposes tremendous emotional and financial burden to the patient's family and community.  The disease has been studied over a century, but acetylcholinesterase inhibitors and memantine are the only drugs currently approved for its management.  These drugs provide symptomatic improvement alone but do less to modify the disease process.  The extensive insight into the mol. and cellular pathomechanism in AD over the past few decades has provided us significant progress in the understanding of the disease.  A no. of novel strategies that seek to modify the disease process have been developed.  The major developments in this direction are the amyloid and tau based therapeutics, which could hold the key to treatment of AD in the near future.  Several putative drugs have been thoroughly investigated in preclin. studies, but many of them have failed to produce results in the clin. scenario; therefore it is only prudent that lessons be learned from the past mistakes.  The current rationales and targets evaluated for therapeutic benefit in AD are reviewed in this article. This article is part of the Special Issue entitled 'The Synaptic Basis of Neurodegenerative Disorders'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojc5hTOMAnpbVg90H21EOLACvtfcHk0lgANeBna8lmaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Wrt7%252FK&md5=6de96960a7d842eb0d8ffe5db1b452e7</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DK.%2BD.%26aulast%3DMahdi%26aufirst%3DA.%2BA.%26atitle%3DTherapeutics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Past%252C%2520present%2520and%2520future%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26spage%3D27%26epage%3D50%26doi%3D10.1016%2Fj.neuropharm.2013.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cummings, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morstorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, K.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drug-development pipeline: few candidates, frequent failures</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="refDoi"> DOI: 10.1186/alzrt269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1186%2Falzrt269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=25024750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=37&author=J.+L.+Cummingsauthor=T.+Morstorfauthor=K.+Zhong&title=Alzheimer%E2%80%99s+disease+drug-development+pipeline%3A+few+candidates%2C+frequent+failures&doi=10.1186%2Falzrt269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease drug-development pipeline: few candidates, frequent failures</span></div><div class="casAuthors">Cummings Jeffrey L; Zhong Kate; Morstorf Travis</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's research & therapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">37</span>
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    </div><div class="casAbstract">INTRODUCTION:  Alzheimer's disease (AD) is increasing in frequency as the global population ages.  Five drugs are approved for treatment of AD, including four cholinesterase inhibitors and an N-methyl-D-aspartate (NMDA)-receptor antagonist.  We have an urgent need to find new therapies for AD.  METHODS:  We examined Clinicaltrials.gov, a public website that records ongoing clinical trials.  We examined the decade of 2002 to 2012, to better understand AD-drug development.  We reviewed trials by sponsor, sites, drug mechanism of action, duration, number of patients required, and rate of success in terms of advancement from one phase to the next.  We also reviewed the current AD therapy pipeline.  RESULTS:  During the 2002 to 2012 observation period, 413 AD trials were performed: 124 Phase 1 trials, 206 Phase 2 trials, and 83 Phase 3 trials.  Seventy-eight percent were sponsored by pharmaceutical companies.  The United States of America (U.S.) remains the single world region with the greatest number of trials; cumulatively, more non-U.S. than U.S. trials are performed.  The largest number of registered trials addressed symptomatic agents aimed at improving cognition (36.6%), followed by trials of disease-modifying small molecules (35.1%) and trials of disease-modifying immunotherapies (18%).  The mean length of trials increases from Phase 2 to Phase 3, and the number of participants in trials increases between Phase 2 and Phase 3.  Trials of disease-modifying agents are larger and longer than those for symptomatic agents.  A very high attrition rate was found, with an overall success rate during the 2002 to 2012 period of 0.4% (99.6% failure).  CONCLUSIONS:  The Clinicaltrials.gov database demonstrates that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem.  The success rate for advancing from one phase to another is low, and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.  The AD drug-development ecosystem requires support.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT__DMPwHFhGGPgL4LrC-0VfW6udTcc2eYLcFhM0LwMuLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cbisFWjtQ%253D%253D&md5=85b84800ce02d7031a4c1046e837e568</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Falzrt269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt269%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%2BL.%26aulast%3DMorstorf%26aufirst%3DT.%26aulast%3DZhong%26aufirst%3DK.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drug-development%2520pipeline%253A%2520few%2520candidates%252C%2520frequent%2520failures%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2014%26volume%3D6%26spage%3D37%26doi%3D10.1186%2Falzrt269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu-Seifert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">Alzheimer’s Disease Cooperative Study Steering Committee; Solanezumab Study Group. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">321</span><span class="refDoi"> DOI: 10.1056/NEJMoa1312889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1056%2FNEJMoa1312889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24450890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=311-321&author=R.+S.+Doodyauthor=R.+G.+Thomasauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=R.+Ramanauthor=X.+Sunauthor=P.+S.+Aisenauthor=E.+Siemersauthor=H.+Liu-Seifertauthor=R.+Mohs&title=Alzheimer%E2%80%99s+Disease+Cooperative+Study+Steering+Committee%3B+Solanezumab+Study+Group.+Phase+3+trials+of+solanezumab+for+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1312889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; Raman, Rema; Sun, Xiaoying; Aisen, Paul S.; Siemers, Eric; Liu-Seifert, Hong; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Alzheimer's disease is characterized by amyloid-beta plaques, neurofibrillary tangles, gliosis, and neuronal loss.  Solanezumab, a humanized monoclonal antibody, preferentially binds sol. forms of amyloid and in preclin. studies promoted its clearance from the brain.  METHODS: In two phase 3, double-blind trials (EXPEDITION 1 and EXPEDITION 2), we randomly assigned 1012 and 1040 patients, resp., with mild-to-moderate Alzheimer's disease to receive placebo or solanezumab (administered i.v. at a dose of 400 mg) every 4 wk for 18 mo.  The primary outcomes were the changes from baseline to week 80 in scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11; range, 0 to 70, with higher scores indicating greater cognitive impairment) and the Alzheimer's Disease Cooperative Study-Activities of Daily Living scale (ADCS-ADL; range, 0 to 78, with lower scores indicating worse functioning).  After anal. of data from EXPEDITION 1, the primary outcome for EXPEDITION 2 was revised to the change in scores on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; range, 0 to 90, with higher scores indicating greater impairment), in patients with mild Alzheimer's disease.  RESULTS: Neither study showed significant improvement in the primary outcomes.  The modeled difference between groups (solanezumab group minus placebo group) in the change from baseline was -0.8 points for the ADAS-cog11 score (95% confidence interval [CI], -2.1 to 0.5; P = 0.24) and -0.4 points for the ADCS-ADL score (95% CI, -2.3 to 1.4; P = 0.64) in EXPEDITION 1 and -1.3 points (95% CI, -2.5 to 0.3; P = 0.06) and 1.6 points (95% CI, -0.2 to 3.3; P = 0.08), resp., in EXPEDITION 2.  Between-group differences in the changes in the ADAS-cog14 score were -1.7 points in patients with mild Alzheimer's disease (95% CI, -3.5 to 0.1; P = 0.06) and -1.5 in patients with moderate Alzheimer's disease (95% CI, -4.1 to 1.1; P = 0.26).  In the combined safety data set, the incidence of amyloid-related imaging abnormalities with edema or hemorrhage was 0.9% with solanezumab and 0.4% with placebo for edema (P = 0.27) and 4.9% and 5.6%, resp., for hemorrhage (P = 0.49).  CONCLUSIONS: Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Ej7A_YXNwLVg90H21EOLACvtfcHk0lijyOqa80AXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt70%253D&md5=c993836d4f7374cc78f155f9cedbc594</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1312889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1312889%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DLiu-Seifert%26aufirst%3DH.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Cooperative%2520Study%2520Steering%2520Committee%253B%2520Solanezumab%2520Study%2520Group.%2520Phase%25203%2520trials%2520of%2520solanezumab%2520for%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D311%26epage%3D321%26doi%3D10.1056%2FNEJMoa1312889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raskind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabbagh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honig, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porsteinsson, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ketter, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nejadnik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenzler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miloslavsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grundman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, H. R.</span><span> </span><span class="NLM_article-title">Bapineuzumab 301 and 302 Clinical Trial Investigators. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">333</span><span class="refDoi"> DOI: 10.1056/NEJMoa1304839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1056%2FNEJMoa1304839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24450891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2014&pages=322-333&author=S.+Sallowayauthor=R.+Sperlingauthor=N.+C.+Foxauthor=K.+Blennowauthor=W.+Klunkauthor=M.+Raskindauthor=M.+Sabbaghauthor=L.+S.+Honigauthor=A.+P.+Porsteinssonauthor=S.+Ferrisauthor=M.+Reichertauthor=N.+Ketterauthor=B.+Nejadnikauthor=V.+Guenzlerauthor=M.+Miloslavskyauthor=D.+Wangauthor=Y.+Luauthor=J.+Lullauthor=I.+C.+Tudorauthor=E.+Liuauthor=M.+Grundmanauthor=E.+Yuenauthor=R.+Blackauthor=H.+R.+Brashear&title=Bapineuzumab+301+and+302+Clinical+Trial+Investigators.+Two+phase+3+trials+of+bapineuzumab+in+mild-to-moderate+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1304839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease</span></div><div class="casAuthors">Salloway, Stephen; Sperling, Reisa; Fox, Nick C.; Blennow, Kaj; Klunk, William; Raskind, Murray; Sabbagh, Marwan; Honig, Lawrence S.; Porsteinsson, Anton P.; Ferris, Steven; Reichert, Marcel; Ketter, Nzeera; Nejadnik, Bijan; Guenzler, Volkmar; Miloslavsky, Maja; Wang, Daniel; Lu, Yuan; Lull, Julia; Tudor, Iulia Cristina; Liu, Enchi; Grundman, Michael; Yuen, Eric; Black, Ronald; Brashear, H. Robert</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">322-333</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Bapineuzumab, a humanized anti-amyloid-beta monoclonal antibody, is in clin. development for the treatment of Alzheimer's disease.  METHODS: We conducted two double-blind, randomized, placebo-controlled, phase 3 trials involving patients with mild-to-moderate Alzheimer's disease - one involving 1121 carriers of the apolipoprotein E (APOE) ε4 allele and the other involving 1331 noncarriers.  Bapineuzumab or placebo, with doses varying by study, was administered by i.v. infusion every 13 wk for 78 wk.  The primary outcome measures were scores on the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog11, with scores ranging from 0 to 70 and higher scores indicating greater impairment) and the Disability Assessment for Dementia (DAD, with scores ranging from 0 to 100 and higher scores indicating less impairment).  A total of 1090 carriers and 1114 noncarriers were included in the efficacy anal.  Secondary outcome measures included findings on positron-emission tomog. amyloid imaging with the use of Pittsburgh compd. B (PIB-PET) and cerebrospinal fluid phosphorylated tau (phospho-tau) concns.  RESULTS: There were no significant between-group differences in the primary outcomes.  At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo group) were -0.2 (P = 0.80) and -1.2 (P = 0.34), resp., in the carrier study; the corresponding differences in the noncarrier study were -0.3 (P = 0.64) and 2.8 (P = 0.07) with the 0.5-mg-per-kilogram dose of bapineuzumab and 0.4 (P = 0.62) and 0.9 (P = 0.55) with the 1.0-mg-per-kilogram dose.  The major safety finding was amyloid-related imaging abnormalities with edema among patients receiving bapineuzumab, which increased with bapineuzumab dose and APOE ε4 allele no. and which led to discontinuation of the 2.0-mg-per-kilogram dose.  Between-group differences were obsd. with respect to PIB-PET and cerebrospinal fluid phospho-tau concns. in APOE ε4 allele carriers but not in noncarriers.  CONCLUSIONS: Bapineuzumab did not improve clin. outcomes in patients with Alzheimer's disease, despite treatment differences in biomarkers obsd. in APOE ε4 carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEl0PP_aoc9LVg90H21EOLACvtfcHk0lijyOqa80AXPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Ggt7o%253D&md5=932fe885aa8d2426379c786620bbd766</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1304839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1304839%26sid%3Dliteratum%253Aachs%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DSperling%26aufirst%3DR.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DKlunk%26aufirst%3DW.%26aulast%3DRaskind%26aufirst%3DM.%26aulast%3DSabbagh%26aufirst%3DM.%26aulast%3DHonig%26aufirst%3DL.%2BS.%26aulast%3DPorsteinsson%26aufirst%3DA.%2BP.%26aulast%3DFerris%26aufirst%3DS.%26aulast%3DReichert%26aufirst%3DM.%26aulast%3DKetter%26aufirst%3DN.%26aulast%3DNejadnik%26aufirst%3DB.%26aulast%3DGuenzler%26aufirst%3DV.%26aulast%3DMiloslavsky%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLull%26aufirst%3DJ.%26aulast%3DTudor%26aufirst%3DI.%2BC.%26aulast%3DLiu%26aufirst%3DE.%26aulast%3DGrundman%26aufirst%3DM.%26aulast%3DYuen%26aufirst%3DE.%26aulast%3DBlack%26aufirst%3DR.%26aulast%3DBrashear%26aufirst%3DH.%2BR.%26atitle%3DBapineuzumab%2520301%2520and%2520302%2520Clinical%2520Trial%2520Investigators.%2520Two%2520phase%25203%2520trials%2520of%2520bapineuzumab%2520in%2520mild-to-moderate%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D370%26spage%3D322%26epage%3D333%26doi%3D10.1056%2FNEJMoa1304839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sevigny, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunstan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Gorman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arastu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chollate, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero-Monzon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikulskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitsch, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandrock, A.</span><span> </span><span class="NLM_article-title">The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">537</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span><span class="refDoi"> DOI: 10.1038/nature19323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fnature19323" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=27582220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=537&publication_year=2016&pages=50-56&author=J.+Sevignyauthor=P.+Chiaoauthor=T.+Bussiereauthor=P.+H.+Weinrebauthor=L.+Williamsauthor=M.+Maierauthor=R.+Dunstanauthor=S.+Sallowayauthor=T.+Chenauthor=Y.+Lingauthor=J.+O%E2%80%99Gormanauthor=F.+Qianauthor=M.+Arastuauthor=M.+Liauthor=S.+Chollateauthor=M.+S.+Brennanauthor=O.+Quintero-Monzonauthor=R.+H.+Scannevinauthor=H.+M.+Arnoldauthor=T.+Engberauthor=K.+Rhodesauthor=J.+Ferreroauthor=Y.+Hangauthor=A.+Mikulskisauthor=J.+Grimmauthor=C.+Hockauthor=R.+M.+Nitschauthor=A.+Sandrock&title=The+antibody+aducanumab+reduces+Abeta+plaques+in+Alzheimer%E2%80%99s+disease&doi=10.1038%2Fnature19323"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The antibody aducanumab reduces Aβ plaques in Alzheimer's disease</span></div><div class="casAuthors">Sevigny, Jeff; Chiao, Ping; Bussiere, Thierry; Weinreb, Paul H.; Williams, Leslie; Maier, Marcel; Dunstan, Robert; Salloway, Stephen; Chen, Tianle; Ling, Yan; O'Gorman, John; Qian, Fang; Arastu, Mahin; Li, Mingwei; Chollate, Sowmya; Brennan, Melanie S.; Quintero-Monzon, Omar; Scannevin, Robert H.; Arnold, H. Moore; Engber, Thomas; Rhodes, Kenneth; Ferrero, James; Hang, Yaming; Mikulskis, Alvydas; Grimm, Jan; Hock, Christoph; Nitsch, Roger M.; Sandrock, Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">537</span>
        (<span class="NLM_cas:issue">7618</span>),
    <span class="NLM_cas:pages">50-56</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is characterized by deposition of amyloid-β (Aβ) plaques and neurofibrillary tangles in the brain, accompanied by synaptic dysfunction and neurodegeneration.  Antibody-based immunotherapy against Aβ to trigger its clearance or mitigate its neurotoxicity has so far been unsuccessful.  Here we report the generation of aducanumab, a human monoclonal antibody that selectively targets aggregated Aβ.  In a transgenic mouse model of AD, aducanumab is shown to enter the brain, bind parenchymal Aβ, and reduce sol. and insol. Aβ in a dose-dependent manner.  In patients with prodromal or mild AD, one year of monthly i.v. infusions of aducanumab reduces brain Aβ in a dose- and time-dependent manner.  This is accompanied by a slowing of clin. decline measured by Clin. Dementia Rating-Sum of Boxes and Mini Mental State Examn. scores.  The main safety and tolerability findings are amyloid-related imaging abnormalities.  These results justify further development of aducanumab for the treatment of AD.  Should the slowing of clin. decline be confirmed in ongoing phase 3 clin. trials, it would provide compelling support for the amyloid hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojFdrufBYOgbVg90H21EOLACvtfcHk0lh5IpaEk3VjDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCqur%252FJ&md5=62aa713f842093cead6b40cb523417a7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnature19323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19323%26sid%3Dliteratum%253Aachs%26aulast%3DSevigny%26aufirst%3DJ.%26aulast%3DChiao%26aufirst%3DP.%26aulast%3DBussiere%26aufirst%3DT.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DWilliams%26aufirst%3DL.%26aulast%3DMaier%26aufirst%3DM.%26aulast%3DDunstan%26aufirst%3DR.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DLing%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Gorman%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DF.%26aulast%3DArastu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DChollate%26aufirst%3DS.%26aulast%3DBrennan%26aufirst%3DM.%2BS.%26aulast%3DQuintero-Monzon%26aufirst%3DO.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DArnold%26aufirst%3DH.%2BM.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DFerrero%26aufirst%3DJ.%26aulast%3DHang%26aufirst%3DY.%26aulast%3DMikulskis%26aufirst%3DA.%26aulast%3DGrimm%26aufirst%3DJ.%26aulast%3DHock%26aufirst%3DC.%26aulast%3DNitsch%26aufirst%3DR.%2BM.%26aulast%3DSandrock%26aufirst%3DA.%26atitle%3DThe%2520antibody%2520aducanumab%2520reduces%2520Abeta%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2016%26volume%3D537%26spage%3D50%26epage%3D56%26doi%3D10.1038%2Fnature19323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer’s disease</span> <span class="citation_source-journal">Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">497</span><span class="NLM_x">–</span> <span class="NLM_lpage">523</span><span class="refDoi"> DOI: 10.1515/REVNEURO.2006.17.5.497</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1515%2FREVNEURO.2006.17.5.497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=17180876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=497-523&author=D.+Puzzoauthor=A.+Palmeriauthor=O.+Arancio&title=Involvement+of+the+nitric+oxide+pathway+in+synaptic+dysfunction+following+amyloid+elevation+in+Alzheimer%E2%80%99s+disease&doi=10.1515%2FREVNEURO.2006.17.5.497"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of the nitric oxide pathway in synaptic dysfunction following amyloid elevation in Alzheimer's disease</span></div><div class="casAuthors">Puzzo, Daniela; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in the Neurosciences (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-523</span>CODEN:
                <span class="NLM_cas:coden">RNEUEO</span>;
        ISSN:<span class="NLM_cas:issn">0334-1763</span>.
    
            (<span class="NLM_cas:orgname">Freund & Pettman</span>)
        </div><div class="casAbstract">A review.  Amyloid-beta (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has attracted scientific interest with the aim of characterizing the mechanisms by which it is involved in AD pathogenesis.  Aβ has been found to markedly impair hippocampal long-term potentiation (LTP), a widely studied cellular model of synaptic plasticity that is thought to underlie learning and memory.  The overall purpose of this review is to define the role of the nitric oxide (NO)/cGMP/cAMP-regulatory element binding (CREB) pathway in beta-amyloid-induced changes of basal neurotransmission and synaptic plasticity in the hippocampus, a structure within the temporal lobe of the brain crit. for memory storage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzLKNBiiakNLVg90H21EOLACvtfcHk0lh5IpaEk3VjDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlentbzJ&md5=faa3271286d20c9cd431f9b001476089</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.5.497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.5.497%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DInvolvement%2520of%2520the%2520nitric%2520oxide%2520pathway%2520in%2520synaptic%2520dysfunction%2520following%2520amyloid%2520elevation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRev.%2520Neurosci.%26date%3D2006%26volume%3D17%26spage%3D497%26epage%3D523%26doi%3D10.1515%2FREVNEURO.2006.17.5.497" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Lu, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, R. D.</span><span> </span><span class="NLM_article-title">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">10250</span><span class="NLM_x">–</span> <span class="NLM_lpage">10261</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1523%2FJNEUROSCI.19-23-10250.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10575022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=10250-10261&author=Y.+F.+Luauthor=E.+R.+Kandelauthor=R.+D.+Hawkins&title=Nitric+oxide+signaling+contributes+to+late-phase+LTP+and+CREB+phosphorylation+in+the+hippocampus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus</span></div><div class="casAuthors">Lu, Yun-Fei; Kandel, Eric R.; Hawkins, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10250-10261</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Long-term potentiation (LTP) in the hippocampus has an early phase (E-LTP) that can be induced by 1- or 2-train tetanization, lasts ∼1 h, and is cAMP-dependent protein kinase A (PKA)- and protein synthesis-independent and a late phase (L-LTP) that can be induced by 3- or 4-train tetanization, lasts >3 h, and is reduced by inhibitors of PKA and of protein or RNA synthesis.  NO is thought to be involved in E-LTP, but until now there has been no information about the role of the NO-signaling pathway in L-LTP.  Here, the authors examd. this question at the Schaffer collateral-CA1 synapses in slices of mouse hippocampus.  An inhibitor of nitric oxide synthase blocked L-LTP induced by 3-train tetanization and reduced L-LTP induced by 4-train tetanization, whereas an inhibitor of PKA was more effective in blocking 4-train L-LTP than 3-train L-LTP.  Three-train L-LTP was also blocked by inhibitors of guanylyl cyclase or cGMP-dependent protein kinase G (PKG).  Conversely, either NO or cGMP analogs paired with 1-train tetanization produced late-phase potentiation, and the cGMP-induced potentiation was blocked by inhibitors of protein or RNA synthesis and an inhibitor of PKG, but not by an inhibitor of PKA.  To test a possible downstream target of PKG, the authors examd. changes in phospho-CRE-binding protein (phospho-CREB) immunofluorescence in the CA1 cell body area and obtained results similar to those of the electrophysiol. expts.  The results suggested that NO contributes to L-LTP by stimulating guanylyl cyclase and PKG, which acts in parallel with PKA to increase phosphorylation of transcription factor CREB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY0i0LYOPf7LVg90H21EOLACvtfcHk0ljqjTF37S_0Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyrt70%253D&md5=6d09b68560c09b81e38354826f7c21b6</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-23-10250.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-23-10250.1999%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%2BF.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26aulast%3DHawkins%26aufirst%3DR.%2BD.%26atitle%3DNitric%2520oxide%2520signaling%2520contributes%2520to%2520late-phase%2520LTP%2520and%2520CREB%2520phosphorylation%2520in%2520the%2520hippocampus%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D10250%26epage%3D10261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wong, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fiscus, R. R.</span><span> </span><span class="NLM_article-title">Cyclic GMP/protein kinase G type-Ialpha (PKG-Ialpha) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Ialpha kinase activity synergizes with cisplatin in non-small cell lung cancer cells</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">–</span> <span class="NLM_lpage">3598</span><span class="refDoi"> DOI: 10.1002/jcb.24237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1002%2Fjcb.24237" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2012&pages=3587-3598&author=J.+C.+Wongauthor=M.+Bathinaauthor=R.+R.+Fiscus&title=Cyclic+GMP%2Fprotein+kinase+G+type-Ialpha+%28PKG-Ialpha%29+signaling+pathway+promotes+CREB+phosphorylation+and+maintains+higher+c-IAP1%2C+livin%2C+survivin%2C+and+Mcl-1+expression+and+the+inhibition+of+PKG-Ialpha+kinase+activity+synergizes+with+cisplatin+in+non-small+cell+lung+cancer+cells&doi=10.1002%2Fjcb.24237"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1002%2Fjcb.24237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.24237%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DJ.%2BC.%26aulast%3DBathina%26aufirst%3DM.%26aulast%3DFiscus%26aufirst%3DR.%2BR.%26atitle%3DCyclic%2520GMP%252Fprotein%2520kinase%2520G%2520type-Ialpha%2520%2528PKG-Ialpha%2529%2520signaling%2520pathway%2520promotes%2520CREB%2520phosphorylation%2520and%2520maintains%2520higher%2520c-IAP1%252C%2520livin%252C%2520survivin%252C%2520and%2520Mcl-1%2520expression%2520and%2520the%2520inhibition%2520of%2520PKG-Ialpha%2520kinase%2520activity%2520synergizes%2520with%2520cisplatin%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2012%26volume%3D113%26spage%3D3587%26epage%3D3598%26doi%3D10.1002%2Fjcb.24237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Silva, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kogan, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankland, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kida, S.</span><span> </span><span class="NLM_article-title">CREB and memory</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span><span class="refDoi"> DOI: 10.1146/annurev.neuro.21.1.127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1146%2Fannurev.neuro.21.1.127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=9530494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1cXhsFyitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1998&pages=127-148&author=A.+J.+Silvaauthor=J.+H.+Koganauthor=P.+W.+Franklandauthor=S.+Kida&title=CREB+and+memory&doi=10.1146%2Fannurev.neuro.21.1.127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">CREB and memory</span></div><div class="casAuthors">Silva, Alcino J.; Kogan, Jeffrey H.; Frankland, Paul W.; Kida, Satoshi</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127-148</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with many refs.  The cAMP responsive element binding protein (CREB) is a nuclear protein that modulates the transcription of genes with cAMP responsive elements in their promoters.  Increases in the concn. of either calcium or cAMP can trigger the phosphorylation and activation of CREB.  This transcription factor is a component of intracellular signaling events that regulate a wide range of biol. functions, from spermatogenesis to circadian rhythms and memory.  Here we review the key features of CREB-dependent transcription, as well as the involvement of CREB in memory formation.  Evidence from Aplysia, Drosophila, mice, and rats shows that CREB-dependent transcription is required for the cellular events underlying long-term but not short-term memory.  While the work in Aplysia and Drosophila only involved CREB function in very simple forms of conditioning, genetic and pharmacol. studies in mice and rats demonstrate that CREB is required for a variety of complex forms of memory, including spatial and social learning, thus indicating that CREB may be a universal modulator of processes required for memory formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIxnm0AHtktbVg90H21EOLACvtfcHk0ljqjTF37S_0Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsFyitbs%253D&md5=de4b3f14712110f1d3693e8286317e3d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.21.1.127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.21.1.127%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DA.%2BJ.%26aulast%3DKogan%26aufirst%3DJ.%2BH.%26aulast%3DFrankland%26aufirst%3DP.%2BW.%26aulast%3DKida%26aufirst%3DS.%26atitle%3DCREB%2520and%2520memory%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D1998%26volume%3D21%26spage%3D127%26epage%3D148%26doi%3D10.1146%2Fannurev.neuro.21.1.127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Barco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alarcon, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kandel, E. R.</span><span> </span><span class="NLM_article-title">Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">689</span><span class="NLM_x">–</span> <span class="NLM_lpage">703</span><span class="refDoi"> DOI: 10.1016/S0092-8674(02)00657-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2FS0092-8674%2802%2900657-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2002&pages=689-703&author=A.+Barcoauthor=J.+M.+Alarconauthor=E.+R.+Kandel&title=Expression+of+constitutively+active+CREB+protein+facilitates+the+late+phase+of+long-term+potentiation+by+enhancing+synaptic+capture&doi=10.1016%2FS0092-8674%2802%2900657-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900657-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900657-8%26sid%3Dliteratum%253Aachs%26aulast%3DBarco%26aufirst%3DA.%26aulast%3DAlarcon%26aufirst%3DJ.%2BM.%26aulast%3DKandel%26aufirst%3DE.%2BR.%26atitle%3DExpression%2520of%2520constitutively%2520active%2520CREB%2520protein%2520facilitates%2520the%2520late%2520phase%2520of%2520long-term%2520potentiation%2520by%2520enhancing%2520synaptic%2520capture%26jtitle%3DCell%26date%3D2002%26volume%3D108%26spage%3D689%26epage%3D703%26doi%3D10.1016%2FS0092-8674%2802%2900657-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Benito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barco, A.</span><span> </span><span class="NLM_article-title">CREB’s control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span><span class="refDoi"> DOI: 10.1016/j.tins.2010.02.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.tins.2010.02.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=230-240&author=E.+Benitoauthor=A.+Barco&title=CREB%E2%80%99s+control+of+intrinsic+and+synaptic+plasticity%3A+implications+for+CREB-dependent+memory+models&doi=10.1016%2Fj.tins.2010.02.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.tins.2010.02.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tins.2010.02.001%26sid%3Dliteratum%253Aachs%26aulast%3DBenito%26aufirst%3DE.%26aulast%3DBarco%26aufirst%3DA.%26atitle%3DCREB%25E2%2580%2599s%2520control%2520of%2520intrinsic%2520and%2520synaptic%2520plasticity%253A%2520implications%2520for%2520CREB-dependent%2520memory%2520models%26jtitle%3DTrends%2520Neurosci.%26date%3D2010%26volume%3D33%26spage%3D230%26epage%3D240%26doi%3D10.1016%2Fj.tins.2010.02.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bender, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beavo, J. A.</span><span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">488</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1124/pr.58.3.5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1124%2Fpr.58.3.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=16968949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=488-520&author=A.+T.+Benderauthor=J.+A.+Beavo&title=Cyclic+nucleotide+phosphodiesterases%3A+molecular+regulation+to+clinical+use&doi=10.1124%2Fpr.58.3.5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use</span></div><div class="casAuthors">Bender, Andrew T.; Beavo, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">488-520</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels of the second messengers, cAMP and cGMP, by controlling their rates of degrdn.  There are 11 different PDE families, with each family typically having several different isoforms and splice variants.  These unique PDEs differ in their three-dimensional structure, kinetic properties, modes of regulation, intracellular localization, cellular expression, and inhibitor sensitivities.  Current data suggest that individual isoenzymes modulate distinct regulatory pathways in the cell.  These properties therefore offer the opportunity for selectively targeting specific PDEs for treatment of specific disease states.  The feasibility of these enzymes as drug targets is exemplified by the com. and clin. successes of the erectile dysfunction drugs, sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra).  PDE inhibitors are also currently available or in development for treatment of a variety of other pathol. conditions.  In this review the basic biochem. properties, cellular regulation, expression patterns, and physiol. functions of the different PDE isoforms will be discussed.  How these properties relate to the current and future development of PDE inhibitors as pharmacol. agents is esp. considered.  PDEs hold great promise as drug targets and recent research advances make this an exciting time for the field of PDE research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJl4RDiZ0ugrVg90H21EOLACvtfcHk0ljN50GsZ85Urw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhtLfI&md5=af31cf6952efe7adb428a951779f36bc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fpr.58.3.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.58.3.5%26sid%3Dliteratum%253Aachs%26aulast%3DBender%26aufirst%3DA.%2BT.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%253A%2520molecular%2520regulation%2520to%2520clinical%2520use%26jtitle%3DPharmacol.%2520Rev.%26date%3D2006%26volume%3D58%26spage%3D488%26epage%3D520%26doi%3D10.1124%2Fpr.58.3.5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Maurice, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manganiello, V. C.</span><span> </span><span class="NLM_article-title">Advances in targeting cyclic nucleotide phosphodiesterases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span><span class="refDoi"> DOI: 10.1038/nrd4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fnrd4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24687066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=290-314&author=D.+H.+Mauriceauthor=H.+Keauthor=F.+Ahmadauthor=Y.+Wangauthor=J.+Chungauthor=V.+C.+Manganiello&title=Advances+in+targeting+cyclic+nucleotide+phosphodiesterases&doi=10.1038%2Fnrd4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in targeting cyclic nucleotide phosphodiesterases</span></div><div class="casAuthors">Maurice, Donald H.; Ke, Hengming; Ahmad, Faiyaz; Wang, Yousheng; Chung, Jay; Manganiello, Vincent C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-314</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cyclic GMP, thereby regulating the intracellular concns. of these cyclic nucleotides, their signalling pathways and, consequently, myriad biol. responses in health and disease.  Currently, a small no. of PDE inhibitors are used clin. for treating the pathophysiol. dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.  However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMRfUs-zUmLVg90H21EOLACvtfcHk0ljN50GsZ85Urw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D&md5=410c8d5bb5fbd7d2906e30dc1b5f2876</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4228%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DD.%2BH.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DManganiello%26aufirst%3DV.%2BC.%26atitle%3DAdvances%2520in%2520targeting%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D290%26epage%3D314%26doi%3D10.1038%2Fnrd4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Heckman, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wouters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer’s disease: a translational overview</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span><span class="refDoi"> DOI: 10.2174/1381612820666140826114601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.2174%2F1381612820666140826114601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=317-331&author=P.+R.+Heckmanauthor=C.+Woutersauthor=J.+Prickaerts&title=Phosphodiesterase+inhibitors+as+a+target+for+cognition+enhancement+in+aging+and+Alzheimer%E2%80%99s+disease%3A+a+translational+overview&doi=10.2174%2F1381612820666140826114601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140826114601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140826114601%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DP.%2BR.%26aulast%3DWouters%26aufirst%3DC.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520inhibitors%2520as%2520a%2520target%2520for%2520cognition%2520enhancement%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520translational%2520overview%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D21%26spage%3D317%26epage%3D331%26doi%3D10.2174%2F1381612820666140826114601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Garcia-Osta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuadrado-Tejedor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barroso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Phosphodiesterases as therapeutic targets for Alzheimer’s disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">832</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span><span class="refDoi"> DOI: 10.1021/cn3000907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn3000907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=832-844&author=A.+Garcia-Ostaauthor=M.+Cuadrado-Tejedorauthor=C.+Garcia-Barrosoauthor=J.+Oyarzabalauthor=R.+Franco&title=Phosphodiesterases+as+therapeutic+targets+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn3000907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease</span></div><div class="casAuthors">Garcia-Osta, Ana; Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Oyarzabal, Julen; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">832-844</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia among the elderly.  In AD patients, memory loss is accompanied by the formation of beta-amyloid plaques and the appearance of tau in a pathol. form.  Given the lack of effective treatments for AD, the development of new management strategies for these patients is crit.  The continued failure to find effective therapies using mols. aimed at addressing the anti-beta amyloid pathol. has led researchers to focus on other non-amyloid-based approaches to restore memory function.  Promising non-amyloid related candidate targets include phosphosdiesterases (PDEs), and indeed, Rolipram, a specific PDE4 inhibitor, was the first compd. found to effectively restore cognitive deficits in animal models of AD.  More recently, PDE5 inhibitors have also been shown to effectively restore memory function.  Accordingly, inhibitors of other members of the PDE family may also improve memory performance in AD and non-AD animal models.  Hence, in this review, we will summarize the data supporting the use of PDE inhibitors as cognitive enhancers and we will discuss the possible mechanisms of action underlying these effects.  We shall also adopt a medicinal chem. perspective that leads us to propose the most promising PDE candidates on the basis of inhibitor selectivity, brain distribution, and mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeOP4NskdvrVg90H21EOLACvtfcHk0ljQFNTtGGgVpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK&md5=53c6dfed22bb240b17132672b13fdcf1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fcn3000907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn3000907%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPhosphodiesterases%2520as%2520therapeutic%2520targets%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D832%26epage%3D844%26doi%3D10.1021%2Fcn3000907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacob, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">–</span> <span class="NLM_lpage">6897</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.5291-04.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1523%2FJNEUROSCI.5291-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=16033898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=6887-6897&author=D.+Puzzoauthor=O.+Vitoloauthor=F.+Trincheseauthor=J.+P.+Jacobauthor=A.+Palmeriauthor=O.+Arancio&title=Amyloid-beta+peptide+inhibits+activation+of+the+nitric+oxide%2FcGMP%2FcAMP-responsive+element-binding+protein+pathway+during+hippocampal+synaptic+plasticity&doi=10.1523%2FJNEUROSCI.5291-04.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity</span></div><div class="casAuthors">Puzzo, Daniela; Vitolo, Ottavio; Trinchese, Fabrizio; Jacob, Joel P.; Palmeri, Agostino; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">6887-6897</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Amyloid-β (Aβ), a peptide thought to play a crucial role in Alzheimer's disease (AD), has many targets that, in turn, activate different 2nd-messenger cascades.  Interestingly, Aβ was found to markedly impair hippocampal long-term potentiation (LTP).  To identify a new pathway that might be responsible for such impairment, the authors analyzed the role of the NO/sol. guanylyl cyclase (sGC)/cGMP/cGMP-dependent protein kinase (cGK)/cAMP-responsive element-binding protein (CREB) cascade because of its involvement in LTP.  The use of the NO donor 2-(N,N-dethylamino)-diazenolate-2-oxide diethylammonium salt (DEA/NO), the sGC stimulator 3-(4-amino-5-cyclopropylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine, or the cGMP-analogs 8-bromo-cGMP and 8-(4-chlorophenylthio)-cGMP reversed the Aβ-induced impairment of CA1-LTP through cGK activation.  Furthermore, these compds. reestablished the enhancement of CREB phosphorylation occurring during LTP in slices exposed to Aβ.  We also found that Aβ blocks the increase in cGMP immunoreactivity occurring immediately after LTP and that DEA/NO counteracts the effect of Aβ.  These results strongly suggest that, when modulating hippocampal synaptic plasticity, Aβ downregulates the NO/cGMP/cGK/CREB pathway; thus, enhancement of the NO/cGMP signaling may provide a novel approach to the treatment of AD and other neurodegenerative diseases with elevated prodn. of Aβ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT_M3WUlYelLVg90H21EOLACvtfcHk0ljQFNTtGGgVpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmslClt78%253D&md5=448717d56147ceb9665d8c1ce8136c98</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.5291-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.5291-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DVitolo%26aufirst%3DO.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DJacob%26aufirst%3DJ.%2BP.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DAmyloid-beta%2520peptide%2520inhibits%2520activation%2520of%2520the%2520nitric%2520oxide%252FcGMP%252FcAMP-responsive%2520element-binding%2520protein%2520pathway%2520during%2520hippocampal%2520synaptic%2520plasticity%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D6887%26epage%3D6897%26doi%3D10.1523%2FJNEUROSCI.5291-04.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Privitera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leznik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer’s disease mouse model</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">8075</span><span class="NLM_x">–</span> <span class="NLM_lpage">8086</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.0864-09.2009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1523%2FJNEUROSCI.0864-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=19553447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=8075-8086&author=D.+Puzzoauthor=A.+Staniszewskiauthor=S.+X.+Dengauthor=L.+Priviteraauthor=E.+Leznikauthor=S.+Liuauthor=H.+Zhangauthor=Y.+Fengauthor=A.+Palmeriauthor=D.+W.+Landryauthor=O.+Arancio&title=Phosphodiesterase+5+inhibition+improves+synaptic+function%2C+memory%2C+and+amyloid-beta+load+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1523%2FJNEUROSCI.0864-09.2009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-β load in an Alzheimer's disease mouse model</span></div><div class="casAuthors">Puzzo, Daniela; Staniszewski, Agnieszka; Deng, Shi Xian; Privitera, Lucia; Leznik, Elena; Liu, Shumin; Zhang, Hong; Feng, Yan; Palmeri, Agostino; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">8075-8086</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Memory loss, synaptic dysfunction, and accumulation of amyloid β-peptides (Aβ) are major hallmarks of Alzheimer's disease (AD).  Downregulation of the nitric oxide/cGMP/cGMP-dependent protein kinase/c-AMP responsive element-binding protein (CREB) cascade has been linked to the synaptic deficits after Aβ elevation.  Here, we report that the phosphodiesterase 5 inhibitor (PDE5) sildenafil (Viagra), a mol. that enhances phosphorylation of CREB, a mol. involved in memory, through elevation of cGMP levels, is beneficial against the AD phenotype in a mouse model of amyloid deposition.  We demonstrate that the inhibitor produces an immediate and long-lasting amelioration of synaptic function, CREB phosphorylation, and memory.  This effect is also assocd. with a long-lasting redn. of Aβ levels.  Given that side effects of PDE5 inhibitors are widely known and do not preclude their administration to a senile population, these drugs have potential for the treatment of AD and other diseases assocd. with elevated Aβ levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq69pOrzfjxY7Vg90H21EOLACvtfcHk0ljQFNTtGGgVpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotFKgtbw%253D&md5=5aead1f7c92b6166b8591c3e7951f78d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0864-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0864-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DPrivitera%26aufirst%3DL.%26aulast%3DLeznik%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPhosphodiesterase%25205%2520inhibition%2520improves%2520synaptic%2520function%252C%2520memory%252C%2520and%2520amyloid-beta%2520load%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D8075%26epage%3D8086%26doi%3D10.1523%2FJNEUROSCI.0864-09.2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fiorito, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeed, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staniszewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thakkar, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landry, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span><span class="refDoi"> DOI: 10.1016/j.ejmech.2012.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.ejmech.2012.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=23313637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2013&pages=285-294&author=J.+Fioritoauthor=F.+Saeedauthor=H.+Zhangauthor=A.+Staniszewskiauthor=Y.+Fengauthor=Y.+I.+Francisauthor=S.+Raoauthor=D.+M.+Thakkarauthor=S.+X.+Dengauthor=D.+W.+Landryauthor=O.+Arancio&title=Synthesis+of+quinoline+derivatives%3A+discovery+of+a+potent+and+selective+phosphodiesterase+5+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2012.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of quinoline derivatives: Discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Fiorito, Jole; Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Feng, Yan; Francis, Yitshak I.; Rao, Sudha; Thakkar, Devarshi M.; Deng, Shi-Xian; Landry, Donald W.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">285-294</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphodiesterase type 5 (PDE5) mediates the degrdn. of cGMP in a variety of tissues including brain.  Recent studies have demonstrated the importance of the nitric oxide/cGMP/cAMP-responsive element-binding protein (CREB) pathway to the process of learning and memory.  Thus, PDE5 inhibitors (PDE5Is) are thought to be promising new therapeutic agents for the treatment of Alzheimer's disease (AD), a neurodegenerative disorder characterized by memory loss.  To explore this possibility, a series of quinoline derivs. were synthesized and evaluated.  We found that compd. I selectively inhibits PDE5 with an IC50 of 0.27 nM and readily crosses the blood brain barrier.  In an in vivo mouse model of AD, compd. I rescues synaptic and memory defects.  Quinoline-based, CNS-permeant PDE5Is have potential for AD therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6B39cj4LBh7Vg90H21EOLACvtfcHk0liicQMaXXosuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVemsrg%253D&md5=335f11f0576ec3fe8dc1bcf5df2cebdc</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DFiorito%26aufirst%3DJ.%26aulast%3DSaeed%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DStaniszewski%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DFrancis%26aufirst%3DY.%2BI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DThakkar%26aufirst%3DD.%2BM.%26aulast%3DDeng%26aufirst%3DS.%2BX.%26aulast%3DLandry%26aufirst%3DD.%2BW.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520quinoline%2520derivatives%253A%2520discovery%2520of%2520a%2520potent%2520and%2520selective%2520phosphodiesterase%25205%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D60%26spage%3D285%26epage%3D294%26doi%3D10.1016%2Fj.ejmech.2012.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Puzzo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmeri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Behavioral assays with mouse models of Alzheimer’s disease: practical considerations and guidelines</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">450</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span><span class="refDoi"> DOI: 10.1016/j.bcp.2014.01.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.bcp.2014.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=24462904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFGqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2014&pages=450-467&author=D.+Puzzoauthor=L.+Leeauthor=A.+Palmeriauthor=G.+Calabreseauthor=O.+Arancio&title=Behavioral+assays+with+mouse+models+of+Alzheimer%E2%80%99s+disease%3A+practical+considerations+and+guidelines&doi=10.1016%2Fj.bcp.2014.01.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Behavioral assays with mouse models of Alzheimer's disease: Practical considerations and guidelines</span></div><div class="casAuthors">Puzzo, Daniela; Lee, Linda; Palmeri, Agostino; Calabrese, Giorgio; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">450-467</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  In Alzheimer's disease (AD) basic research and drug discovery, mouse models are essential resources for uncovering biol. mechanisms, validating mol. targets and screening potential compds.  Both transgenic and non-genetically modified mouse models enable access to different types of AD-like pathol. in vivo.  Although there is a wealth of genetic and biochem. studies on proposed AD pathogenic pathways, as a disease that centrally features cognitive failure, the ultimate readout for any interventions should be measures of learning and memory.  This is particularly important given the lack of knowledge on disease etiol. - assessment by cognitive assays offers the advantage of targeting relevant memory systems without requiring assumptions about pathogenesis.  A multitude of behavioral assays are available for assessing cognitive functioning in mouse models, including ones specific for hippocampal-dependent learning and memory.  Here we review the basics of available transgenic and non-transgenic AD mouse models and detail three well-established behavioral tasks commonly used for testing hippocampal-dependent cognition in mice - contextual fear conditioning, radial arm water maze and Morris water maze.  In particular, we discuss the practical considerations, requirements and caveats of these behavioral testing paradigms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-saArfdb-bVg90H21EOLACvtfcHk0liicQMaXXosuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFGqsbc%253D&md5=91f85c57030dd20d389187cd73009f92</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2014.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2014.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DPuzzo%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DPalmeri%26aufirst%3DA.%26aulast%3DCalabrese%26aufirst%3DG.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DBehavioral%2520assays%2520with%2520mouse%2520models%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520practical%2520considerations%2520and%2520guidelines%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2014%26volume%3D88%26spage%3D450%26epage%3D467%26doi%3D10.1016%2Fj.bcp.2014.01.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Snieckus, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onouchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boekelheide, V.</span><span> </span><span class="NLM_article-title">Stereoselective syntheses of isoquinuclidones. I</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2845</span><span class="NLM_x">–</span> <span class="NLM_lpage">2848</span><span class="refDoi"> DOI: 10.1021/jo00983a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00983a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1972&pages=2845-2848&author=V.+A.+Snieckusauthor=T.+Onouchiauthor=V.+Boekelheide&title=Stereoselective+syntheses+of+isoquinuclidones.+I&doi=10.1021%2Fjo00983a011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00983a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00983a011%26sid%3Dliteratum%253Aachs%26aulast%3DSnieckus%26aufirst%3DV.%2BA.%26aulast%3DOnouchi%26aufirst%3DT.%26aulast%3DBoekelheide%26aufirst%3DV.%26atitle%3DStereoselective%2520syntheses%2520of%2520isoquinuclidones.%2520I%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1972%26volume%3D37%26spage%3D2845%26epage%3D2848%26doi%3D10.1021%2Fjo00983a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Wolinska, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekaterina</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strekowski, L.</span><span> </span><span class="NLM_article-title">Facile synthesis of 1,2,3,4-tetrahydrobenzo[<i>b</i>][1,6]naphthyridines</span> <span class="citation_source-journal">Heterocycl. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1515%2FHC.2009.15.1.63" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlShtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=63-65&author=E.+P.+Wolinskaauthor=+Ekaterinaauthor=L.+Strekowski&title=Facile+synthesis+of+1%2C2%2C3%2C4-tetrahydrobenzo%5Bb%5D%5B1%2C6%5Dnaphthyridines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of 1,2,3,4-tetrahydrobenzo[b][1,6]naphthyridines</span></div><div class="casAuthors">Wolinska, Ewa; Paliakov, Ekaterina; Strekowski, Lucjan</div><div class="citationInfo"><span class="NLM_cas:title">Heterocyclic Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">63-65</span>CODEN:
                <span class="NLM_cas:coden">HCOMEX</span>;
        ISSN:<span class="NLM_cas:issn">0793-0283</span>.
    
            (<span class="NLM_cas:orgname">Freund Publishing House Ltd.</span>)
        </div><div class="casAbstract">Synthesis of title compds. I [R1 = H, MeO, OH; R2 = Me, Et; R3 = (CH2)2NMe2, CH(Me)(CH2)3NEt2], which analogs of known immunosuppressive quinolines, by cyclocondensation of corresponding anthranilic acids with N-alkyl-4-piperidones followed by nucleophilic substitution/amination with with alkyl diamines and (in 1 case) demethylation, is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZqG8uv82j9bVg90H21EOLACvtfcHk0lishmDV3lET6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlShtb7K&md5=57a93680f3f0b0d556115830bff7a3ad</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1515%2FHC.2009.15.1.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FHC.2009.15.1.63%26sid%3Dliteratum%253Aachs%26aulast%3DWolinska%26aufirst%3DE.%2BP.%26aulast%3DEkaterina%26aulast%3DStrekowski%26aufirst%3DL.%26atitle%3DFacile%2520synthesis%2520of%25201%252C2%252C3%252C4-tetrahydrobenzo%255Bb%255D%255B1%252C6%255Dnaphthyridines%26jtitle%3DHeterocycl.%2520Commun.%26date%3D2009%26volume%3D15%26spage%3D63%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hu, D. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grice, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, S. V.</span><span> </span><span class="NLM_article-title">Rotamers or diastereomers? An overlooked NMR solution</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5198</span><span class="NLM_x">–</span> <span class="NLM_lpage">5202</span><span class="refDoi"> DOI: 10.1021/jo300734r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo300734r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1WktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=5198-5202&author=D.+X.+Huauthor=P.+Griceauthor=S.+V.+Ley&title=Rotamers+or+diastereomers%3F+An+overlooked+NMR+solution&doi=10.1021%2Fjo300734r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Rotamers or Diastereomers? An Overlooked NMR Solution</span></div><div class="casAuthors">Hu, Dennis X.; Grice, Peter; Ley, Steven V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5198-5202</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The existence of rotamers in a soln. of analyte complicates 1H NMR anal., esp. when the presence of diastereomers is also possible.  Org. chemists have often responded to this problem by conducting variable-temp. (VT) NMR expts., changing NMR solvents, or adding complexing agents.  Here, with specific examples, we illustrate the use of simple yet widely overlooked chem.-exchange NMR expts. which allow the nonintrusive rapid distinguishment of rapidly equilibrating small mols. such as rotamers from nonequilibrating diastereomers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtqd6tSDTVhLVg90H21EOLACvtfcHk0lishmDV3lET6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1WktLs%253D&md5=0bd585493dc77fd7c9c8c441ddd6cd88</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo300734r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo300734r%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DD.%2BX.%26aulast%3DGrice%26aufirst%3DP.%26aulast%3DLey%26aufirst%3DS.%2BV.%26atitle%3DRotamers%2520or%2520diastereomers%253F%2520An%2520overlooked%2520NMR%2520solution%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D5198%26epage%3D5202%26doi%3D10.1021%2Fjo300734r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Cote, R. H.</span><span> </span><span class="NLM_article-title">Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5</span> <span class="citation_source-journal">Int. J. Impotence Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">S28</span><span class="NLM_x">–</span> <span class="NLM_lpage">S33</span><span class="refDoi"> DOI: 10.1038/sj.ijir.3901212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fsj.ijir.3901212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=15224133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=S28-S33&author=R.+H.+Cote&title=Characteristics+of+photoreceptor+PDE+%28PDE6%29%3A+similarities+and+differences+to+PDE5&doi=10.1038%2Fsj.ijir.3901212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5</span></div><div class="casAuthors">Cote, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S28-S33</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 6 (PDE6) is highly concd. in the retina.  It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cGMP in rod and cone outer segments in response to light.  The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits.  Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding).  The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cAMP (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains.  Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrGvfie0U1bVg90H21EOLACvtfcHk0lgA5n9dil1p7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D&md5=7700b18905668782047be0bbdd461726</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901212%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DCharacteristics%2520of%2520photoreceptor%2520PDE%2520%2528PDE6%2529%253A%2520similarities%2520and%2520differences%2520to%2520PDE5%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2004%26volume%3D16%26spage%3DS28%26epage%3DS33%26doi%3D10.1038%2Fsj.ijir.3901212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Role of the active-site solvent in the thermodynamics of factor Xa ligand binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">2817</span><span class="NLM_x">–</span> <span class="NLM_lpage">2831</span><span class="refDoi"> DOI: 10.1021/ja0771033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja0771033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=2817-2831&author=R.+Abelauthor=T.+Youngauthor=R.+Faridauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Role+of+the+active-site+solvent+in+the+thermodynamics+of+factor+Xa+ligand+binding&doi=10.1021%2Fja0771033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding</span></div><div class="casAuthors">Abel, Robert; Young, Tom; Farid, Ramy; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2817-2831</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Understanding the underlying physics of the binding of small-mol. ligands to protein active sites is a key objective of computational chem. and biol.  It is widely believed that displacement of water mols. from the active site by the ligand is a principal (if not the dominant) source of binding free energy.  Although continuum theories of hydration are routinely used to describe the contributions of the solvent to the binding affinity of the complex, it is still an unsettled question as to whether or not these continuum solvation theories describe the underlying mol. physics with sufficient accuracy to reliably rank the binding affinities of a set of ligands for a given protein.  Here we develop a novel, computationally efficient descriptor of the contribution of the solvent to the binding free energy of a small mol. and its assocd. receptor that captures the effects of the ligand displacing the solvent from the protein active site with at. detail.  This descriptor quant. predicts (R2 = 0.81) the binding free energy differences between congeneric ligand pairs for the test system factor Xa, elucidates phys. properties of the active site solvent that appear to be missing in most continuum theories of hydration, and identifies several features of the hydration of the factor Xa active site relevant to the structure-activity relationship of its inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS42r59nNXH7Vg90H21EOLACvtfcHk0lgA5n9dil1p7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhvFWgurk%253D&md5=8eefe76547a82bccaea38f2c84e6cd5f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fja0771033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0771033%26sid%3Dliteratum%253Aachs%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DRole%2520of%2520the%2520active-site%2520solvent%2520in%2520the%2520thermodynamics%2520of%2520factor%2520Xa%2520ligand%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D2817%26epage%3D2831%26doi%3D10.1021%2Fja0771033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Young, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span> </span><span class="NLM_article-title">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">808</span><span class="NLM_x">–</span> <span class="NLM_lpage">813</span><span class="refDoi"> DOI: 10.1073/pnas.0610202104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1073%2Fpnas.0610202104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=17204562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=808-813&author=T.+Youngauthor=R.+Abelauthor=B.+Kimauthor=B.+J.+Berneauthor=R.+A.+Friesner&title=Motifs+for+molecular+recognition+exploiting+hydrophobic+enclosure+in+protein-ligand+binding&doi=10.1073%2Fpnas.0610202104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding</span></div><div class="casAuthors">Young, Tom; Abel, Robert; Kim, Byungchan; Berne, Bruce J.; Friesner, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The thermodn. properties and phase behavior of water in confined regions can vary significantly from that obsd. in the bulk.  This is particularly true for systems in which the confinement is on the mol.-length scale.  In this study, we use mol. dynamics simulations and a powerful solvent anal. technique based on inhomogeneous solvation theory to investigate the properties of water mols. that solvate the confined regions of protein active sites.  Our simulations and anal. indicate that the solvation of protein active sites that are characterized by hydrophobic enclosure and correlated hydrogen bonds induce atypical entropic and enthalpic penalties of hydration.  These penalties apparently stabilize the protein-ligand complex with respect to the independently solvated ligand and protein, which leads to enhanced binding affinities.  Our anal. elucidates several challenging cases, including the super affinity of the streptavidin-biotin system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWumQ61YTqILVg90H21EOLACvtfcHk0lgA5n9dil1p7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVegtr4%253D&md5=1109e3f48670cd910885f7fd527eb880</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0610202104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0610202104%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DT.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DB.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26atitle%3DMotifs%2520for%2520molecular%2520recognition%2520exploiting%2520hydrophobic%2520enclosure%2520in%2520protein-ligand%2520binding%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D808%26epage%3D813%26doi%3D10.1073%2Fpnas.0610202104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span> </span><span class="NLM_article-title">Structure-brain exposure relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7559</span><span class="NLM_x">–</span> <span class="NLM_lpage">7583</span><span class="refDoi"> DOI: 10.1021/jm060642i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060642i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7559-7583&author=S.+A.+Hitchcockauthor=L.+D.+Pennington&title=Structure-brain+exposure+relationships&doi=10.1021%2Fjm060642i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-brain exposure relationships</span></div><div class="casAuthors">Hitchcock, Stephen A.; Pennington, Lewis D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">7559-7583</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the use of structure modification to influence blood-brain barrier penetration by modulating either passive diffusion or active transport.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3V-TERRGy07Vg90H21EOLACvtfcHk0ljFYakztFih0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yrtrnK&md5=97dff583ffae6d0ef66512ffbee38c34</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm060642i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060642i%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26atitle%3DStructure-brain%2520exposure%2520relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7559%26epage%3D7583%26doi%3D10.1021%2Fjm060642i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Rowan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klyubin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anwyl, R.</span><span> </span><span class="NLM_article-title">Synaptic plasticity in animal models of early Alzheimer’s disease</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span><span class="refDoi"> DOI: 10.1098/rstb.2002.1240</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1098%2Frstb.2002.1240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=12740129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlSrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2003&pages=821-828&author=M.+J.+Rowanauthor=I.+Klyubinauthor=W.+K.+Cullenauthor=R.+Anwyl&title=Synaptic+plasticity+in+animal+models+of+early+Alzheimer%E2%80%99s+disease&doi=10.1098%2Frstb.2002.1240"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synaptic plasticity in animal models of early Alzheimer's disease</span></div><div class="casAuthors">Rowan, Michael J.; Klyubin, Igor; Cullen, William K.; Anwyl, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1432</span>),
    <span class="NLM_cas:pages">821-828</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  Amyloid β-protein (Aβ) is believed to be a primary cause of Alzheimer's disease (AD).  Recent research has examd. the potential importance of sol. species of Aβ in synaptic dysfunction, long before fibrillary Aβ is deposited and neurodegenerative changes occur.  Hippocampal excitatory synaptic transmission and plasticity are disrupted in transgenic mice overexpressing human amyloid precursor protein with early onset familial AD mutations, and in rats after exogenous application of synthetic Aβ both in vitro and in vivo.  Recently, naturally produced sol. Aβ was shown to block the persistence of long-term potentiation (LTP) in the intact hippocampus.  Sub-nanomolar concns. of oligomeric Aβ were sufficient to inhibit late LTP, pointing to a possible reason for the sensitivity of hippocampus-dependent memory to impairment in the early preclin. stages of AD.  Having identified the active species of Aβ that can play havoc with synaptic plasticity, it is hoped that new ways of targeting early AD can be developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkl4rsjYmPzbVg90H21EOLACvtfcHk0ljFYakztFih0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlSrurg%253D&md5=930c93d4f02254e38482ec26140905e4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1098%2Frstb.2002.1240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2002.1240%26sid%3Dliteratum%253Aachs%26aulast%3DRowan%26aufirst%3DM.%2BJ.%26aulast%3DKlyubin%26aufirst%3DI.%26aulast%3DCullen%26aufirst%3DW.%2BK.%26aulast%3DAnwyl%26aufirst%3DR.%26atitle%3DSynaptic%2520plasticity%2520in%2520animal%2520models%2520of%2520early%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2003%26volume%3D358%26spage%3D821%26epage%3D828%26doi%3D10.1098%2Frstb.2002.1240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battaglia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">–</span> <span class="NLM_lpage">814</span><span class="refDoi"> DOI: 10.1002/ana.20101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1002%2Fana.20101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=15174014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=801-814&author=F.+Trincheseauthor=S.+Liuauthor=F.+Battagliaauthor=S.+Walterauthor=P.+M.+Mathewsauthor=O.+Arancio&title=Progressive+age-related+development+of+Alzheimer-like+pathology+in+APP%2FPS1+mice&doi=10.1002%2Fana.20101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice</span></div><div class="casAuthors">Trinchese, Fabrizio; Liu, Shumin; Battaglia, Fortunato; Walter, Sean; Mathews, Paul M.; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">801-814</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Increasing evidence points to synaptic plasticity impairment as one of the first events in Alzheimer's disease (AD).  However, studies on synaptic dysfunction in different transgenic AD models that overexpress familial AD mutant forms of amyloid precursor protein (APP) and/or presenilin (PS) have provided conflicting results.  Both long-term potentiation (LTP) and basal synaptic transmission (BST) have been found to be both unchanged and altered in different models and under differing exptl. conditions.  Because of their more robust amyloid-β (Aβ) deposition, double transgenic mice currently are used by several labs. as an AD model.  Here, we report that mice overexpressing APP (K670N: M671L) together with PS1 (M146L) have abnormal LTP as early as 3 mo of age.  Interestingly, reduced LTP paralleled plaque appearance and increased Aβ levels and abnormal short-term memory (working memory).  BST and long-term memory (ref. memory) are impaired only later (approx. 6 mo) as amyloid burden increases.  Aβ pathol. across different ages did not correlate with synaptic and cognitive deficits, suggesting that Aβ levels are not a marker of memory decline.  In contrast, progression of LTP impairment correlated with the deterioration of working memory, suggesting that percentage of potentiation might be an indicator of the cognitive decline and disease progression in the APP/PS1 mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-0Sep8mnVgLVg90H21EOLACvtfcHk0ljFYakztFih0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVCktbc%253D&md5=87f7a6dea17b0d35a775712088213641</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fana.20101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20101%26sid%3Dliteratum%253Aachs%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBattaglia%26aufirst%3DF.%26aulast%3DWalter%26aufirst%3DS.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DProgressive%2520age-related%2520development%2520of%2520Alzheimer-like%2520pathology%2520in%2520APP%252FPS1%2520mice%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D801%26epage%3D814%26doi%3D10.1002%2Fana.20101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mensch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyarzabal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustijns, P.</span><span> </span><span class="NLM_article-title">In vivo, in vitro and in silico methods for small molecule transfer across the BBB</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">4429</span><span class="NLM_x">–</span> <span class="NLM_lpage">4468</span><span class="refDoi"> DOI: 10.1002/jps.21745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1002%2Fjps.21745" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2009&pages=4429-4468&author=J.+Menschauthor=J.+Oyarzabalauthor=C.+Mackieauthor=P.+Augustijns&title=In+vivo%2C+in+vitro+and+in+silico+methods+for+small+molecule+transfer+across+the+BBB&doi=10.1002%2Fjps.21745"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjps.21745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21745%26sid%3Dliteratum%253Aachs%26aulast%3DMensch%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DMackie%26aufirst%3DC.%26aulast%3DAugustijns%26aufirst%3DP.%26atitle%3DIn%2520vivo%252C%2520in%2520vitro%2520and%2520in%2520silico%2520methods%2520for%2520small%2520molecule%2520transfer%2520across%2520the%2520BBB%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2009%26volume%3D98%26spage%3D4429%26epage%3D4468%26doi%3D10.1002%2Fjps.21745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Gong, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitolo, O. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trinchese, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelanski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arancio, O.</span><span> </span><span class="NLM_article-title">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">1624</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span><span class="refDoi"> DOI: 10.1172/JCI22831</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1172%2FJCI22831" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=15578094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2004&pages=1624-1634&author=B.+Gongauthor=O.+V.+Vitoloauthor=F.+Trincheseauthor=S.+Liuauthor=M.+Shelanskiauthor=O.+Arancio&title=Persistent+improvement+in+synaptic+and+cognitive+functions+in+an+Alzheimer+mouse+model+after+rolipram+treatment&doi=10.1172%2FJCI22831"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment</span></div><div class="casAuthors">Gong, Bing; Vitolo, Ottavio V.; Trinchese, Fabrizio; Liu, Shumin; Shelanski, Michael; Arancio, Ottavio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1624-1634</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Evidence suggests that Alzheimer disease (AD) begins as a disorder of synaptic function, caused in part by increased levels of amyloid β-peptide 1-42 (Aβ42).  Both synaptic and cognitive deficits are reproduced in mice double transgenic for amyloid precursor protein (AA substitution K670N,M671L) and presenilin-1 (AA substitution M146V).  Here the authors demonstrate that brief treatment with the phosphodiesterase 4 inhibitor rolipram ameliorates deficits in both long-term potentiation (LTP) and contextual learning in the double-transgenic mice.  Most importantly, this beneficial effect can be extended beyond the duration of the administration.  One course of long-term systemic treatment with rolipram improves LTP and basal synaptic transmission as well as working, ref., and associative memory deficits for at least 2 mo after the end of the treatment.  This protective effect is possibly due to stabilization of synaptic circuitry via alterations in gene expression by activation of the cAMP-dependent protein kinase (PKA)/cAMP regulatory element-binding protein (CREB) signaling pathway that make the synapses more resistant to the insult inflicted by Aβ.  Thus, agents that enhance the cAMP/PKA/CREB pathway have potential for the treatment of AD and other diseases assocd. with elevated Aβ42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoI79h3DC1rU7Vg90H21EOLACvtfcHk0lit_KfLJotCpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVKhur3I&md5=72e43d10754678b58a452160fe7142e2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1172%2FJCI22831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI22831%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DVitolo%26aufirst%3DO.%2BV.%26aulast%3DTrinchese%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DShelanski%26aufirst%3DM.%26aulast%3DArancio%26aufirst%3DO.%26atitle%3DPersistent%2520improvement%2520in%2520synaptic%2520and%2520cognitive%2520functions%2520in%2520an%2520Alzheimer%2520mouse%2520model%2520after%2520rolipram%2520treatment%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2004%26volume%3D114%26spage%3D1624%26epage%3D1634%26doi%3D10.1172%2FJCI22831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Hughes, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maddux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph Rogier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jon Jacobsen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rumsey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macinnes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bond, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.</span><span> </span><span class="NLM_article-title">Investigation of the pyrazinones as PDE5 inhibitors: evaluation of regioisomeric projections into the solvent region</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">6348</span><span class="NLM_x">–</span> <span class="NLM_lpage">6352</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.08.106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1016%2Fj.bmcl.2011.08.106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6348-6352&author=R.+O.+Hughesauthor=T.+Madduxauthor=D.+Joseph+Rogierauthor=S.+Luauthor=J.+K.+Walkerauthor=E.+Jon+Jacobsenauthor=J.+M.+Rumseyauthor=Y.+Zhengauthor=A.+Macinnesauthor=B.+R.+Bondauthor=S.+Han&title=Investigation+of+the+pyrazinones+as+PDE5+inhibitors%3A+evaluation+of+regioisomeric+projections+into+the+solvent+region&doi=10.1016%2Fj.bmcl.2011.08.106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.08.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.08.106%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DR.%2BO.%26aulast%3DMaddux%26aufirst%3DT.%26aulast%3DJoseph%2BRogier%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DS.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%26aulast%3DJon%2BJacobsen%26aufirst%3DE.%26aulast%3DRumsey%26aufirst%3DJ.%2BM.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMacinnes%26aufirst%3DA.%26aulast%3DBond%26aufirst%3DB.%2BR.%26aulast%3DHan%26aufirst%3DS.%26atitle%3DInvestigation%2520of%2520the%2520pyrazinones%2520as%2520PDE5%2520inhibitors%253A%2520evaluation%2520of%2520regioisomeric%2520projections%2520into%2520the%2520solvent%2520region%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6348%26epage%3D6352%26doi%3D10.1016%2Fj.bmcl.2011.08.106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sastry, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adzhigirey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annabhimoju, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, W.</span><span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">234</span><span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-234&author=G.+M.+Sastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Sastry G Madhavi; Adzhigirey Matvey; Day Tyler; Annabhimoju Ramakrishna; Sherman Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of computer-aided molecular design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-34</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepared prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove atomic clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addition, ligands must be prepared to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system preparation is generally accepted in the field, an extensive study of the preparation steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in preparing a system for virtual screening.  We first explore a large number of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper preparation and that neglecting certain steps of the preparation process produces a systematic degradation in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the preparation that impact database enrichment.  While the work presented here was performed with the Protein Preparation Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQd2Qiai-OqeXqj_yg7twvpfW6udTcc2eZROWcz7W3Dfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3srksFekug%253D%253D&md5=9eb1a820e121aca2742ed53f24481ace</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D234%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frye, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1750</span><span class="NLM_x">–</span> <span class="NLM_lpage">1759</span><span class="refDoi"> DOI: 10.1021/jm030644s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030644s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1750-1759&author=T.+A.+Halgrenauthor=R.+B.+Murphyauthor=R.+A.+Friesnerauthor=H.+S.+Beardauthor=L.+L.+Fryeauthor=W.+T.+Pollardauthor=J.+L.+Banks&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+2.+Enrichment+factors+in+database+screening&doi=10.1021%2Fjm030644s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening</span></div><div class="casAuthors">Halgren, Thomas A.; Murphy, Robert B.; Friesner, Richard A.; Beard, Hege S.; Frye, Leah L.; Pollard, W. Thomas; Banks, Jay L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1750-1759</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Glide's ability to identify active compds. in a database screen is characterized by applying Glide to a diverse set of nine protein receptors.  In many cases, two, or even three, protein sites are employed to probe the sensitivity of the results to the site geometry.  To make the database screens as realistic as possible, the screens use sets of "druglike" decoy ligands that have been selected to be representative of what we believe is likely to be found in the compd. collection of a pharmaceutical or biotechnol. company.  Results are presented for releases 1.8, 2.0, and 2.5 of Glide.  The comparisons show that av. measures for both "early" and "global" enrichment for Glide 2.5 are 3 times higher than for Glide 1.8 and more than 2 times higher than for Glide 2.0 because of better results for the least well-handled screens.  This improvement in enrichment stems largely from the better balance of the more widely parametrized GlideScore 2.5 function and the inclusion of terms that penalize ligand-protein interactions that violate established principles of phys. chem., particularly as it concerns the exposure to solvent of charged protein and ligand groups.  Comparisons to results for the thymidine kinase and estrogen receptors published by Rognan and co-workers (J. Med. Chem. 2000, 43, 4759-4767) show that Glide 2.5 performs better than GOLD 1.1, FlexX 1.8, or DOCK 4.01.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT2ptubbKbvLVg90H21EOLACvtfcHk0lhjGQeyvQN92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit78%253D&md5=33d68dd968e65626b449df61e44e37be</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm030644s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030644s%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DPollard%26aufirst%3DW.%2BT.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25202.%2520Enrichment%2520factors%2520in%2520database%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1750%26epage%3D1759%26doi%3D10.1021%2Fjm030644s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klicic, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoll, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenkin, P. S.</span><span> </span><span class="NLM_article-title">Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1739</span><span class="NLM_x">–</span> <span class="NLM_lpage">1749</span><span class="refDoi"> DOI: 10.1021/jm0306430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0306430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1739-1749&author=R.+A.+Friesnerauthor=J.+L.+Banksauthor=R.+B.+Murphyauthor=T.+A.+Halgrenauthor=J.+J.+Klicicauthor=D.+T.+Mainzauthor=M.+P.+Repaskyauthor=E.+H.+Knollauthor=M.+Shelleyauthor=J.+K.+Perryauthor=D.+E.+Shawauthor=P.+Francisauthor=P.+S.+Shenkin&title=Glide%3A+a+new+approach+for+rapid%2C+accurate+docking+and+scoring.+1.+Method+and+assessment+of+docking+accuracy&doi=10.1021%2Fjm0306430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Glide: A new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy</span></div><div class="casAuthors">Friesner, Richard A.; Banks, Jay L.; Murphy, Robert B.; Halgren, Thomas A.; Klicic, Jasna J.; Mainz, Daniel T.; Repasky, Matthew P.; Knoll, Eric H.; Shelley, Mee; Perry, Jason K.; Shaw, David E.; Francis, Perry; Shenkin, Peter S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1739-1749</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor, Glide approximates a complete systematic search of the conformational, orientational, and positional space of the docked ligand.  In this search, an initial rough positioning and scoring phase that dramatically narrows the search space is followed by torsionally flexible energy optimization on an OPLS-AA nonbonded potential grid for a few hundred surviving candidate poses.  The very best candidates are further refined via a Monte Carlo sampling of pose conformation; in some cases, this is crucial to obtaining an accurate docked pose.  Selection of the best docked pose uses a model energy function that combines empirical and force-field-based terms.  Docking accuracy is assessed by redocking ligands from 282 cocrystd. PDB complexes starting from conformationally optimized ligand geometries that bear no memory of the correctly docked pose.  Errors in geometry for the top-ranked pose are less than 1 Å in nearly half of the cases and are greater than 2 Å in only about one-third of them.  Comparisons to published data on rms deviations show that Glide is nearly twice as accurate as GOLD and more than twice as accurate as FlexX for ligands having up to 20 rotatable bonds.  Glide is also found to be more accurate than the recently described Surflex method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPuigu31qMMLVg90H21EOLACvtfcHk0lhjGQeyvQN92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit74%253D&md5=8cc2f0022318b12dd972e9c493375bf9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm0306430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306430%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DKlicic%26aufirst%3DJ.%2BJ.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DKnoll%26aufirst%3DE.%2BH.%26aulast%3DShelley%26aufirst%3DM.%26aulast%3DPerry%26aufirst%3DJ.%2BK.%26aulast%3DShaw%26aufirst%3DD.%2BE.%26aulast%3DFrancis%26aufirst%3DP.%26aulast%3DShenkin%26aufirst%3DP.%2BS.%26atitle%3DGlide%253A%2520a%2520new%2520approach%2520for%2520rapid%252C%2520accurate%2520docking%2520and%2520scoring.%25201.%2520Method%2520and%2520assessment%2520of%2520docking%2520accuracy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1739%26epage%3D1749%26doi%3D10.1021%2Fjm0306430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lazaridis, T.</span><span> </span><span class="NLM_article-title">Inhomogeneous fluid approach to solvation thermodynamics. 1. Theory</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3531</span><span class="NLM_x">–</span> <span class="NLM_lpage">3541</span><span class="refDoi"> DOI: 10.1021/jp9723574</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp9723574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1cXivVOltr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3531-3541&author=T.+Lazaridis&title=Inhomogeneous+fluid+approach+to+solvation+thermodynamics.+1.+Theory&doi=10.1021%2Fjp9723574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Inhomogeneous Fluid Approach to Solvation Thermodynamics. 1. Theory</span></div><div class="casAuthors">Lazaridis, Themis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3531-3541</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The solvation energy and entropy at infinite diln. consist of a solute-solvent term and a solvent reorganization term representing the contributions of changes in solvent structure upon solute insertion.  In the std., homogeneous treatment of solns., changes in solvent structure are expressed through derivs. of the homogeneous pair correlation function, which are very difficult to obtain by simulation.  Tractable expressions for the solvation energy and entropy are here derived by viewing the soln. as an inhomogeneous system with the solute fixed at a certain point.  The solvent reorganization terms in the inhomogeneous view contain two contributions: the local, "correlation" contributions, which are due to correlations between the solute and the solvent and dominate at high densities, and the nonlocal, "liberation" contributions, which are due to the effective diln. of the solvent caused by the thermal motion of the solute and dominate at low densities.  The liberation contributions are independent of the nature or size of the solute and depend only on the properties of the solvent.  For common liq. solvents the nonlocal terms are negligible and the solvation properties arise almost entirely from effects localized around the solute.  The new expressions are tested by calcns. of the solvent reorganization energy and entropy in ideal hard-sphere and Lennard-Jones mixts. (solute identical to solvent).  The solvent reorganization energy and entropy make distinct and significant contributions to the solvation free energy.  The theory can be applied to truly inhomogeneous systems as well as small solute solvation, thus providing a connection between interfacial phenomena and microscopic solvation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxEN_nWI8WfbVg90H21EOLACvtfcHk0lhjGQeyvQN92g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVOltr8%253D&md5=99755c87ffc33abd5e7df89c9996a665</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjp9723574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp9723574%26sid%3Dliteratum%253Aachs%26aulast%3DLazaridis%26aufirst%3DT.%26atitle%3DInhomogeneous%2520fluid%2520approach%2520to%2520solvation%2520thermodynamics.%25201.%2520Theory%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D1998%26volume%3D102%26spage%3D3531%26epage%3D3541%26doi%3D10.1021%2Fjp9723574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Lazaridis, T.</span><span> </span><span class="NLM_article-title">Inhomogeneous fluid approach to solvation thermodynamics. 2. Applications to simple fluids</span> <span class="citation_source-journal">J. Phys. Chem. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3542</span><span class="NLM_x">–</span> <span class="NLM_lpage">3550</span><span class="refDoi"> DOI: 10.1021/jp972358w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jp972358w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=1%3ACAS%3A528%3ADyaK1cXivVOltrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3542-3550&author=T.+Lazaridis&title=Inhomogeneous+fluid+approach+to+solvation+thermodynamics.+2.+Applications+to+simple+fluids&doi=10.1021%2Fjp972358w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhomogeneous Fluid Approach to Solvation Thermodynamics. 2. Applications to Simple Fluids</span></div><div class="casAuthors">Lazaridis, Themis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry B</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3542-3550</span>CODEN:
                <span class="NLM_cas:coden">JPCBFK</span>;
        ISSN:<span class="NLM_cas:issn">1089-5647</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the previous paper expressions for the partial molar energy and entropy at infinite diln. have been derived based on the inhomogeneous forms of the energy equation and the correlation expansion for the entropy.  These expressions are here applied to a series of solutes of varying size in dense hard-sphere and Lennard-Jones solvents, some of which serve as ref. systems for comparison with water.  Numerical results are obtained under the assumption that the inhomogeneous solvent-solvent pair correlation function in the mixt. is equal to the bulk solvent radial distribution function (Kirkwood superposition approxn.).  The correlation functions required are obtained by both integral equation theory (Percus-Yevick approxn.) and Monte Carlo simulations.  The thermodn. results are compared with equation of state, integral equation, and free energy simulation results for the same systems.  For hard-sphere systems the excess entropies are in good agreement with equation-of-state results but in many Lennard-Jones systems the calcd. partial molar energies and entropies are lower than the expected values.  This is attributable to overestimation of the structure of the bulk triplet correlation function by the superposition approxn.  The decompn. of the chem. potential shows that similar solvation free energies can have entirely different phys. origins.  Specifically, in solvents of high cohesive energy d. the chem. potential is dominated by the breakup of solvent-solvent interactions locally around the solute.  In solvents of low cohesive energy d. it is dominated by the pressure-vol. term.  Increase in solvent-solvent interaction strength leads to increase in the chem. potential of the solute due to the higher solvent reorganization energy, which is insufficiently compensated by an increase in solvent reorganization entropy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwkuoqtHxPLVg90H21EOLACvtfcHk0liTD7jRS7bZ6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXivVOltrw%253D&md5=63ce8d44f2f6c8d50f81303dba75924f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjp972358w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp972358w%26sid%3Dliteratum%253Aachs%26aulast%3DLazaridis%26aufirst%3DT.%26atitle%3DInhomogeneous%2520fluid%2520approach%2520to%2520solvation%2520thermodynamics.%25202.%2520Applications%2520to%2520simple%2520fluids%26jtitle%3DJ.%2520Phys.%2520Chem.%2520B%26date%3D1998%26volume%3D102%26spage%3D3542%26epage%3D3550%26doi%3D10.1021%2Fjp972358w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Alamed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilcock, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, D.</span><span> </span><span class="NLM_article-title">Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">1671</span><span class="NLM_x">–</span> <span class="NLM_lpage">1679</span><span class="refDoi"> DOI: 10.1038/nprot.2006.275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;key=10.1038%2Fnprot.2006.275" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=1671-1679&author=J.+Alamedauthor=D.+M.+Wilcockauthor=D.+M.+Diamondauthor=M.+N.+Gordonauthor=D.+Morgan&title=Two-day+radial-arm+water+maze+learning+and+memory+task%3B+robust+resolution+of+amyloid-related+memory+deficits+in+transgenic+mice&doi=10.1038%2Fnprot.2006.275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2006.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2006.275%26sid%3Dliteratum%253Aachs%26aulast%3DAlamed%26aufirst%3DJ.%26aulast%3DWilcock%26aufirst%3DD.%2BM.%26aulast%3DDiamond%26aufirst%3DD.%2BM.%26aulast%3DGordon%26aufirst%3DM.%2BN.%26aulast%3DMorgan%26aufirst%3DD.%26atitle%3DTwo-day%2520radial-arm%2520water%2520maze%2520learning%2520and%2520memory%2520task%253B%2520robust%2520resolution%2520of%2520amyloid-related%2520memory%2520deficits%2520in%2520transgenic%2520mice%26jtitle%3DNat.%2520Protoc.%26date%3D2006%26volume%3D1%26spage%3D1671%26epage%3D1679%26doi%3D10.1038%2Fnprot.2006.275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OEW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OEW','PDB','4OEW'); return false;">PDB: 4OEW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OEX" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4OEX','PDB','4OEX'); return false;">PDB: 4OEX</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i98"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00979">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51812"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00979">10.1021/acs.jmedchem.7b00979</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H NMR and 1D NOESY spectra of compound <b>5c</b> and <b>6c</b>, PDE5 cGMP pocket in available crystal structures, compounds <b>6c</b> and <b>24a</b> superposed in their two docking poses, interaction diagrams for compound <b>24a</b> docking poses, predicted binding free energies for compounds in the naphthydrine and 1<i>H</i>-pyrroloquinolinone series, cued learning test, and visible platform and speed tests for compound <b>6c</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf">PDF</a>)</p></li><li><p class="inline">SMILES strings and IC<sub>50</sub> data for compounds <b>6a</b>–<b>g</b>, <b>14</b>, <b>17a</b>–<b>d</b>, and <b>24a</b>–<b>f</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_001.pdf">jm7b00979_si_001.pdf (7.68 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00979/suppl_file/jm7b00979_si_002.csv">jm7b00979_si_002.csv (2.82 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00979&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-21%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00979%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00979" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991145483c3dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
